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FUNCTIONS OF DCP2 AND SKI7 IN MRNA DEGRADATION

Minseon Kim, M.S.

Advisory Professor: Ambro van Hoof, Ph.D.

Posttranscriptional gene regulation is essential to maintain gene expression
fidelity. This is partially achieved by mRNA decay. When no longer required, mRNA is
degraded by two alternative pathways. The decapping enzyme Dcp2 removes the 5` m7G
cap of mRNAs, allowing Xrn1 to degrade the mRNA from the 5` end. Alternatively,
mRNA is degraded from the 3` end by the RNA exosome.
While decapping by Dcp2 is a critical step in mRNA decay, its physiological
function has been unclear. Null mutations of Saccharomyces cerevisiae DCP2 have
been reported to be lethal in some studies but slow-growing in others. In this study, I
show that Dcp2 is required for continuous growth under standard laboratory conditions. I
found multiple suppressors of the growth defect of a DCP2 null mutant via experimental
evolution and genome sequencing. These suppressors act by at least three independent
mechanisms. They do not rescue defects in mRNA decay. Instead, they appear to
partially alleviate global disturbance of the transcriptome in the dcp2 mutant, which
confers growth improvement. One of the suppressors appears to suppress by affecting
translation of CUY codons.
mRNAs that are generated by mistakes need to be degraded. Nonstop mRNAs
are transcripts that lack an in-frame stop codon. Thus, the ribosome translating the
nonstop mRNA reads through downstream of the coding region and produces aberrant
nonstop proteins that are potentially toxic to cells. Cells exploit surveillance mechanisms
to suppress the expression of nonstop mRNAs. The RNA exosome and its cofactors, the
Ski complex and Ski7, are required for degradation of nonstop mRNAs. While Ski7 is
v

known to have nonstop decay specific function, its exact role in nonstop decay remains
unknown. Moreover, whether Ski7-mediated nonstop mRNA decay is mechanistically
linked to the surveillance pathway for nonstop protein has been unclear. In this study, I
determine the genetic interactions between components of the two surveillance
pathways and show that the Ski7-mediated nonstop mRNA decay mechanism functions
independently of nonstop protein degradation mechanism.
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Chapter 1. Introduction, background, and significance
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1.1. INTRODUCTION AND BACKGROUND
1.1.1. General mechanisms of cytoplasmic mRNA turnover in eukaryotes
Regulation of gene expression is a fundamental biological process present in
every organism, which ensures the normal physiology of the organism. Gene expression
is tightly regulated by different types of cellular machinery at the transcriptional and posttranscriptional levels. At the post-transcriptional level, cells exploit different mechanisms
to monitor and control the expression level, cellular localization, and quality of RNAs.
Among different types of RNA regulation, I will discuss how the turnover of normal
cytoplasmic messenger RNAs (mRNAs) is mediated as well as how aberrant mRNAs
are degraded.
During gene expression, mRNA is used as a template for protein production (F.
H. Crick, 1958). Once mRNA becomes no longer required, it has to be degraded to
maintain RNA homeostasis. Dysregulation of RNA homeostasis impairs proteostasis and
leads to the pathological state (Ramaswami et al., 2013). In eukaryotes, two general
mRNA decay pathways that involve multiple ribonucleases mediate turnover of
cytoplasmic mRNA (Figure 1.1).
In eukaryotes, mature mRNA is modified with a 7-methyl-guanosine (m7G) cap at
the 5`- end and a polyadenosine tail (poly(A) tail) at the 3` end during transcription.
These two modifications are not only required for proper translation of the mRNA but
also protect it from degradation (Gallie, 1991). Degradation of normal mRNAs in the
cytoplasm begins with the removal of poly(A) tail (Decker and Parker, 1993) (Figure 1.1).
In eukaryotes, there are several deadenylases that shorten the poly(A) tail, including the
Pan2-Pan3 complex, the Ccr4-Not complex, and the vertebrate-specific deadenylase
enzyme PARN (Brown and Sachs, 1998; Chen et al., 2002; Dehlin et al., 2000; Draper
et al., 1995; Körner and Wahle, 1997; Körner et al., 1998; Temme et al., 2004; Tucker et
al., 2001, 2002; Uchida et al., 2004). There is only one deadenylase, Pan2, in the Pan22

Figure 1. 1. Cytoplasmic mRNA decay pathways in eukaryotes.
Eukaryotic cytoplasmic mRNA turnover is initiated by the removal of the poly(A) tail at
the 3`-end. Deadenylated mRNAs are further degraded by Xrn1-mediated 5` to 3`
decay and RNA exosome-mediated 3` to 5` decay. For the 5` to 3` decay, the Dcp1Dcp2 decapping complex hydrolyzes m7G cap, and Xrn1 exoribonuclease further
degrades the remaining RNA. The 3` to 5` decay is mediated by the RNA exosome
complex with the help of the Ski complex and DcpS scavenger enzyme.
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Pan3 complex, whereas there are two deadenylases, Ccr4 and Caf1, in the Ccr4-Not
complex where Ccr4 is the major catalytic subunit functioning in vivo deadenylation.
(Boeck et al., 1996; Brown et al., 1996; Viswanathan et al., 2004). It has been shown
that the Pan2-Pan3 complex initially degrades the poly(A) tail and the Ccr4-Not complex
degrades the rest of it (Tucker et al., 2001; Yamashita et al., 2005). Once the poly(A) tail
is removed, deadenylated RNA is degraded by two different pathways, 5`-to-3` decay or
3`-to-5` decay (Figure 1.1).
The 5`-to-3` decay of deadenylated RNA is initiated with the removal of the 5`
m7

G cap structure by the decapping enzyme complex, Dcp1-Dcp2. The Nudix family

enzyme Dcp2 is the catalytic subunit in the complex, but the Dcp1 subunit is also
required for decapping (van Dijk et al., 2002; Dunckley and Parker, 1999). Once the m7G
cap is removed, the 5` end of RNA now has monophosphate and can be degraded by
Xrn1 in a processive manner (Jinek et al., 2011; Larimer et al., 1992; Muhlrad et al.,
1994; Stevens and Poole, 1995). Xrn1 interacts with the decapping complex either by
directly binding to Dcp1 or by binding to cofactors of the decapping complex such as
Pat1 or Edc4. These interactions couple mRNA decapping and exonucleolytic decay in
the 5`-to-3` pathway (Braun et al., 2012; Chang et al., 2014, 2019; Charenton et al.,
2017).
Deadenylated RNA is also degraded in the 3`-to-5` direction. An exoribonuclease
complex, the RNA exosome, processively degrades RNA in the 3`-to-5` direction with
the help of its cytoplasmic cofactor, the Ski complex (Dziembowski et al., 2007; Liu et al.,
2006). The cytoplasmic RNA exosome consists of a core complex and one catalytic
subunit that sits at the bottom of the core. The core complex comprises nine subunits
forming a barrel-like structure that provides a path for RNA substrate. In most
eukaryotes except plants, the core complex is catalytically inert requiring an additional
subunit with the catalytic activity (Kowalinski et al., 2016; Liu et al., 2006; Wasmuth and
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Lima, 2012). The RNA exosome core interacts with the catalytic subunit Rrp44 in
budding yeast. Mammals have three homologues of Rrp44, Dis3, Dis3L1, and Dis3L2.
(Staals et al., 2010; Tomecki et al., 2010). Dis3 functions in the nucleus, and Dis3L1 and
Dis3L2 are present in the cytoplasm. While Dis3L1 interacts with the cytoplasmic RNA
exosome core, Dis3L2 does not contain the PIN domain that confers the interaction with
the core. The cytoplasmic RNA exosome interacts with highly conserved cofactors, the
Ski complex and Ski7, for mRNA decay. The DExH helicase Ski2 of the Ski complex
unwinds the substrate and feeds it to the RNA channel of the RNA exosome core, then
the substrate travels to the active site of Rrp44/Dis3L1 positioned at the bottom of the
complex. (Halbach et al., 2013). Ski7, another cytoplasmic cofactor, mediates the
interaction between the RNA exosome and Ski complex (Araki et al., 2001; Kowalinski et
al., 2016). The N-terminal domain of Ski7 that binds to the RNA exosome and Ski
complex is essential for cytoplasmic RNA exosome function. A Ski7-like protein is also
expressed in animals, and it has been shown that it interacts with the RNA exosome and
Ski complex (Kalisiak et al., 2017; Kowalinski et al., 2016; Marshall et al., 2018).
Recently, other factors have been identified as cytoplasmic RNA exosome interacting
partners. These include RST1 in plants, its homolog, FOCAD, in mammals and the
unrelated Ska1 in yeast (Lange et al., 2019; Tuck et al., 2020; Zhang et al., 2019). Each
of these have been shown to interact with the RNA exosome and/or Ski complex, but
their exact roles in 3`-to-5`decay remain to be determined. Finally, the last few
nucleotides that are left from RNA exosome-mediated decay are further degraded by the
scavenger decapping enzyme, DcpS (or Dcs1 in budding yeast) (Liu et al., 2002, 2004b;
Wang and Kiledjian, 2001).
The 5`-to-3` decay and 3`-to-5` decay pathways do not equally contribute to
overall cytoplasmic mRNA turnover. In budding yeast, 5`-to-3` decay is the major
pathway that degrades normal cytoplasmic mRNA, while the RNA exosome-mediated 3`
to 5` decay has a minor role in mRNA turnover (Anderson and Parker, 1998; Muhlrad et
5

al., 1994, 1995). Despite the conservation of mRNA decay factors throughout
eukaryotes, the contribution of each pathway to overall cytoplasmic mRNA turnover is
not always conserved in different eukaryotic organisms. Unlike in budding yeast as
explained above, it has been reported that in mammals, 3`-to-5` decay has a major role
in normal mRNA turnover, while 5`-to-3` decay has a minor impact (Wang and Kiledjian,
2001). However, a recent study showed that 5`-to-3` decay acts as a major pathway,
while 3`-to-5` decay has a more specialized role in mRNA surveillance (Tuck et al.,
2020).
In addition to the two general pathways for cytoplasmic mRNA turnover, another
pathway has recently been suggested for degradation of bulk mRNA. Ribothrypsis is the
mechanism in which the mRNA is endonucleolytically cleaved by an unknown
endonuclease for degradation when translation is paused or stalled on the mRNA
(Ibrahim et al., 2018). This pathway is proposed to exist in both mammals and budding
yeast. Mutations that block decapping stabilize many mRNAs, and mRNAs are further
stabilized if the cytoplasmic RNA exosome is also inactivated, suggesting that
ribothrypsis is a less important pathway.
Many key factors involved in the regulation of cytoplasmic mRNA turnover have
been initially discovered in budding yeast and most of these factors, including Dcp2,
Xrn1, the RNA exosome, and the Ski complex, are very-well conserved among
eukaryotes. The conservation of cytoplasmic mRNA decay factors during evolution
shows the functional importance of these pathways in cell physiology across eukaryotes
(Bergmiller et al., 2012; Cohen et al., 2016; Jordan et al., 2002; Siwaszek et al., 2014).

1.1.2. Additional mechanisms for cytoplasmic mRNA turnover that are less
conserved

6

In addition to the aforementioned canonical mRNA decay pathways, additional
pathways have been identified for mRNA turnover. These additional mRNA turnover
pathways are conserved to a lesser degree. Some of them are present in most
eukaryotic organisms, but clearly absent in some. Others may be used by very a limited
number of species.
First, cytoplasmic mRNA is degraded by another 3`-to-5` exoribonuclease,
Dis3L2 (Dis3-Like exoribonuclease 2) that is expressed in most eukaryotes including
fission yeast, plants, fly and mammals (Lubas et al., 2013; Malecki et al., 2013; Staals et
al., 2010; Tomecki et al., 2010). Although Dis3L2 is a homolog of Dis3, Dis3L2-mediated
mRNA decay is distinct from the RNA exosome-mediated 3`-to-5` decay. Unlike
Rrp44/Dis3L1, Dis3L2 lacks the PIN domain that is the binding site to the RNA exosome
core. Instead, Dis3L2 functions independently of the RNA exosome. It degrades mRNAs
and non-coding RNAs that are uridylated at the 3`-end by cytoplasmic terminal
uridylyltransferases (TUTases) (Figure 1.2) (De Almeida et al., 2018; łabno et al., 2016;
Lim et al., 2014; Reimão-Pinto et al., 2016; Rissland and Norbury, 2009; Ustianenko et
al., 2013). In budding yeast and many other fungi DIS3L2 (Ssd1 in budding yeast) has
lost its catalytic activity and instead acts as an mRNA binding protein (Ballou et al.,
2020; Bayne et al., 2020).
Next, degradation of cytoplasmic mRNA is also mediated by endonucleases
including Argonaute (Ago) in RNA interference (RNAi), Smg6 in nonsense-mediated
decay, Ire1 in regulated IRE1-dependent decay of mRNA (RIDD), and the tRNA splicing
endonuclease (TSEN) complex (Figure 1.3). The first endonuclease to discuss is the
Argonaute family. This family is also widespread in eukaryotes, present in fission yeast,
plants, fly and mammals and is the catalytic subunit of the RNA-induced silencing
complex (RISC) that mediates post-transcriptional gene silencing called RNAi (Gregory
et al., 2005; Liu et al., 2004a; Meister et al., 2004). RNAi induces translational repression

7

Figure 1. 2. Uridylation-dependent mRNA decay.
Uridylation of mRNAs with a short poly(A) tail is mediated by terminal uridylyl
transferases (TUTase). Uridylated mRNA is degraded by conventional mRNA decay
pathways (as in Figure 1.1) or 3`-to-5` exoribonuclease, Dis3L2.

8

Figure 1. 3. Endonucleolytic cleavage-mediated mRNA decay.
Upon endonucleolytic cleavage, cleavage fragments are degraded by Xrn1 and the
RNA exosome. As explained in text, endonucleases include Ago, Smg6, Ire1, and
TSEN complex.

9

or mRNA degradation through sequence-dependent target mRNA recognition (Fire et
al., 1998; Zamore et al., 2000). Argonaute proteins can trigger mRNA decay in two
distinct manners. They can recruit deadenylases and the decapping enzyme to specific
mRNAs to accelerate their decay through the 5`-to-3` pathway described above. In
addition, some argonaute family members (Ago2 in mammals or mainly Ago1 in plants)
are active endonucleases that cleave target mRNAs (Baumberger and Baulcombe,
2005; Liu et al., 2004a; Meister et al., 2004). Cleaved products are further degraded by
the RNA exosome and/or Xrn1 (Orban and Izaurralde, 2005; Rymarquis et al., 2011).
Smg6 is an endonuclease in metazoans, but it appears absent in other
eukaryotes. Smg6 is involved in an mRNA surveillance pathway for mRNA containing a
premature termination codon (PTC) (Eberle et al., 2009; Gatfield and Izaurralde, 2004;
Huntzinger et al., 2008; Pulak and Anderson, 1993). In addition to its role in the
degradation of nonsense mRNAs, Smg6 cleaves ‘normal’ mRNAs and targets them for
degradation. For example, a long 3’ untranslated region (UTR) leads to inefficient
association of termination factors with poly(A) binding protein (PABP) (Silva et al., 2008).
The ineffective translation termination caused by this long 3’ UTR results in the Smg6induced endonucleolytic cleavage. Cleaved products are further degraded by the 5`-to-3`
and 3`-to-5` decay pathways (Eberle et al., 2009; Gatfield and Izaurralde, 2004;
Huntzinger et al., 2008).
The third endonuclease that is involved in mRNA degradation is Ire1. Ire1 is an
ER membrane endonuclease expressed in most eukaryotes and activated upon proteinfolding stress at the ER (ER stress). Its best known target is the XBP1 mRNA (in
Metazoa; HAC1 in yeast), which gets cleaved in two specific locations and then ligated
together in an unusual splicing reaction (Hetz, 2012). In addition to this splicing reaction,
Ire1 in fission yeast and metazoan, but not in budding yeast, mediates regulated IRE1dependent decay of mRNA (RIDD), which is the endonucleolytic cleavage of some ER
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membrane-localized mRNAs to maintain ER homeostasis (Han et al., 2009; Hollien and
Weissman, 2006; Hollien et al., 2009; Kimmig et al., 2012; Niwa et al., 2005).
Endonuclease-mediated degradation of normal mRNA has been shown in
budding yeast as well. For example, the TSEN complex is an endonuclease complex
that functions in splicing of intron-containing tRNAs. In addition to its role in tRNA
processing that is conserved among eukaryotes, the TSEN complex has been
suggested to be involved in mRNA decay in budding yeast (Tsuboi et al., 2015). The
TSEN complex cleaves CBP1 mRNA, and cleaved fragments are degraded by Xrn1and the RNA exosome-mediated decay pathways. In contrast to the TSEN complex in
budding yeast that is present on the cytoplasmic surface of mitochondria, mammalian
TSEN is nuclear, suggesting that it is unlikely that the TSEN complex-mediated
cytoplasmic mRNA decay mechanism is conserved in mammals (Paushkin et al., 2004;
Yoshihisa et al., 2003, 2007).
Unlike general decay pathways explained in 1.1.1. that mediate global mRNA
turnover, some of these additional pathways are known to degrade specific substrates
and/or under certain conditions. However, these additional pathways could be
complementing defects in general mRNA decay pathways.

1.1.3. Specialized pathways degrade aberrant mRNAs in the cytoplasm
Despite the multiple layers of mechanisms ensuring the fidelity of gene
expression, errors in mRNA are inevitably generated by erroneous transcription and
processing (Gout et al., 2017; Lang and Murray, 2008; Shaw et al., 2002; Zhu et al.,
2014). Thus, in addition to regulating normal mRNA turnover, cells exploit quality control
mechanisms to eliminate faulty mRNA to maintain mRNA homeostasis.
There are many possible scenarios where aberrant mRNAs are generated in the
cell. For instance, aberrant mRNAs can be produced by transcription of mutant genes or
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by mistakes during mRNA transcription and processing. Although mRNA surveillance
pathways in the nucleus remove many faulty pre-mRNAs and prevent them from being
exported to the cytoplasm, some aberrant mRNAs are not recognized by nuclear mRNA
surveillance (Ogami et al., 2018; Singh et al., 2018). Thus, cells also have cytoplasmic
mRNA surveillance pathways that are responsible for the quality control of abnormal
mRNA in the cytoplasm.
There are different types of cytoplasmic mRNA surveillance pathways:
nonsense-mediated mRNA decay, no-go decay, and nonstop mRNA decay (Wagner
and Lykke-Andersen, 2002). Each of these surveillance pathways targets aberrant
mRNAs that cannot be successfully translated into functional proteins. Which pathway is
responsible for the decay of aberrant mRNAs is dependent on the nature of the
translation failure (Figure 1.4). (Belgrader et al., 1993; Doma and Parker, 2006;
Frischmeyer et al., 2002; Shoemaker and Green, 2012).

Nonsense-mediated mRNA decay
Nonsense codons or premature termination codons (PTC) in mRNAs are
introduced by genomic mutations or transcriptional errors. Translation of these aberrant
mRNAs is prematurely terminated at the PTC and produces truncated proteins. To
prevent deleterious consequences resulting from the accumulation of truncated proteins,
eukaryotes utilize the translation-dependent nonsense-mediated mRNA decay pathway
that removes mRNAs harboring PTC. Upf1 is conserved throughout eukaryotes and the
key factor involved in nonsense-mediated decay. Upf1 is an ATP-dependent helicase
that interacts with the eRF1-eRF3 translation termination complex at PTCs and
sometimes with the 3` UTR of the PTC harboring mRNA as well. Subsequently, Upf1 is
phosphorylated, and modified Upf1 recruits RNA decay machinery including the
endoribonuclease Smg6, the decapping enzyme Dcp2, or both for degradation of
12

Figure 1. 4. Aberrant mRNAs that are subject to surveillance pathways in
eukaryotes.
Schematics of normal mRNA (left) and aberrant mRNAs that are subject to mRNA
surveillance pathways (right). i) an mRNA that has premature stop codon within the
coding region is subject to nonsense-mediated decay, NMD. ii) an mRNA that triggers
no-go decay possesses RNA sequences that are slowing down the ribosome. These
include RNAs forming a strong secondary structure or encoding rare codons. iii) A
nonstop mRNA is generated due to the premature polyadenylation. Consequently, it
does not have an in-frame stop codon and is subject to nonstop mRNA decay.
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aberrant mRNAs (reviewed in (Kurosaki et al., 2019). Although Upf1 is conserved, there
is variation in the mechanism by which it distinguishes PTCs from normal stop codons,
and the degradation enzymes that it recruits.

No-go decay
mRNAs that possess sequences that interfere with translation elongation are
targeted for degradation through another surveillance pathway called no-go decay. Nogo decay targets include mRNAs with poorly translated codons (e.g., CGA for Arginine
and AAA for Lysine) (Arthur et al., 2015; Letzring et al., 2010) or strong secondary
structures (Doma and Parker, 2006). When ribosome pausing is prolonged, no-go decay
is triggered. No-go decay has been shown to involve endonucleolytic cleavage of
substrate RNA (Doma and Parker, 2006). Recent studies identified Cue2 in budding
yeast or NONU-1 in nematodes as an endonuclease that functions in no-go decay
(D’Orazio et al., 2019; Glover et al., 2020). These endonucleases cleave the region of
mRNA where stalled ribosomes collide and generate two cleavage products. These two
RNA cleavage products are then degraded by the RNA exosome-mediated 3` to 5`
decay and Xrn1-mediated 5` to 3` decay. Although Cue2-mediated endonucleolytic
cleavage followed by the degradation of the cleaved fragments is involved in no-go
decay, decapping- and Xrn1-mediated degradation of full-length no-go mRNA has a
greater impact on the degradation of no-go mRNA (D’Orazio et al., 2019). Furthermore,
Cue2 and NONU-1 deletion mutants do not completely repress no-go decay, suggesting
that additional endonucleases might be involved.
After endonucleolytic cleavage, the Hbs1-Dom34 complex in budding yeast or
Hbs1L-Pelota in mammals is recruited to the A site of ribosome. Dom34/Pelota in turn
recruits Ril1 in budding yeast or ABCE1 in mammals. Rli1/ABCE1 dissociates the
ribosome (Becker et al., 2011; Chen et al., 2010; Doma and Parker, 2006; Ikeuchi et al.,
14

2016; Pisareva et al., 2011; Shoemaker et al., 2010; Szádeczky-Kardoss et al., 2018).
This ribosome dissociation does not include peptidyl tRNA hydrolysis or nascent protein
release. Therefore, peptidyl-tRNA is still bound to the 60S ribosome subunit even after
stalled ribosome dissociation (Frolova et al., 1999). The aberrant nascent peptide is
targeted for degradation by a protein surveillance pathway called ribosome-associated
quality control (RQC), which will be discussed in-depth in chapter 5.

Nonstop mRNA decay
Nonstop mRNAs refer the mRNAs lacking an in-frame stop codon, and they can
be generated by mistakes in multiple ways. For example, if a mutation changes a stop
codon to a sense codon, the resulting mRNA could be missing stop codon. An example
of this is a nonstop mutation in the RPS19 gene, which causes depletion of RPS19 and
leads to Diamond-Blackfan anemia (Chatr-Aryamontri et al., 2004). Nonstop mRNAs are
also generated due to alternative polyadenylation during mRNA processing.
Endogenous alternative polyadenylation sites in yeast and human have been examined
in multiple studies (Guydosh and Green, 2017; Ozsolak et al., 2010; Pelechano et al.,
2013). When an alternative polyadenylation signal in the coding region is used during
the processing of the 3` end of pre-mRNA, this mRNA lacks any in-frame stop codon.
For example, the CBP1 gene produces two different transcripts, full-length and short
transcripts, through alternative polyadenylation, and the truncated transcript is subject to
nonstop decay (Frischmeyer et al., 2002; Mayer and Dieckmann, 1989; Sparks and
Dieckmann, 1998).
As briefly mentioned earlier, mRNA surveillance pathways are tightly associated
with translation of aberrant mRNAs. Ribosomes translate the poly(A) tail of the nonstop
mRNA to poly-lysine, which causes ribosome stalling. Although it is unclear how exactly
the stalled ribosomes are dissociated, the nonstop mRNA is mainly degraded by the
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RNA exosome-mediated 3`-to-5` decay pathway (van Hoof et al., 2002; Schaeffer and
van Hoof, 2011). In contrast, the 5`-to-3` decay has no or less effect on the degradation
of nonstop mRNAs (Frischmeyer et al., 2002).
How factors involved in 3` to 5` decay mediate nonstop mRNA decay is not
entirely understood. Ski7 bridges the interaction of the RNA exosome with the Ski
complex (Araki et al., 2001; Kowalinski et al., 2015; Wang et al., 2005). Although it has
not been directly proved by experimentally, Ski7 is thought to mediate recognition or
recycling of stalled ribosomes during nonstop decay. This hypothesis is based on
multiple observations. First, the C-terminal domain of Ski7 is important for nonstop
decay but not for any other Ski7 function (van Hoof et al., 2002). Second, this C-terminal
domain of Ski7 is homologous to translational GTPases including eEF1A, eRF3, or
Hbs1, that interact with the ribosome A site (Shao et al., 2016). Although the GTPase
domain of Ski7 is not catalytically active, it adopts an analogous structure (Kowalinski et
al., 2015). Since the functions of Ski7 in the nonstop decay is not fully understood, I
further investigated the function of Ski7 in nonstop mRNA decay in chapter 5.
Similar to no-go decay, aberrant nascent peptides are produced during the
translation of nonstop mRNAs. Since the A site of stalled ribosome is not occupied by a
termination codon, the translational termination factors do not terminate translation of
nonstop mRNAs. As a result, the nascent peptide is not released from the stalled
ribosome. Degradation of this aberrant nascent peptide is mediated by the RQC
machinery, and I will further discuss the RQC in chapter 5.

1.1.4. Decapping enzymes in eukaryotes
All RNA polymerase II-transcribed RNA is co-transcriptionally modified with a m7G
cap at the 5`-end of the transcript (Bentley, 2014; Neugebauer, 2002). The 5`-m7G cap
and proteins that interact with the cap are critical for regulating the processing, cellular
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localization, stability, and translation of mRNAs (Ramanathan et al., 2016; Topisirovic et
al., 2011). As mentioned above, the 5` to 3` decay for the cytoplasmic mRNA turnover is
initiated by decapping by Dcp2, and it is essential for subsequent Xrn1-mediated RNA
degradation (van Dijk et al., 2002; Dunckley and Parker, 1999; Jinek et al., 2011;
Larimer et al., 1992; Stevens and Poole, 1995). Although Dcp2 is considered the
canonical decapping enzyme for cytoplasmic mRNA turnover, we cannot rule out the
possibility that other decapping enzymes remove m7G cap for cytoplasmic mRNA
turnover especially when Dcp2 is missing.
Dcp2 is a Nudix (nucleoside diphosphates linked to x, x=any moiety) hydrolase.
Dcp2 hydrolyzes the 5`-5` linked m7G cap and produces a 7-methylguanosine
diphosphate (m7GDP) and a 5`-monophosphate-ended mRNA (Bessman et al., 1996;
Kramer and McLennan, 2018). Other Nudix proteins in budding yeast have distinct roles.
For example, Pcd1 degrades oxidatively damaged dGTP and prevents it from being
incorporated into DNA and Ddp1 degrades signaling molecules such as inositol
pyrophosphates and diadenosine polyphosphates (Cartwright and McLennan, 1999;
Nunoshiba et al., 2004). However, Ddp1 has also been reported to decap mRNAs in
vitro (Song et al., 2013). Whether these additional Nudix proteins contribute to mRNA
decay is unclear. Mammalian cells also express multiple Nudix hydrolases including
Dcp2, Nudt3 (a homolog of Ddp1), and five more Nudix proteins (Nudt2, 12, 16, 17 and
19). Several of these have been suggested to contribute to mRNA decapping. (van Dijk
et al., 2002; SGrudzien-Nogalska and Kiledjian, 2017; Song et al., 2010, 2013; Wang et
al., 2002).
Besides Nudix hydrolases, other enzymes possess decapping activity, each with
different substrate specificity or mechanism of action compared to Dcp2. One of them is
DcpS, a member of the Histidine Triad (HIT-motif) family. DcpS hydrolyzes the m7G cap
from short nucleotides such as decay products from the RNA exosome-mediated
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degradation and from the

m7

GDP product of Dcp2-mediated mRNA decapping (Liu et

al., 2002, 2004b; Wang and Kiledjian, 2001). Unlike Dcp2, DcpS releases 7-methyl
guanosine monophosphate (m7GMP).
Another family of decapping enzymes is composed of Dxo1 and Rai1. Dxo1 and
Rai1 can hydrolyze mRNAs with m7G caps at a low efficiency, but prefer other aberrant 5’
ends (GpppN, pppN and N), and also have distributive exoribonuclease activity (Chang
et al., 2012; Doamekpor et al., 2020; Jiao et al., 2010, 2013; Xiang et al., 2009)
As mentioned earlier, the m7G cap is crucial for the processing, localization,
stability, and translation of mRNAs (Ramanathan et al., 2016; Topisirovic et al., 2011).
This is not an exception for viral mRNAs that hijack eukaryotic host machineries for its
proliferation, and in many cases need a cap. Some viral mRNAs acquire those caps by
transferring the cap from a cellular mRNA onto their own mRNAs, thereby creating
uncapped host mRNAs. For instance, the yeast L-A double-stranded RNA virus
expresses a GAG coat protein that removes m7GMP caps from host mRNAs for capping
of its own mRNAs (Fujimura and Esteban, 2011, 2012). Most yeast strains are
persistently infected by this L-A virus and the related L-BC virus, and thus their GAG
proteins add two potential decapping enzymes to the yeast proteome. Any of these
decapping enzymes might act on a specific subset of mRNAs, or under specific
circumstances.

1.1.5. When things are going wrong: the physiological impact of cytoplasmic
mRNA decay
Regulating mRNA levels and quality is essential for gene expression of all
organisms and many factors are involved in these processes. Studies have
characterized the roles of the mRNA decay enzymes and showed the consequence of
defective mRNA decay machineries at the molecular level (Parker, 2012). Although
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elaborate mechanisms were elucidated, how the global transcriptome is regulated by
each pathway is not fully understood. Here, I will discuss how defects in or dysregulation
of mRNA decay pathways affect the physiology of the organisms.
There are multiple human diseases associated with impaired mRNA decay
pathways. However, the exact mechanism for the pathogenesis of most of these
diseases remains to be elusive. For example, mutations in subunits of the Ski complex in
humans (SKIV2L or TTC37) cause Trichohepatoenteric (THE) syndrome (Eckard et al.,
2014; Fabre et al., 2011, 2012; Hartley et al., 2010). Patients with THE syndrome have
intractable diarrhea, facial dysmorphism, wooly hair, and immunodeficiency. Mutations in
DIS3L2 cause Perlman syndrome (Astuti et al., 2012; Hunter et al., 2018). Perlman
syndrome is characterized by overgrowth and high frequency of Wilms tumor, and
similar phenotypes were observed for loss of DIS3L2 in mice (Astuti et al., 2012; Hunter
et al., 2018). Another example is the overexpression of Dcp2 and its association with
celiac disease (Castellanos-Rubio et al., 2016). In celiac disease patients, an increased
level of Dcp2 decreases the expression of long non-coding RNA lnc13 and consequently
de-represses inflammatory genes whose expression is regulated by lnc13. In addition to
Dcp2, disruption of another key enzyme in the 5` to 3` decay pathway, Xrn1, is
associated with osteogenic sarcoma as mutations in XRN1 are found in patients’
biopsies and primary osteosarcoma cell lines. These mutations result in a decreased
level of XRN1 expression (Zhang et al., 2002a). Both hypo- and hyperfunction of mRNA
decay factors affect normal cell physiology, indicating the normal function of mRNA
decay factors is critical. However, the exact mechanisms by which the disruption of
general mRNA decay pathways affects organismal function are not known.
The importance of the mRNA decay machineries for normal physiology has been
implied in different eukaryotic organisms as well. Defects in the mRNA decay
machineries affect the physiology of Arabidopsis thaliana. Upon disruption of the
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decapping complex, A. thaliana displays defects in post-embryonic development
(Iwasaki et al., 2007; Xu and Chua, 2009; Xu et al., 2006). Depletion of AtSki8, a plant
homolog of the yeast Ski complex component Ski8, showed dwarf and infertility
phenotypes. Similarly, a plant homolog of the yeast Ski2 is required for normal
development as its depletion showed a dwarf phenotype (Dorcey et al., 2012). Other
cytoplasmic cofactors of the plant exosome are required for cuticular wax biosynthesis
(Chen et al., 2005; Lange et al., 2019; Zhao and Kunst, 2016). Furthermore, some
defective mRNA decay machineries impair the physiology of budding yeast, including
growth and viability. Upon disruption of deadenylases, Ccr4 or Pop2, cell size and
morphology are altered (Manukyan et al., 2008; Traven et al., 2009). Additionally, a null
mutant of CCR4 has a slow growth defect (Ito et al., 2011). While null mutants of the Ski
complex do not have any significant impact on the growth or viability of the cell,
disrupting key enzymes in the 5` to 3` decay exhibit a greater impact on cell growth. For
example, the XRN1 null mutant shows a slow growth defect (Hsu and Stevens, 1993;
Larimer and Stevens, 1990; Larimer et al., 1992). Another key enzyme in this pathway is
Dcp2. Until now, our understanding of the physiological impact of Dcp2 has been
incomplete and also inconsistent among different studies. Some studies showed that the
DCP2 null mutant has a slow growth defect, while others showed that the DCP2 null is
lethal, and DCP2 is annotated as an essential gene in the Saccharomyces genome
database (yeastgenome.org) (Dunckley and Parker, 1999; Geisler et al., 2012; Giaever
et al., 2002; He and Jacobson, 2015). Thus, in chapters 3 and 4, I investigated the
genetic variations that lead to this difference. Furthermore, it is intriguing that disruption
of a key enzyme in either of these two pathways significantly impacts the physiology of
the cell despite the presence of multiple and what seem to be redundant pathways. This
led us to investigate what the exact physiological function of each mRNA decay factor is,
which may be independent of its role in the general mRNA turnover. Additionally,
inactivating both pathways simultaneously by disrupting the decapping complex and the
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Ski complex leads to drastic mRNA stabilization and shows synthetic lethality (Anderson
and Parker, 1998). These data imply that the two canonical pathways are somewhat
redundant but major pathways for normal mRNA turnover in yeast (Anderson and
Parker, 1998; van Hoof et al., 2002; Johnson and Kolodner, 1995).
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1.2. SIGNIFICANCE
Regulating gene expression is critical for maintaining normal cellular physiology,
and this is a universal feature of organisms. One of the key mechanisms that regulates
gene expression is cytoplasmic mRNA turnover, and the mRNA degrading enzymes are
highly conserved among eukaryotes. Another mechanism that ensures normal gene
expression is mRNA surveillance pathways. When key factors in these pathways are
impaired, the organism is incapable of maintaining RNA homeostasis. Defective mRNA
decay pathways result in the accumulation of mRNAs, and the degree of defect varies
among different mutants. Also, this imbalance results in pleiotropic phenotypes as in a
wide spectrum of human diseases caused by mutations in RNA decay factors as
explained in 1.1.5.
Many studies determined the biochemical function of key factors in mRNA decay
pathways and revealed the molecular mechanisms. However, functions of these factors
are still not fully understood. For instance, Ski7 that is involved in the nonstop decay
pathway was discovered over 20 years ago, but it is still not clear how exactly Ski7
mediates nonstop mRNA decay. Additionally, our current understanding of the
physiological significance of mRNA decay pathways is largely unknown. Incomplete
knowledge of fundamental pathways prevents us from understanding the mechanism of
many diseases related to defective mRNA decay. Thus, it is necessary to thoroughly
study these pathways to fully understand the fundamental mechanism of gene
expression.
In this study, I have investigated two different pathways of mRNA decay, normal
cytoplasmic mRNA turnover and nonstop mRNA decay. I closely looked into how the
major mRNA decapping enzyme Dcp2 plays a role in shaping normal physiology by
focusing on its impact on growth. Additionally, I studied the function of Ski7 in nonstop
decay. I utilized well-established genetic tools in a yeast model system to study mRNA
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decay mechanisms that are highly conserved from yeast to humans. This study will
provide insights into mRNA decay mechanisms and their physiological roles. Ultimately,
this study will also help to better understand the pathology of many human diseases
related to mRNA decay defects.

23

Chapter 2. Materials and Methods

Portions of this chapter have been taken from the following published article*:
Kim, M., & van Hoof, A. (2020). Suppressors of mRNA Decapping Defects Restore
Growth Without Major Effects on mRNA Decay Rates or Abundance. Genetics, 216(4),
1051–1069. https://doi.org/10.1534/genetics.120.303641
*Permission from the Genetics Society of America is not needed if an article on which I
am an author is reproduced for dissertation.
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Strains, plasmids, and oligonucleotides
The yeast strains, plasmids, and oligonucleotides used in this study are listed in
Table 2.1, 2.2, and 2.3, respectively.
Plasmids were generated by standard cloning methods. Briefly, DNA (plasmids,
PCR amplified DNA, or in vitro synthesized oligonucleotides) was digested with
restriction enzymes (New England Biolabs). Digested DNA was purified using
Zymoclean Gel DNA Recovery Kit (Zymo Research), then ligated using T4 DNA ligase
(New England Biolabs). Ligated DNA was transformed into Escherichia coli competent
cells.
For E. coli transformation, ~1 ug of DNA was transformed into E. coli competent
cells by heat shock at 42°C for 1 minute. E. coli cells were then plated on LB solid media
containing 100 µg/ml ampicillin and incubated at 37°C for ~16 hours. To select plasmids
and grow E. coli, LB media containing 100 µg/ml of ampicillin for solid and 50 µg/ml of
ampicillin for liquid of ampicillin were used. DNA was extracted from ~5 mL E.
coli culture grown at 37°C for ~16 h using Wizard Plus SV Minipreps DNA Purification
System (Promega).

Yeast growth conditions
Yeast were grown either in yeast extract peptone (YEP) media containing 2%
dextrose or galactose or in yeast nitrogen base (YNB) containing 2% dextrose and yeast
synthetic drop-out media supplement as required (Sunrise Science Products, Inc.; San
Diego, CA). To select knockout mutants, G418 (0.67 mg/ml), hygromycin B (325 U/mL)
and/or clonNAT (100 µg/ml) was added to media as required. Cells were incubated at
30 °C unless otherwise indicated.
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Yeast transformation
For yeast transformation, cells that were freshly grown on solid media and ~1ug
of DNA (plasmids or PCR amplified DNA) were incubated in 40% polyethylene glycol,
0.1M LiAC, 10mM Tris-HCl (pH 7.5) and 1mM EDTA at room temperature for ~16 hours.
The collected cell pellet was resuspended in water, then plated on selective media.

Tetrad dissection
Diploid cells were grown in nutrient-depleted sporulation media. Sporulated cells
were treated with zymolase. Each of four spores from single ascus was separated with a
microneedle and placed on the agar plate in a row (Sherman and Hicks, 1991).

Random spore isolation
To induce sporulation, diploid cells were grown in nutrient-depleted media for 4-5
days. Sporulated cells were resuspended in water with Glusulase (Perkin Elmer). This
reaction was incubated at 30°C for 30 minutes. Ascus digestion was terminated using
water. Multiple washes with water were followed by dispersion of spores through
sonication in 0.01% Triton X-100. Dispersed spores were plated on selective media.

Experimental evolution
For experimental evolution, four haploid dcp2∆ spore progeny from a single
tetrad were inoculated in YEP containing 2% dextrose, G418 (167 mg/L), and ampicillin
(50 mg/L) in duplicate. Cells were grown at 30˚C until the optical density at a wavelength
of 600 nm (OD600nm) of the culture reached > 8.5. Then, this culture was diluted 500X
into 5 mL of fresh media of the same type. Culturing and dilution diluting was repeated
30 times.
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Growth assay
For the growth assay on solid media, exponentially growing cells were serially
diluted and spotted on the indicated media. For the growth assay in liquid media,
exponentially growing cells were diluted to OD600nm of 0.1, and then diluted cultures were
transferred to 96-well plate. Cells were incubated at 30˚C or 37˚C in a BioTek SynergyTM
Mx Microplate Reader. OD600nm was measured every 10 minutes for ~14 hours.
Collected data were processed through Gen5 software (BioTek).

Microscopy
To examine cell morphology, exponentially growing cells were used to prepare a
wet mount slide. Samples were analyzed by differential interference contrast microscopy
using Olympus BX60 microscope. A 100X oil objective was used.

Protein analysis using western blotting
Preparation of protein
Total protein was extracted in IP50 buffer (50mM Tris-HCl (pH7.5), 50mM NaCl,
2mM MgCl2, 0.1% Triton X-100) with 0.007% beta-mercaptoethanol and 0.00174%
PMSF, and complete protease EDTA-free mini tablet (Roche) by bead beating. The
supernatant was isolated from whole cell extract by centrifugation at 4˚C.
For pull-down of HA tagged proteins, total protein extract was extracted in IP50
buffer with 10% glycerol, 0.007% beta-mercaptoethanol and 0.00174% PMSF, and
complete protease EDTA-free mini tablet (Roche) by bead beating. The supernatant was
isolated from whole cell extract by centrifugation at 4˚C. Protein extracts were incubated
with anti-HA antibody on a nutator at 4˚C for ~16 hours. Then, Protein A sepharose
beads were added to samples followed by incubation at 4˚C for 1 hour. Beads were
collected by centrifugation. Harvested pellet was washed with the same buffer used for
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total protein extraction. Bound proteins were eluted by boiling samples in SDS sample
buffer and analyzed by western blot.
For pull-down of biotinylated proteins, total protein extract was extracted in IP50
buffer with 0.007% beta-mercaptoethanol and 0.00174% PMSF, and complete protease
EDTA-free mini tablet (Roche) by bead beating. The supernatant was isolated from
whole cell extract by centrifugation at 4˚C. Isolated supernatant was incubated with
DynabeadTMMyOneTMStreptavidin C1 (Invitrogen) at 4˚C for ~16 hours. Protein-coated
beads were separated with a magnet, washed by PBS, and resuspended in the same
buffer used for total protein extraction. Bound proteins were eluted by boiling samples in
SDS sample buffer and analyzed by western blot.

Western blot
Protein was analyzed by electrophoresis through 8%, 10%, or 12% SDS-PAGE
gel. Proteins were transferred from SDS-PAGE gel to a nitrocellulose membrane and
probed with antibodies at room temperature for 1 hour or at 4°C for 16 hours. Blots were
probed with rabbit anti-Protein A (Sigma-Aldrich) at 1:100,000, mouse anti-Pgk1
(Invitrogen) at 1:10,000, mouse anti-HA at 1:5,000 (Roche), rabbit anti-Kap123 (gifted
from Valerie Doyle lab (Floch et al., 2014)) at 1:5,000, goat anti-rabbit (Bidrad) at
1:5,000, goat anti-mouse (Biorad) at 1:5,000, or Streptavidin-HRP conjugate (gifted from
Ziyin Li lab) at 1:2,000. The membrane was developed using Amersham ECL Prime
Western Blotting Detection Reagent (GE Healthcare; Chicago, IL). Images were
acquired and analyzed using an ImageQuantTM LAS 4000 biomolecular imager (GE
Healthcare) and ImageQuant TL image analysis software, respectively.

RNA analysis using northern blotting
Preparation of RNA
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For analyzing the steady-state RNA level, cells exponentially growing at 30°C
were harvested otherwise indicated. For analyzing the steady-state RNA level of dcp2-7
mutants, exponentially growing cells in YEP containing 2% galactose at 21˚C were
transferred into a 37°C incubator for 90 minutes to inactivate dcp2-7. After inactivation of
the decapping enzyme, cells were harvested.
For analyzing RNA stability of dcp2-7 mutants, exponentially growing cells in
YEP containing 2% galactose at 21˚C were transferred into a 37°C incubator for 1 hour
to inactivate the decapping enzyme. Cells were washed with YEP, then 40% dextrose
stock solution was added to a final concentration of 2% to repress transcription of GAL
genes. While cells were incubated at 37˚C, samples were collected at the indicated time
points.
For RNA preparation, the harvested cell pellet was lysed by bead beating. RNA
was purified through two rounds of phenol/chloroform/LET (LiCl-EDTA-Tris HCl, pH8.0)
treatment and additional chloroform. Then, RNA was precipitated with 3M NaOAC from
isolated supernatant.

Northern blot
Total RNA was analyzed through northern blotting. Briefly, 10 µg of total RNA
was analyzed by electrophoresis on 1.3% formaldehyde agarose gel or 6%
polyacrylamide (19:1) 8M urea gel, as indicated. RNA was transferred to a nylon
membrane and probed with 32P 5` end-labeled oligonucleotides (Table 2.3). Blots were
imaged by phosphorimaging using a Typhoon FLA 7000 instrument (GE Healthcare),
and quantitated using ImageQuant software.
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Whole genome sequencing analysis
Total genomic DNA was isolated from exponentially growing cells using the
phenol-chloroform extraction method and further purified with the use of a DNeasy Blood
& Tissue Kit (Qiagen; Hilden, Germany) and a MasterPureTM Yeast DNA Purification Kit
(Lucigen; Middleton, WI). The library was prepared for PE150 Illumina sequencing and
sequenced through Novogene Co., Ltd. and Arias lab (Department of Internal Medicine,
McGovern Medical School).
Analysis of whole genome sequencing data was done using tools equipped in Galaxy
(usegalaxy.org). Sequencing reads were groomed with FASTQ Groomer (Blankenberg
et al., 2010), trimmed with Trim Sequences (http://hannonlab.cshl.edu/fastx_toolkit/), and
quality checked with FastQC
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Most reads were ~150
nucleotides long (reads for sequencing done by Arias lab are ~35-150 nucleotides long).
Sequencing reads were then mapped to S. cerevisiae reference genome R64-1-1
(www.emsembl.org) using Bowtie2 (Langmead and Salzberg, 2012; Langmead et al.,
2009). Throughout the samples, the number of total reads was ~4.3-~7.2 million reads,
and the overall alignment rate was ~91-~99%. Before calling variants, BAM datasets for
individual dcp2∆ strain and heterozygous diploid DCP2/dcp2∆ strain were merged using
MergeSamFiles (http://broadinstitute.github.io/picard/). Datasets were further processed
for left realignment through BamLeftAlign (Garrison and Marth, 2012). In order to call all
the variants, FreeBayes (http://www.gnu.org/s/parallel) (Garrison and Marth, 2012)) for
detection and SnpEff Eff 4.3 (Cingolani et al., 2012) for annotation were used. Integrated
Genome Viewer (Robinson et al., 2011; Thorvaldsdóttir et al., 2013) was used to inspect
candidate SNPs. Lastly, identified variants that were already present in heterozygous
diploid DCP2/dcp2D strain were filtered out.
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Transcriptomic analysis
For RNA sequencing analysis of dcp2 mutants, exponentially growing cells were
transferred into a 37˚C incubator and incubated for 90 minutes to inactivate the Dcp1Dcp2 decapping enzyme before harvesting. Total RNA was extracted using the hot
phenol method. Briefly, the cell pellet was resuspended in 65˚C phenol that has been
equilibrated in 50.1 mM NaOAc and 10 mM EDTA. The supernatant was isolated, then
phenol treatment was repeated four times. Isolated supernatant was then treated with
phenol and chloroform in 10 mM Tris (pH8.0), 5 mM EDTA. RNA was isolated with 70%
ethanol precipitation.
For sequencing, poly(A) + selected RNA was used to construct a library for
PE150 Illumina sequencing. Similar to whole genome sequencing analysis, tools
equipped in Galaxy (usegalaxy.org) were used for RNA sequencing analysis. Raw
datasets were trimmed using Trim Galore!
(https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) followed quality check
by FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Trimmed
sequences were mapped to S. cerevisiae reference genome R64-1-1 with TopHat2 (Kim
et al., 2013). Next, gene expression level was examined by featureCounts (Liao et al.,
2014). For all genes, R64-1-1 version of gene annotation file downloaded from the
Ensembl Genome Browser (www.emsembl.org) was used, and XUT annotation file was
used for XUT genes only (http://vm-gb.curie.fr/XUT/index.htm) (van Dijk et al., 2011).
Datasets from featureCounts were used to determine differential expression between
strains through DESeq2 (Love et al., 2014). Lastly, Gene ontology analysis was
performed through the GO Term Finder (Version 0.86).
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Table 2. 1. Yeast strains used
Name

Genotype

Reference
(Anderson and
Parker, 1998)
(Dunckley and
Parker, 1999)

yRP1192

MATα leu2-3,112 ura3-52 his4-539 lys2-201 trp1-Δ1 ski2::LEU2

yRP1346

MATa leu2-3,112 ura3-52 his4-539 lys2-201 trp1-Δ1 dcp2::TRP1 cup1::LEU2/PGK1pG/MFA2pG

BY4741

MATa leu2-∆0 ura3-∆0 his3∆1 met15∆0

yAV313

MATα leu2-3,112 lys2-201 trp1 ura3-52 cup1::LEU2/PGK1pG/MFA2pG dcp1-2::TRP1
ski7Δ::NEO

(van Hoof et al.,
2000)

yAV517

MATa TRP1 LYS2 HIS4 CUP1 leu2-Δ0 uea3-Δ0 his3-Δ1 met15-Δ0 ski2Δ::NEO

(Giaever et al., 2002)

yAV709

MATa TRP1 leu2- LYS2 ura3- HIS4 CUP1 his3Δ1 met15Δ0 ltn1Δ::NEO

(Giaever et al., 2002)

yAV746

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 met15-∆0 dcp2-7::URA3

This study

yAV753

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO

This study

yAV754

MATα leu2-∆0 ura3-∆0 his3∆1 dcp2Δ::NEO

This study

yAV755

MATα leu2-∆0 ura3-∆0 his3∆1 met15-∆0 dcp2Δ::NEO

This study

yAV756

MATa leu2-∆0 ura3-∆0 his3∆1 dcp2Δ::NEO

This study

yAV871

MATα leu2 lys2 ura3 his3 hbs1Δ::HYG

yAV987

MATα TRP1 leu2-Δ0 lys2-Δ0 ura3-Δ0 HIS4 CUP1 his3Δ1 ski7Δ::HYG

(Wilson et al., 2007)

yAV1728

MATa ura3-Δ0 leu2-Δ0 his3Δ1 met15-Δ0 tae2Δ::NEO

(Giaever et al., 2002)
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yAV1777

MATa TRP1 HIS4 CUP1 leu2-Δ0 lys2-Δ0 ura3-Δ0 his3Δ1 met15Δ0 ltn1Δ::NEO ski7Δ::HYG

This study

yAV1780

MATa TRP1 HIS4 CUP1 leu2-Δ0 lys2-Δ0 ura3-Δ0 his3Δ1 met15Δ0 ltn1Δ::NEO hbs1Δ::HYG

This study

yAV1787

MATa TRP1 HIS4 CUP1 leu2-Δ0 lys2-Δ0 ura3-Δ0 his3Δ1 met15Δ0 tae2Δ::NEO ski7Δ::HYG

This study

yAV1790

MATa TRP1 HIS4 CUP1 leu2-Δ0 lys2-Δ0 ura3-Δ0 his3Δ1 met15Δ0 tae2Δ::NEO hbs1Δ::HYG

This study

yAV1823

MATα leu2 ura3 his3 met15 ski7Δ::NEO hbs1Δ::HYG

This study

yAV2072

MATa/MATα leu2-Δ0/leu2-Δ0 ura3-Δ0/ura3-Δ0 his3-Δ1/his3-Δ1 LYS2/lys2-Δ0 MET15/met15-Δ0
DCP2/dcp2Δ::NEO

(Giaever et al., 2002)

yAV2355

MATa bpl1-ts::URA3 can1Δ::LEU2-MFA1pr::HIS3 ura3Δ leu2Δ his3Δ lys2Δ MET15

(Kofoed et al., 2015)

yAV2397

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO [MFA2pG LEU2]

yAV2398

MATα leu2-∆0 ura3-∆0 his3∆1 dcp2Δ::NEO [MFA2pG LEU2]

yAV2399

MATα leu2-∆0 ura3-∆0 his3∆1 met15-∆0 dcp2Δ::NEO [MFA2pG LEU2]

yAV2400

MATa leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO [MFA2pG LEU2]

yAV2401

MATα leu2-∆0 ura3-∆0 his3∆1 dcp2Δ::NEO whi4 rpo21 [MFA2pG LEU2]

yAV2402

MATa leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO tl(gag)g [MFA2pG LEU2]

yAV2403

MATα leu2-∆0 ura3-∆0 his3∆1 met15-∆0 dcp2Δ::NEO whi2 cse2 psp2 [MFA2pG LEU2]

yAV2404

MATa leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO tl(gag)g psr1 [MFA2pG LEU2]

yAV2405

MATα leu2-∆0 ura3-∆0 his3∆1 dcp2Δ::NEO tl(gag)g whi4 [MFA2pG LEU2]
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This study (Nonevolved_1 isolate)
This study (Nonevolved_2 isolate)
This study (Nonevolved_3 isolate)
This study (Nonevolved_4 isolate)
This study
(Evolved_2-1 isolate)
This study
(Evolved_4-1 isolate)
This study
(Evolved_3-1 isolate)
This study
(Evolved_4-2 isolate)
This study
(Evolved_2-2isolate)

This study
(Evolved_3-2 isolate)
This study
(Evolved_1-1 isolate)
This study
(Evolved_1-2 isolate)

yAV2406

MATα leu2-∆0 ura3-∆0 his3∆1 met15-∆0 dcp2Δ::NEO cse2 ira1 sar1 sgt2 [MFA2pG LEU2]

yAV2407

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO whi2 atg22 gpa2 nup157 [MFA2pG LEU2]

yAV2408

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2Δ::NEO whi2 atg22 gpa2 set1 puf3 [MFA2pG LEU2]

yAV2409

MATa leu2-∆0 ura3-∆0 his3∆1 met15∆0 [MFA2pG LEU2]

This study

yAV2470

MATa leu2-∆0 ura3-∆0 his3∆1 met15-Δ0 kap123Δ::NEO

(Giaever et al., 2002)

yAV2491

MATa leu2-∆0 ura3-∆0 his3∆1 met15-Δ0 whi2Δ::NEO

(Giaever et al., 2002)

yAV2587

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-Δ0 tl(gag)gΔ::NAT

This study

yAV2507
yAV2536
yAV2539

MATa/MATα leu2-Δ0/leu2-Δ0 ura3-Δ0/ura3-Δ0 his3-Δ1/his3-Δ1 LYS2/lys2-Δ0 MET15/met15-Δ0
DCP2/dcp2Δ::NEO KAP123/kap123Δ::HYG [DCP2-RFP URA3]
MATa/MATα leu2-Δ0/leu2-Δ0 ura3-Δ0/ura3-Δ0 his3-Δ1/his3-Δ1 LYS2/lys2-Δ0 MET15/met15-Δ0
DCP2/dcp2Δ::NEO tL(GAG)G/tl(gag)gΔ::HYG [DCP2-RFP URA3]
MATa/MATα leu2-Δ0/leu2-Δ0 ura3-Δ0/ura3-Δ0 his3-Δ1/his3-Δ1 LYS2/lys2-Δ0 MET15/met15-Δ0
DCP2/dcp2Δ::NEO WHI2/whi2Δ::HYG [DCP2-RFP URA3]

This study
This study
This study

yAV2562

MATa leu2-∆0 ura3-∆0 his3∆1 lys2-Δ0 met15-Δ0 dcp2Δ::NEO [DCP2-RFP URA3]

This study

yAV2587

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-Δ0 tl(gag)gΔ::NAT

This study

yAV2589

MATα leu2-∆0 ura3-∆0 his3∆1 met15-∆0 dcp2-7::URA3 kap123Δ::NEO

This study

yAV2608

MATa leu2-∆0 ura3-∆0 his3∆1 lys2-Δ0 met15-Δ0 dcp2Δ::NEO kap123Δ::HYG tl(gag)gΔ::NAT
[DCP2-RFP URA3]

This study

yAV2613

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 met15-∆0 dcp2-7::URA3 kap123Δ::NEO tl(gag)gΔ::HYG

This study

yAV2924

MATα leu2-∆0 ura3-∆0 his3∆1 lys2-∆0 dcp2-7::URA3 kap123Δ::NEO tl(gag)gΔ::HYG ski2::LEU2

This study
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Table 2. 2. Plasmids used
Name

Description

Marker

References

p4339

pFA6a-natMX6

natMX6

pAG32

pFA6a-hphMX4

hphMX4

pRP488

GAL-MFA2pG

LEU2

(Tong et al., 2001)
(Goldstein and McCusker,
1999)
Roy Parker

pRP1186

DCP2-RFP

URA3

(Teixeira et al., 2005)

pRS415

Empty vector for LEU2

LEU2

pRS416

Empty vector for URA3

URA3

36047

pcA3.1 MCS-BirA(R118G)-HA

Amp/Kan

(Roux et al., 2012)

107167

TurboID-V5-pRS415

LEU2

(Branon et al., 2018)

pAV152

SKI7-3HA

URA3

(van Hoof et al., 2002)

pAV175

pgk1-nonstop

URA3

(Frischmeyer et al., 2002)

pAV184

Protein A-nonstop

URA3

(Meaux and van Hoof, 2006)

pAV189

his3- nonstop

URA3

(van Hoof et al., 2002)

pAV215

Protein A-RZ-GFP

URA3

(Meaux and van Hoof, 2006)

pAV226

Protein A-STOP-RZ-GFP

URA3

(Meaux and van Hoof, 2006)

pAV1235

SKI7-BirA*-3HA

URA3

This study

pAV1237

ski7∆226-3HA

URA3

This study

pAV1238

ski7∆265-3HA

URA3

This study

pAV1239

ski7∆213-3HA

URA3

This study

pAV1240

ski7∆226-BirA*-3HA

URA3

This study

pAV1244

ski7∆265-BirA*-3HA

URA3

This study
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pAV1319

Flag-HIS3-opt-CUY

URA3

This study

pAV1320

Flag-HIS3-opt-CUA

URA3

This study

pAV1321

Flag-HIS3-CUY

URA3

This study

pAV1322

Flag-HIS3-CUA

URA3

This study

pAV1324

Protein A-(CUC)12-GFP

URA3

pAV1325

Protein A-(CUA)12-GFP

URA3

This study
This study

pAV1331

tL(GAG)G

LEU2

This study

pAV1332

tl(gag)g_nt25_G>T

LEU2

This study

pAV1333

tl(gag)g_nt47_T>C

LEU2

This study

pAV1343

ski7∆265-TurboID-3HA

URA3

This study

pAV1344

ski7∆213-TurboID-3HA

URA3

This study

pAV1384

SKI7-TurboID-3HA

URA3

This study

pAV1385
pAV1451

ski7∆226-TurboID-3HA
tl(gag)g_G34U

URA3
LEU2

This study
This study

pAV1453

tl(gag)g_C33U

LEU2

This study

pAV1455

tl(gag)g_anticodon loop

LEU2

This study

pAV1457

tl(gag)g_A57G

LEU2

This study

pAV1459

tl(gag)g_A73C

LEU2

This study

pAV1461

tl(gag)g_U55G

LEU2

This study
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Table 2. 3. Oligonucleotides used
Name

Sequences

Description

Northern blot probes
oAV72

TCTACTTTCGGCGCCTGAGCATCATTT

Protein A

oAV224

GTCTAGCCGCGAGGAAGG

SCR1

oAV267

CTCTTGCTTCTCTGGAGAGATCGTCAGTC

GAL7

oAV1381

AATTGATCTATCGAGGAATTCC

pgk1-nonstop 3`UTR

oAV1460

TACGGCTTCATCGTGTTGCGCAAGG

Protein A-5`

oAV1461

ATCCGGTGACAGGGGATCCATTCGC

Protein A-3`

oAV1927

GAGTGAGCAACATGGAGACCAC

GAL1

oAV1928

GGGAATCTCGTAGCATCACCATAGACAG

GAL10

oAV2039

AGACCACTCGGCCAGAGTAC

tL(GAG)G

oAV3028

AGAGTACCAATTCATCTG

pre-tL(GAG)G

oAV3064

ATATTGATTAGATCAGGAATTCC

MFA2pG

CGACGACCCGGGGATCCGATGGGTGGCAATGAATGAATG

ski7∆265_R

Cloning
oAV1556
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oAV1557

CCCTCGAGGTCGACGGTATCGATAAGC

SKI7_F

oAV1558

CGACGACCCGGGAAGGACAACACCGTGCCCC

BirA_F

oAV1559

CGACGACCCGGGCTTCTCTGCGCTTCTCAGG

BirA_R

oAV1583

CGACGACCCGGGGATCCGATTGAAAGCATTAAGTTGGGC

ski7∆226_R

oAV1597

CGACGACCCGGGGATCCGAGGACTTGGTCTATTGAAATT

ski7∆213_R

oAV1681

AAATTGCGTTTGCTTTATTCCCTTACCCAACAGATGAATTGACATGGAGGCCCAGAATACCCT

tL(GAG)G_F1

oAV1682
oAV1689
oAV1690

AGCCTAATTCTTATTGAAGTGCGTAGATTCAAAAAAATATCAGTATAGCGACCAGCATTCACA
TACGA
CTGAGGGACGAAAAACACTTTTTTAGTATCAAGTAGTATAGACATGGAGGCCCAGAATACCC
T
TTATCGAAACAGACGAGAATAAAAAATGGTTTTAAAAAAACAGTATAGCGACCAGCATTCACA
TACGA

tL(GAG)G_R1
KAP123_F1
KAP123_R1

oAV1691

TAAAGATAAAGGTTGTCTGAGCTTACACTTATTATAAACAGACATGGAGGCCCAGAATACCCT

WHI2_F1

oAV1692

GATCTCTTTCCATTTCTTTCTCTAATATATTATATACACCAGTATAGCGACCAGCATTCACATA
CGA

WHI2_R1

oAV1702

TTTTGCAAAGCTTCACTTAAATGGCGTATCTTCCTTTTATAAATTGCGTTTGCTTTATTC

tL(GAG)G_F2

oAV1703

AATACTTTTGGTACATAGAAAAAAAATGCTATCCTAACAGCCTAATTCTTATTGAAGTGC

tL(GAG)G_R2

oAV1704

TTCTGTATATTACCAAAATCCTGCCTTAGCAGCATAAAAACTGAGGGACGAAAAACACTT

KAP123_F2

oAV1705

AAAAATAATGAAGGAAGGTATACTTATATAAGCGCTGTTTATCGAAACAGACGAGAATAA

KAP123_R2

oAV1706

ACACTTAGGCTATTAATTTTCCCGCCTCCCCATTAATTGATAAAGATAAAGGTTGTCTGA

WHI2_F2
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oAV1707

TACCAAGAAACCATACTGTTACATATTGTGTCTTTGGCCCGATCTCTTTCCATTTCTTTC

WHI2_R2

oAV1744

AGTTCGATTCTTATTATATATAGTCACAGCAGTGGT

tL(GAG)G_F3

oAV1745

TTGGCTACAATAGCCATCAATGGAATGT

tL(GAG)G_R3

oAV1750

[PHOS]GATCCCCTGGTCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCAGGG

(CUC)12_F

oAV1751

[PHOS]GATCCCCTGGTCTACTACTACTACTACTACTACTACTACTACTACTACAGGG

(CUA)12_F

oAV1752

[PHOS]GATCCCCTGTAGTAGTAGTAGTAGTAGTAGTAGTAGTAGTAGTAGACCAGGG

(CUA)12_R

oAV1760

[PHOS]GATCCCCTGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGACCAGGG

(CUC)12_R

oAV1763

TAGAAAAGGATTTGAGGGCAAACGCA

KAP123_F3

oAV1764

CTAATTAGTAACGTGCCGTGATTCTTTCA

KAP123_R3

oAV1765

GATCCGAGCTCCGGAGTAATTGACTTGATTTTGCA

tL(GAG)G_SacI

oAV1793

GATCCACTAGTTGCTATCCTAACAGCCTAATTCTTATTGAAGT

tL(GAG)G_SpeI

oAV1857

CGACGACCCGGGGCTCGGGATCCACCGGT

TurboID_F

oAV1858

CGACGACCCGGGGCTAGCCTTTTCGGCAGACC

TurboID_R

oAV1995

TCTAAGGCGTCAGGTCTAGGTCCTGATCTCTTC

F-UAG (G34U)

oAV1996

GAAGAGATCAGGACCTAGACCTGACGCCTTAGA

R-UAG (G34U)

oAV1997

GTCTAAGGCGTCAGGTTGAGGTCCTGATCTCTT

F-C33U
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oAV1998

AAGAGATCAGGACCTCAACCTGACGCCTTAGAC

R-C33U

oAV1999

CGAGTGGTCTAAGGCGTCAGATTTAGGCTCTGATCTCTTCGGAGGCGCG

F-ac stem

oAV2000

CGCGCCTCCGAAGAGATCAGAGCCTAAATCTGACGCCTTAGACCACTCG

R-ac stem

oAV2001

GGCGCGGGTTCGAACCCCGCGGG

F-A57G

oAV2002

CCCGCGGGGTTCGAACCCGCGCC

R-A57G
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Chapter 3. Experimental evolution and transcriptomic analysis reveal essential
functions of the mRNA decapping enzyme beyond mRNA decapping

Portions of this chapter have been taken from the following published article*:
Kim, M., & van Hoof, A. (2020). Suppressors of mRNA Decapping Defects Restore
Growth Without Major Effects on mRNA Decay Rates or Abundance. Genetics, 216(4),
1051–1069. https://doi.org/10.1534/genetics.120.303641
*Permission from the Genetics Society of America is not needed if an article on which I
am an author is reproduced for dissertation.
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3.1. INTRODUCTION
There are two major mRNA decay pathways in eukaryotes, Xrn1-mediated 5`-to3` decay and RNA exosome-mediated 3`-to-5` decay. In the 5`-to-3` decay pathway,
Dcp1-Dcp2 complex-mediated decapping plays a critical role (Parker, 2012). Because
Xrn1 can only degrade RNAs with the 5`-monophosphate, removal of the 5` cap
structure is required for the complete degradation of mRNAs (Jinek et al., 2011; Stevens
and Poole, 1995). Interestingly, disrupting 5`-to-3` decay by deleting either DCP2 or
XRN1 results in different consequences in the budding yeast Saccharomyces cerevisiae.
Both xrn1∆ and dcp2∆ stabilize many endogenous yeast mRNAs modestly (Dunckley
and Parker, 1999; Larimer et al., 1992). However, while xrn1∆ shows a slow growth
defect, the phenotype of dcp2∆ is reported inconsistently among different studies. Some
reported that dcp2∆ is viable but slow-growing, while others reported that dcp2∆ is lethal
(Dunckley and Parker, 1999; Geisler et al., 2012; Giaever et al., 2002; He and Jacobson,
2015). This phenotypic difference between null mutations of two genes in the same
pathway led me to hypothesize that there is an additional function of DCP2, probably not
related to XRN1 or mRNA turnover by 5`-to-3` decay, that supports the growth of
budding yeast. In this chapter, I sought to determine the essential role of Dcp2 beyond
its mRNA decapping function.
Previously, suppressor screens of the decapping mutants (dcp1 or dcp2
conditional mutants) have identified EDC1, EDC2, EDC3, SBP1, and DCP2 itself as
high-copy suppressors in budding yeast (Dunckley and Parker, 1999; Dunckley et al.,
2001; Kshirsagar and Parker, 2004; Segal et al., 2006). In each case, improved growth
by suppressors was correlated with improved decapping activity and mRNA degradation
suggesting that the major function of the Dcp1-Dcp2 decapping enzyme is indeed mRNA
decapping. However, these previous studies are limited to high-copy suppressor screen
of conditional alleles in the decapping enzymes, which may not have revealed the full
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functions of Dcp2 due to the residual activity of the decapping complex and/or the
inability to screen loss-of-function mutations.
In this chapter, I identified suppressors of growth defect of decapping mutant via
a complementary experimental evolution to better understand the function of Dcp2. By
analyzing whole genome sequences of decapping mutants that have undergone the
experimental evolution, I identified mutations in several genes that have no obvious
connection to mRNA decay as suppressors of dcp2∆ lethality. Among several other
potential suppressors, I have focused on two genes, KAP123 and tL(GAG)G. Loss-offunction mutations in these genes suppress growth defect of dcp2∆. These results
suggest that dcp2∆ grows extremely slowly and cannot be continuously cultured without
suppressor(s). Suppression of the growth defect of dcp2∆ is not caused by improved
cytoplasmic mRNA. Instead, suppressors partially restore RNA homeostasis that has
been disturbed in the absence of DCP2.
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3.2. RESULTS
3.2.1. DCP2 is required for the normal growth of yeast
While DCP2 is annotated as an essential gene in the Saccharomyces Genome
Database (SGD), there are other studies showing that DCP2 is not an essential gene
(Dunckley and Parker, 1999; Geisler et al., 2012; Giaever et al., 2002; He and Jacobson,
2015). Thus, it is necessary to elucidate whether DCP2 is essential gene or not to fully
understand its function. Otherwise, these conflicting results on the viability
of dcp2∆ strain complicate understanding of functions of DCP2 at the organismal
level. Thus, I first examined how DCP2 and dcp2∆ alleles are segregated and affect cell
viability by tetrad analysis of the heterozygous diploid DCP2/dcp2∆ strain (Figure 3.1.A).
It is expected that sporulation of the heterozygous diploid DCP2/dcp2∆ would produce
viable wild-type and inviable dcp2∆ progeny in a 1:1 ratio if DCP2 is an essential gene
as currently annotated by SGD. However, viable dcp2∆ (34%) along with wild type (51%)
and inviable dcp2∆ (14%) was isolated (Figure 3.1.B).
I found that viable dcp2∆ strains form smaller colonies compared to wild type.
Thus, I decided to further examine the growth and morphology of dcp2∆ strains. First,
cells were serially diluted, spotted on YPD, then cultured at 30°C. Although viable,
these dcp2∆ strains grow extremely slowly compared to wild type (Figure 3.2.A). Next,
the morphology of dpc2∆ strains in the exponential growth phase was analyzed by light
microscopy. I found that dcp2∆ cells had an irregular and heterogenous morphology and
were elongated and clumped together (Figure 3.2.B). Additionally, multiple vacuole-like
organelles in different sizes accumulated in these cells. Taken together, DCP2 is
required for normal growth and morphology of budding yeast.
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Figure 3. 1. Isolation of viable dcp2Δ mutants through tetrad dissection analysis
of heterozygous diploid DCP2/dcp2Δ.
(A) Diagram of tetrad analysis of heterozygous diploid DCP2/dcp2∆. (B) Tetrad
dissection results in wild-type and dcp2∆ colonies. If DCP2 is essential as annotated,
50% of the spores would be expected to be inviable. Instead 34% of the spores
analyzed were dcp2∆ and viable.
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Figure 3. 2. Severe growth and morphological defects were observed in viable
dcp2Δ isolated from heterozygous diploid DCP2/dcp2Δ.
(A) A growth assay shows a growth defect in dcp2∆ resulting from tetrad dissection.
Serially diluted cells were spotted on YPD plate and cultured at 30°C. The growth was
examined over time. (B) Microscopic image of dcp2∆ shows that dcp2∆ resulting from
tetrad dissection has a morphological defect. Cells were incubated in YPD at 30°C
until the exponential growth phase and examined by light microscopy. Bar represents
10µm.
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3.2.2. An experimental evolution of dcp2∆ strains results in the growth and
morphological improvement
To understand the function of DCP2 that affects cell growth, I decided to identify
suppressors of the growth defect of dcp2∆. I used an experimental evolution approach
that allows cells to accumulate mutations and enrich those suppressors that are
advantageous for fitness in the absence of DCP2 (dcp2∆), which can be more powerful
than high-copy suppressor screen in identifying smaller effects and double mutants. For
this, I grew four dcp2∆ strains that were isolated from distinct tetrads obtained from
tetrad dissection in biological duplicate. I then transferred dcp2∆ strains to new media in
iterations until the growth defect of dcp2∆ was rescued (Figure 3.3). Throughout the
experimental evolution process, growth of all dcp2∆ strains including
starting dcp2∆ strains (non-evolved) and dcp2∆ populations that are in the process of
evolution was examined either by measuring OD600nm of cells growing in YPD liquid
media at 30°C (Figure 3.4). During the course of evolution, I observed growth
improvement at the 90th generation compared to generation 0 (or non-evolved), and
further growth improvement was observed at the 180th generation. However, in most
cases, the growth improvement from 180 generation to 270 generations was insignificant
(Figure 3.4). Thus, I stopped the experimental evolution process after approximately 270
generations and further analyzed these dcp2∆ populations (evolved dcp2∆). All eight
evolved dcp2∆ populations show improved growth compared to their parental nonevolved dcp2∆ strain. However, evolved dcp2∆ populations still grow slower than the
wild-type control (Figure 3.4). These results indicate that the growth defect in nonevolved dcp2∆ strains is partially restored through the experimental evolution process.
Similar to the growth improvement, the morphological defects in nonevolved dcp2∆ strains are partially rescued in evolved dcp2∆ populations (Figure 3.5).
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Figure 3. 3. Diagram of experimental evolution.
Four non-evolved dcp2∆ (middle) from distinct heterozygous diploids (left) were
subject to serial passage in duplicate. For serial passage, cells were grown at 30°C
until the optical density at a wavelength of 600 nm (OD600) of the culture was > 8.5.
Then, the samples were transferred to new media in iterations until the growth rate
increases (right).
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Figure 3. 4. Improved growth of evolved dcp2Δ populations.
The growth curves of wild type (black), non-evolved dcp2Δ strains (green), their
evolving dcp2Δ populations after 90 generations (orange) and 180 generations
(purple) and evolved dcp2Δ populations (blue). Cells were grown in YPD at 30°C, and
OD600nm was measured every 10minutes for ~14 hours. Shown is the average OD from
two replicate cultures and their standard deviations, plotted on a log scale.
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Figure 3. 5. Morphological defects are partially rescued in evolved dcp2Δ
populations.
Representative microscopic images of a wild-type strain, four non-evolved dcp2∆
strains and eight evolved dcp2∆ populations are shown. Bar represents 10µm.
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Evolved dcp2∆ cells had a rather homogenous morphology, and they were less
elongated compared to non-evolved dcp2∆ cells. These results show that experimental
evolution of dcp2∆ successfully introduces suppressor mutations that confer growth
improvement of dcp2∆ strains.

3.2.3. Whole genome sequence analysis identified suppressors of dcp2Δ lethality
To identify suppressor mutations that conferred growth improvement to dcp2Δ
strains, I performed whole genome sequence (WGS) analysis on evolved dcp2Δ strains.
The genetic heterogeneity within a population could complicate the interpretation when
the genome of the population is analyzed. Thus, I isolated a single clone from each
evolved dcp2Δ population. As I observed in the evolved dcp2Δ populations in Figure
3.4, all eight evolved dcp2Δ isolates grew better than their non-evolved dcp2Δ
counterparts (Figure 3.6). In addition to population heterogeneity, there are intrinsic
variations between the reference S288C genome and the genome of its derivatives,
BY4741-4743 strains, that were used in the evolution experiment. Moreover, the four
starting dcp2∆ strains for the evolution that were generated from the DCP2/dcp2∆ diploid
would have polymorphisms unrelated to the loss of DCP2. Thus, I included the
heterozygous diploid DCP2/dcp2∆ strain to filter out those pre-existing variations. I
included one of the non-evolved dcp2Δ for the WGS analysis as well.
The WGS analysis revealed mutations in several genes in evolved dcp2Δ
isolates (Table 3.1). Each evolved dcp2Δ isolate contains nonsynonymous mutations in
two to six genes that are not present in the heterozygous diploid DCP2/dcp2Δ strain.
Most of them were point mutations including substitution and deletion/insertion of a small
number of bases, and no large deletion of genomic sequence or chromosome was
identified. Additionally, I analyzed the coverage of reads over all chromosomes to
determine if there is any aneuploidy that is often accompanied by the deletion of an
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Figure 3. 6. Experimental evolution of dcp2∆ strains results in growth
improvement.
A single colony was isolated from each evolved population and haploid starting strain.
Each of these genetically homogeneous strains was serially diluted, spotted on YPD
solid media, and grown at 30°C. Shown is the growth at day 2.
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Table 3. 1. Whole genome sequencing identifies multiple null mutations in
KAP123 and tL(GAG)G.
Whole genome sequences were determined for the eight evolved dcp2∆ isolates and
compared to the DCP2/dcp2∆ starting diploid. Nonsynonymous mutations that are not
present in the starting diploid are listed. fs: frame-shift mutation, X: nonsense
mutation.
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Figure 3. 7. Coverage depth of whole genome sequencing reads by
chromosome.
No sign of aneuploidy in eight evolved dcp2∆ isolates was observed. The coverage
depth for each chromosome was normalized to the coverage of the genome for that
strain and plotted. The mitochondrial genome is present in multiple copies, resulting in
higher coverage depth.
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essential gene (Liu et al., 2015). The coverage of reads for each chromosome was
similar among all strains sequenced. Based on reads coverage data, I concluded that
there is no sign of aneuploidy (Figure 3.7).
Interestingly, all eight evolved dcp2Δ strains had independently arising mutations
in the same gene, KAP123, which encodes a karyopherin. In total, six
different kap123 mutant alleles were identified from the evolved dcp2∆ strains.
Additionally, I identified mutations in tL(GAG)G and WHI2 which encodes a leucine tRNA
and a general stress response-mediating gene, respectively. Two mutant alleles for each
gene were identified in three evolved dcp2Δ isolates, but tL(GAG)G and WHI2 were not
mutated together in the same isolates. While there are mutations identified in other
genes or intergenic regions (Table 3.2), I decided to focus on genes that are mutated
multiple times.

3.2.4. A null mutation of KAP123, tL(GAG)G, or WHI2 is sufficient for the
suppression of dcp2Δ lethality
To understand the genetic interaction between DCP2 and the identified genes, I
investigated the consequence of suppressor mutation on the function of each gene.
Four kap123 mutant alleles have either a nonsense mutation or a frame-shift
mutation that generates a premature stop codon, and two mutations are missense
mutations, A550V and R1068S. Crystal structures of Kap123 in complex with cargo
revealed that R1068 is involved in intramolecular interaction (An et al., 2017) (Figure
3.8.A; PDB 5W0V). Although A550 has not been shown to interact with the substrate
directly, it is in HEAT repeat 13 that forms a binding pocket for the substrate (Figure
3.8.B; 5EV8). Therefore, it is likely that S. cerevisiae Kap123 A550 and R1068 are
important for substrate binding and intramolecular interaction, respectively. Thus, I
predict that kap123-A550V and kap123-R1068S are hypofunctional or nonfunctional. To
55

Table 3. 2. Whole genome sequence analysis of evolved dcp2∆ isolates revealed
mutation.
Mutations that are present outside of exonic region are summarized.
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Figure 3. 8. Crystal structure of Kluyveromyces lactis Kap123 in complex with
cargo.
A close-up view of K. lactis Kap123 shows (A) possible intramolecular interaction
mediated by R1068 and (B) position of A551 (corresponding to A550 of S. cerevisiae
Kap123) within an NLS-biding pocket (An et al., 2017).
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test if identified kap123 mutant alleles generating premature stop codon are unable to
express functional Kap123 protein, I examined the expression of Kap123 in evolved
dcp2Δ isolates as well as non-evolved dcp2∆. Western blot analysis showed that the
Kap123 protein was not detectable from six evolved dcp2∆ isolates harboring nonsense
or frame-shift mutation, implying destabilization of mRNA, protein, or both. In contrast, I
could detect Kap123-A550V and Kap123-R1068S even though the expression levels
appear to be lower than wild-type Kap123 (Figure 3.9).
I have demonstrated that tl(gag)g mutations identified in WGS are likely null, and
I will discuss this separately in chapter 4. I have not demonstrated if identified mutations
in WHI2 affect its function. However, I predict that whi2-Q20X allele would express an
unstable and severely truncated Whi2 protein.
Overall these data suggest that the mutations identified in evolved dcp2Δ isolates
are likely to be null and that disrupted functions of KAP123, tL(GAG)G, or WHI2
suppress the lethality of dcp2Δ. For genes that were mutated in multiple evolved dcp2Δ
isolates, I therefore tested whether a null mutation of each gene is sufficient to suppress
dcp2∆ lethality. To avoid selection of undesired suppressors during generation of
suppressor mutants, I started with the heterozygous DCP2/dcp2∆ strain and introduced
a URA3 plasmid that continuously expresses a functional DCP2. I then deleted KAP123,
WHI2, or tL(GAG)G allele in DCP2/dcp2∆ to generate DCP2/dcp2Δ KAP123/kap123Δ,
DCP2/dcp2Δ WHI2/whi2Δ, or DCP2/dcp2Δ tL(GAG)G/tl(gag)gΔ and performed random
spore isolation to obtain haploid progeny. The resulting strains were serially diluted and
spotted on solid media containing 5-FOA (5-Fluororotic acid). The URA3 gene product
converts 5-FOA to 5-FU (5-fluorouracil) which is toxic to cells. Therefore, 5-FOA media
selects for cells that have lost the wild-type DCP2 allele on the URA3 plasmid. The
deletion of DCP2 alone results in no growth, suggesting that DCP2 is essential for
viability (or normal growth). In contrast, introducing kap123Δ, tl(gag)gΔ, or whi2Δ null
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Figure 3. 9. Identified mutations in KAP123 are likely to be non-functional.
Western blotting shows the expression of Kap123 in evolved dcp2∆ isolates and nonevolved dcp2∆ strains. Pgk1 is used for loading control. Evolved dcp2∆ isolates that
have mutations generating a premature stop codon do not express Kap123. X=stop
codon and fs=frame-shift.
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mutation to dcp2Δ partially suppressed the lethality of dcp2Δ, indicating that the null
mutation of KAP123, tL(GAG)G, or WHI2 is sufficient for this suppression (Figure 3.10).
To test the independence of these genes in the suppression of the growth
phenotype of dcp2∆, dcp2∆ kap123Δ tl(gag)g∆ and dcp2∆ whi2Δ tl(gag)g∆ mutants were
created. Interestingly, the deletion of tL(GAG)G or whi2Δ in kap123Δ mutant produced a
synergistic effect on the growth of dcp2Δ (Figure 3.10), implying the mechanism of
suppression by the tl(gag)g mutation is independent of the kap123 and whi2 mutations.
Although I confirmed that kap123, tl(gag)g, and whi2 mutations are true
suppressors, I speculated that suppression of dcp2Δ lethality by mutations in WHI2 is
not directly related to the loss of DCP2 based on the following reasons. Multiple studies
have reported background mutations of WHI2 in many yeast knockout strains (Comyn et
al., 2017; Lang et al., 2013; Teng et al., 2013). Whi2 inhibits the TORC1 (target of
rapamycin complex 1) signaling pathway that regulates cell growth and stress response.
Thus, the loss of WHI2 would allow a cell to grow by derepressing this inhibitory
regulation, suggesting that the growth enhancement of whi2∆ could be nonspecific
(Loewith and Hall, 2011). Therefore, I decided to focus on KAP123 and tL(GAG)G for
the further analyses.

3.2.5. Other viable yeast strains of dcp2∆ or dcp1∆ possess suppressor mutations
Our WGS data suggest that DCP2 is required for viability of S. cerevisiae, but
this conclusion is not consistent with previous studies reporting that DCP2 is
dispensable for survival (Celik et al., 2017; Geisler et al., 2012). Although the difference
in the viability of dcp2Δ strains has been attributed to different yeast strain backgrounds,
data presented in this study led me to speculate that viable dcp2 strains from previous
studies already accumulated suppressor mutations that allow growth.
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Figure 3. 10. A null mutation of KAP123, WHI2, or tL(GAG)G is sufficient to
suppress the lethality of dcp2∆.
(A-B) Growth assays show that the extremely slow growth of dcp2∆ is suppressed by
kap123∆, tl(gag)g∆, or whi2∆. Null mutations of KAP123 and tL(GAG)G or WHI2 and
tL(GAG)G have an additive effect on the growth. Each strain expresses a URA3
plasmid expression DCP2. Cells were serially diluted and spotted on 5-FOA and SCURA solid media. (Note. Data shown in (B) was obtained by Lee-Ann Notice, a GSBS
student, during her tutorial rotation in the lab).
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To determine this possibility, I re-analyzed publicly available RNA-seq data for
the previously reported viable dcp2∆ and dcp1Δ mutants (Celik et al., 2017). Strains
analyzed in this RNA-seq experiment are in a different strain background, W303, instead
of S288C. Interestingly, I discovered that these decapping mutants indeed contain
mutations in KAP123 that are not present in their wild-type strains: kap123-Y687X allele
in dcp2Δ (Figure 3.11.A) and kap123-∆510-516 allele in dcp1Δ strains (Figure 3.11.B). I
also re-analyzed RNA-seq data for viable dcp2∆ in the S288C background published by
another group (Geisler et al., 2012). This is the same strain as non-evolved dcp2∆_4
parent in our WGS analysis but differently handled in a separate lab over time. I
discovered that this strain contains a kap123-T766fs allele that is different from
mutations that I identified in WGS analysis, but the same tl(gag)g-G25T allele as in my
non-evolved dcp2Δ_4 parent. Lastly, I performed a low-throughput assay to determine
whether other decapping mutant with another strain background have suppressor
mutations (Beelman et al., 1996). Because all of decapping mutants analyzed by either
WGS or RNA-seq contain mutations in KAP123, I focused on revealing potential
mutation in this gene. Supporting our hypothesis, I found a kap123-G727X mutation in
this dcp2∆ mutant.
Thus, the reported variability in the dcp2∆ growth phenotype among different
strains of yeast can be explained by previously undetected mutations in KAP123, not by
an authentic difference between these commonly used yeast strains. Overall, these data
suggest that DCP2 is an essential gene in S. cerevisiae.

3.2.6. There is no hierarchy in the occurrence of suppressors
One advantage of experimental evolution is that it can identify hierarchy in the
occurrence of suppressors, where particular mutation(s) only has an effect in the
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Figure 3. 11. Mutations in KAP123 in decapping mutants that have been
reported viable in other studies.
Shown are IGV snapshot of re-analyzed RNA-seq data. (A) Read coverage along the
KAP123 gene in wild-type and dcp2∆ strains (top). Enlarged sequences shows
mismatches between the TAC codon in the genome and TAA codon in the RNA-seq
reads (bottom). (B) Read coverage along the KAP123 gene in wild-type and dcp1∆
strains (top). Enlarged sequences shows 21 nucleotide deletion converting
CGCCTTGGacgacgttttcgtCGCCTTGG to CGCCTTGG in the RNA-seq reads
(bottom).
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presence of another mutation. To determine the order of suppressor mutations of dcp2Δ,
I compared sets of mutations identified in two evolved dcp2Δ isolates that originated
from the same non-evolved dcp2Δ. For instance, the evolved dcp2Δ_2-1 and 2-2,
two dcp2Δ isolates originated from the non-evolved dcp2∆_2 parent, have the same
mutations in two genes, WHI4 and KAP123. These two mutations are likely to have
arisen before the evolution process. However, distinct mutations were also identified
such as the mutation of RPO21 gene in evolved dcp2Δ_2-1 and the mutation of
tL(GAG)G gene in evolved dcp2Δ_2-2. These mutations are independently arising in
each lineage during evolution. In this way, I could obtain the order of the occurrence of
suppressors albeit incomplete (Figure 3.12). While mutations in KAP123, tL(GAG)G, and
WHI2 were likely to arise before the experimental evolution process in some cases,
these genes were also independently mutated during the evolution process. Therefore, it
appears that there is no hierarchy in the occurrence of mutations among KAP123,
tL(GAG)G, and WHI2.

3.2.7. The KAP123 mRNA level is not affected by the absence of decapping
activity
There are genes in S. cerevisiae whose change in dosage greatly impact the
growth phenotype. KAP123 is identified as one of the most dosage-sensitive genes
(Makanae et al., 2013). Thus, one possible mechanism for the suppression of
dcp2∆ lethality by mutations in KAP123 is that the loss of functional Kap123 reduces the
toxicity caused by stabilized KAP123 mRNA due to the absence of decapping activity of
Dcp2.
I sought to test whether the KAP123 mRNA is increased in the absence of
decapping activity. Because all the viable dcp2∆ strains contain mutations in KAP123, I
analyzed publicly available RNA-seq data for the other decapping mutants, dcp1∆ and
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Figure 3. 12. A schematic of the deduced order of the occurrence of mutations
in the experimental evolution experiment.
Nonsynonymous mutations that arose before the duplicate serial subculturing of
dcp2∆ (left) and nonsynonymous mutations that arose during the duplicate serial
subcultured (right) are indicated.
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the temperature-sensitive dcp2-7. The dcp1∆ mutant has a small in frame deletion in
KAP123, kap123-∆510-516, that would be less destructive on the mRNA level than
nonsense or frame-shift mutations identified in most dcp2∆ strains, and the dcp27 mutant does not possess any mutations in KAP123. I found that the KAP123 mRNA
levels did not change in both dcp1∆ and dcp2-7 mutants (Figure 3.13.A). The expression
of the Kap123 protein also did not change in the dcp2-7 mutant even after disrupting
decapping activity by growing cells at the restrictive temperature (Figure 3.13.B). These
results suggest that suppression of the growth defect of dcp2∆ by the kap123 mutation is
not due to the removal of KAP123 mRNA that can be toxic if stabilized.

3.2.8. Cytoplasmic mRNA decay is not restored by suppressors of dcp2∆
I next used several assays to determine if the suppressor mutations affect mRNA
decay rates or pathways. Because Dcp2 is essential for cytoplasmic mRNA decapping, I
first examined whether the decapping activity is restored in the evolved dcp2Δ strains. It
is possible that other enzymes with decapping activity such as Dcs1, Dxo1, Rai1, or viral
GAG coat protein compensate for the loss of DCP2, which leads to the suppression of
the growth defect of dcp2∆. As mentioned in chapter 1, Dcs1 cleaves the cap structure
that remains after the mRNA is degraded in the 3`-to-5` direction, Dxo1 and Rai1 digest
aberrant caps, and GAG transfers the cap from host cellular mRNAs to viral RNA (Blanc
et al., 1994; Chang et al., 2012; Doamekpor et al., 2020; Fujimura and Esteban, 2011;
Jiao et al., 2010; Liu et al., 2002; Xiang et al., 2009). Although they are not the canonical
enzyme removing m7G cap from the 5` end of mRNA to initiate 5`-to-3` decay, altered
localization, expression and/or substrate specificity of these decapping enzymes could
compensate for the loss of DCP2.
To test this possibility, I compared the decapping activity among wild-type, nonevolved, and evolved dcp2∆. I used a decapping reporter encoding the MFA2 gene with
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Figure 3. 13. Expression of KAP123 is not affected in dcp2 mutants.
(A) Published RNA-seq data were re-analyzed to compare KAP123 expression level in
wild type versus dcp2-7 (left) and wild type versus dcp1∆ (right). (B) Western blotting
shows that expression of Kap123 is not increased in decapping deficient cells. Pgk1 is
used for loading control. Lane 1-2: cells were grown at 30˚C, lane 3-4: cells were
grown at room temperature (RT), and lane 5-6: cells were grown at RT until OD600
reached 0.6~0.8 then transferred to 37˚C for 90 minutes.
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a poly (G) insertion in the 3` UTR. Poly (G) forms a strong secondary structure that
impedes exoribonucleases, and this allows the detection of trapped decay intermediates
that have undergone exonucleolytic degradation initiated from either end of mRNA
(Muhlrad et al., 1994). Northern blot assay of total RNA revealed that all of the nonevolved and evolved dcp2∆ strains did not accumulate decay intermediates as opposed
to wild type (Figure 3.14). This result demonstrates that the evolved dcp2Δ strains are
still defective in mRNA decapping. Furthermore, these data prove that the improved
growth observed in the evolved dcp2∆ strains is not due to the rise of Dcp2-independent
decapping activity.
In addition to exonuclease activity, some endonucleases have been shown to
cleave cytoplasmic mRNA. For example, Ire1 and tRNA splicing endonuclease (TSEN)
complex cleave HAC1 mRNA and CBP1 mRNA, respectively (Sidrauski and Walter,
1997; Tsuboi et al., 2015). Endonucleolytic cleavage of MFA2pG mRNA could initiate
Xrn1-mediated decay of the 3` cleavage fragment without decapping and produce short
decay intermediates trapped at the poly (G) sequence. However, the absence of decay
intermediates in evolved dcp2∆ strains does not support the involvement of
endonuclease in mRNA decay. Taken together, these data indicate that defective mRNA
decay activity has not been restored in the evolved dcp2∆ isolates.
Cytoplasmic mRNA is degraded by decapping and Xrn1-mediated 5`-to-3` decay,
and RNA exosome-mediated 3`-to-5` decay. Although the dcp2∆ suppressor mutants
are defective in the 5`-to-3` decay as shown in Figure 3.14, RNA exosome-mediated
mRNA decay may still be functional and possibly complement the loss of Dcp2. It has
been shown that conditional alleles in the decapping enzymes are synthetic lethal with
null mutations of the Ski complex, a cofactor of the RNA exosome (Anderson and
Parker, 1998). This result suggests that the two pathways are redundant. A growth
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Figure 3. 14. Suppressor mutations of dcp2∆ do not restore 5`-to-3` mRNA
decay.
(A) Norther blotting shows that 5`-to-3` mRNA decay is defective in evolved dcp2∆
strains. SCR1 is used for loading control. (B) Quantification of the MFA2pG mRNA
northern blot data in (A). Plotted is the mean ratio of decay fragment and full-length
mRNA and its standard deviation.
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Figure 3. 15. RNA exosome-mediated decay is required in dcp2∆ suppressor
mutants.
A growth assay shows that dcp2∆ kap123∆ tl(gag)g∆ is no longer viable in the
absence of SKI2. Each strain expresses a URA3 plasmid expressing. Cells were
serially diluted and spotted on 5-FOA and SC-URA solid media.
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assay shows that dcp2∆ kap123∆ tl(gag)g∆ is no longer viable in the absence of
SKI2, indicating that the RNA exosome-mediated 3`-to-5` decay pathway is essential in
decapping mutants (Figure 3.15). I then tested the steady-state level and stability
of endogenous GAL1, GAL7, and GAL10 mRNAs in the dcp2 mutants. Because viable
dcp2∆ strains already have suppressor mutations, I used the temperaturesensitive dcp2-7 allele in this experiment. The steady-state mRNA levels are comparable
among dcp2-7, dcp2-7 kap123∆, and dcp2-7 kap123∆ tl(gag)g∆ (Figure 3.16). Next, I
determined if the suppressors alter the decay rate of mRNAs in the dcp2 mutants. I
examined the stability of the GAL mRNAs, whose expression can be induced by growth
in the presence of galactose or repressed by dextrose in the media. mRNA levels were
measured after transcription was shut-off by adding dextrose in the media. I found that
the decay rate of GAL mRNAs was generally not significantly different among dcp2-7,
dcp2-7 kap123∆, and dcp2-7 kap123∆ tl(gag)g∆ strains (Figure 3.17). This result shows
that suppressor mutations do not alter the stability of endogenous mRNAs in the
decapping mutant.
Taken together, these data show that mRNA decay defect of dcp2-7 is not
restored by suppressors, indicating that the lethality of dcp2∆ is not due to the defective
cytoplasmic mRNA decay.

3.2.9. Global transcriptomic regulation by suppressors ameliorates defects in
dcp2 mutant
To better understand how the identified mutations affect the transcriptome to
suppress the lethality of dcp2∆, I performed global gene expression analysis. Wild type,
dcp2-7, dcp2-7 kap123∆, and dcp2-7 kap123∆ tl(gag)g∆ were subjected to RNA-seq
analysis after enrichment of poly(A)+ RNAs. Compared to wild type, dcp2-7 strain shows
1004 genes significantly (adjusted p-value < 0.05) upregulated by ³ 2-fold and 618
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Figure 3. 16. Steady-state levels of GAL mRNAs are not affected by kap123∆
and/or tl(gag)g∆ in DCP2 deficient cells.
Cells exponentially growing at 21°C in galactose were transferred to 37°C for 90
minutes. Total RNA was isolated and GAL mRNA levels were analyzed by northern
blotting. (A) A representative northern blot of GAL genes (top, 2nd and 3rd panels) from
the indicated strains is shown. SCR1 is used for loading control (bottom). (B) Plotted is
steady-state levels of GAL1, GAL7, and GAL10 mRNA relative to SCR1 levels of two
biological replicates.
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Figure 3. 17. Stability of GAL mRNAs is not affected by kap123∆ and/or tl(gag)g∆
in DCP2 deficient cells.
Cells exponentially growing at 21°C in galactose were transferred to 37°C for 1 hour.
Transcription of GAL was repressed by the addition of dextrose at time 0, and cells
were harvested at multiple time points. Total RNA was isolated and GAL mRNA levels
were analyzed by northern blotting. (A) A representative northern blot of GAL genes
(top, 2nd and 3rd panels) from the indicated strains is shown. SCR1 is used for loading
control (bottom). (B) Plotted is remaining GAL1, GAL7, and GAL10 mRNA levels
relative to SCR1 levels of two biological replicates. Data point triangles are pointing up
for one replicate, and down for the other.

73

genes downregulated by £ 2-fold (Figure 3.18.A). Fewer genes were affected in dcp2-7
kap123∆ mutant where 972 genes were upregulated by ³ 2-fold and 550 genes were
downregulated compared to wild type (Figure 3.18.B). There were even fewer significant
changes in the global transcripts levels in the dcp2-7 kap123∆ tl(gag)g∆ mutant where
752 genes were upregulated by ³ 2-fold and only 340 genes were downregulated by £ 2fold (Figure 3.18.C). Even the triple mutant showed widespread effects, indicating the
suppressors have significant but modest effects on the transcriptome.
Additionally, I compared the gene expression profile of dcp2-7 kap123∆ and
dcp2-7 kap123∆ tl(gag)g∆ to the dcp2-7 strain. Unlike the comparison to wild type, there
were many transcripts showing differential gene expression in the dcp2-7 background.
There were 102 genes upregulated by ³ 2-fold and 201 genes downregulated by £ 2-fold
in dcp2-7 kap123∆ tl(gag)g∆ mutant compared to dcp2-7 (Figure 3.19.A). In dcp27 kap123∆ mutant, there were only 10 genes upregulated by ³ 2-fold and 20 genes
downregulated by £ 2-fold (Figure 3.19.B).
I further analyzed the transcriptomic data to understand the underlying
mechanism of suppression by kap123∆ and tl(gag)g∆ mutations in the Dcp2-deficient
strain. To determine whether the suppression mechanism engages the regulation of
certain biological processes or cellular functions, we examined if any specific biological
processes are enriched in transcripts whose expression significantly changed at least 2fold (adjusted p-value < 0.05) via Gene Ontology (GO) enrichment analysis
(https://www.yeastgenome.org/goTermFinder).
When the gene expression of the dcp2 mutants, dcp2-7, dcp2-7 kap123∆, and
dcp2-7 kap123∆ tl(gag)g∆, were compared to wild type, the top five most enriched GO
terms on upregulated transcripts were related to RNA and ribosomal RNA modifications,
while the top five most enriched GO terms on downregulated transcripts were related to
cell cycle processes (Figure 3.20). Because the GO analysis results were similar among
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Figure 3. 18. Differential expression of transcripts between dcp2-7 mutants and
wild-type strain.
(A-C) Exponentially grown wild-type, dcp2-7, dcp2-7 kap123Δ, and dcp2-7 kap123Δ
tl(gag)gΔ cells were transferred to 37°C for 90 minutes to inactivate dcp2 temperaturesensitive allele. For transcriptomic analysis poly(A)+ RNA were sequenced. Volcano
plots showing differential gene expression of 7127 annotated genes in dcp2-7, dcp2-7
kap123Δ, or dcp2-7 kap123Δ tl(gag)gΔ versus wild-type. Transcripts that significantly
changed at least 2-fold (adjusted p-value <0.05) are in blue.
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Figure 3. 19. Differential expression of transcripts between dcp2-7 suppressor
mutants and dcp2-7.
(A-B) Exponentially grown wild-type, dcp2-7, dcp2-7 kap123Δ, and dcp2-7 kap123Δ
tl(gag)gΔ cells were transferred to 37°C for 90 minutes to inactivate dcp2 temperaturesensitive allele. For transcriptomic analysis poly(A)+ RNA were sequenced. Volcano
plots showing differential gene expression of 7127 annotated genes in dcp2-7
kap123Δ or dcp2-7 kap123Δ tl(gag)gΔ versus dcp2-7. Transcripts that significantly
changed at least 2-fold (adjusted p-value <0.05) are in blue.
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Figure 3. 20. Gene Ontology (GO) enrichment analysis of dcp2-7 mutants
compared to wild type.
(A-C) GO terms enriched for transcripts that were significantly upregulated and
downregulated at least 2-fold (adjusted p-value <0.05 in DESeq2) in dcp2-7 mutants
are in black and white, respectively. Default p-value of 0.01 was selected in GO Term
Finder analysis.
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Figure 3. 21. Gene Ontology (GO) enrichment analysis of dcp2-7 suppressor
mutants compared to dcp2-7.
(A-B) GO terms enriched for transcripts that were significantly upregulated and
downregulated at least 2-fold (adjusted p-value <0.05 in DESeq2) in dcp2-7
suppressor mutants are in black and white, respectively. Default p-value of 0.01 was
selected in GO Term Finder analysis.
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all three dcp2 mutants, we looked into transcripts that are differentially expressed
between dcp2-7 and dcp2-7 with suppressor mutations. The GO term analysis on
transcripts upregulated in dcp2-7 kap123∆ relative to dcp2-7 revealed enrichment of the
biological process related to cell adhesion, while the same analysis on transcripts
downregulated revealed the enrichment of the biological process related to organization
of nucleic acids (Figure 3.21.A). Interestingly, transcripts downregulated in dcp2-7
kap123∆ tl(gag)g∆ relative to dcp2-7 are enriched for rRNA modification process (Figure
3.21.B). This was particularly interesting because the RNA modification-related GO
terms were enriched in transcripts upregulated in dcp2-7 mutants relative to wild type.
Among the lists of genes that were queried for GO analysis, genes annotated in RNA
and rRNA modification-related GO terms were mostly encoding small nucleolar RNAs
(snoRNAs). Thus, snoRNA dysregulation in dcp2-7 compared to wild type was alleviated
by suppressor mutations.
To validate this prediction, I compared the changes in snoRNA levels in dcp2-7
and dcp2-7 with suppressors relative to wild type. The accumulation of snoRNA was
reduced in dcp2-7 kap123∆ and further reduced in dcp2-7 kap123∆ tl(gag)g∆ compared
to dcp2-7 (Figure 3.22). This result showed that defective snoRNA regulations in Dcp2deficient cells is partially rescued by suppressors. This pattern of regulation was not
limited to snoRNAs. mRNA dysregulation was also alleviated by suppressor mutations.
(Figure 3.23). However, it is still notable that RNA and ribosomal RNA modificationrelated genes are enriched in differentially expressed transcripts in Dcp2-deficient cells
leaving a possibility that Dcp2 regulates snoRNA expression.
In addition to the snoRNAs and mRNAs, another subset of RNAs was examined
for differential expression between dcp2-7 and dcp2-7 with suppressors. Xrn1-sensitive
unstable transcripts (XUTs) are known to be subject to Xrn1-mediated degradation (van
Dijk et al., 2011). Because Xrn1 functions downstream of Dcp2 in the cytoplasmic mRNA
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Figure 3. 22. Suppressors ameliorate expression defects from snoRNA loci in
dcp2-7 mutant.
(A-B) Defective snoRNA expression in dcp2-7 mutant was alleviated by kap123∆ and
further by kap123∆ tl(gag)g∆. Plotted is the differential expression of snoRNA loci in
suppressor mutants versus dcp2-7 mutant (relative to wild type). Of 77 snoRNA genes
in S. cerevisiae, 53 and 49 transcripts that are statistically significant (adjusted p-value
<0.05 of DESeq2) were plotted, respectively. The grey dashed line with slope 1 is the
predicted outcome if kap123∆ and tl(gag)g∆ had no effect. The red dashed line with
slope <1 depicts linear regression analysis results.
81

Figure 3. 23. Suppressors ameliorate defects in expression of protein coding
mRNA in dcp2-7 mutant.
(A-B) Defective mRNA expression in dcp2-7 mutant was alleviated by kap123∆ and
further by kap123∆ tl(gag)g∆. Plotted is the differential expression of mRNA loci in
suppressor mutants versus dcp2-7 mutant (relative to wild type). Of 6691 mRNA
genes in S. cerevisiae, 3236 and 3302 transcripts that are statistically significant
(adjusted p-value < 0.05 of DESeq2) were plotted, respectively. YBR115C,
YCR097W, YEL021W, YNL145W, YER110C and YPL187W are not plotted. The grey
dashed line with slope 1 is the predicted outcome if kap123∆ and tl(gag)g∆ had no
effect. The red dashed line with slope <1 depicts linear regression analysis results.
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Figure 3. 24. Suppressors ameliorate defects in expression of XUT noncoding RNA in dcp2-7 mutant.
(A-B) Defective XUT expression in dcp2-7 mutant was alleviated by kap123∆ and
further by kap123∆ tl(gag)g∆. Plotted is the differential expression of XUT loci in
suppressor mutants versus dcp2-7 mutant relative to wild type. Of 1658 XUT
genes in S. cerevisiae, 948 and 898 transcripts that are statistically significant
(adjusted p- value <0.05) were plotted, respectively. The grey dashed line with
slope 1 is the predicted outcome if kap123∆ and tl(gag)g∆ had no effect. The red
dashed line with slope <1 depicts linear regression analysis results.
83

decay pathway, we investigated whether the expression of XUTs is differentially
regulated with suppressors in Dcp2-deficient cells. Like mRNAs, dysregulation of XUTs
was also alleviated by kap123∆ and further by kap123∆ tl(gag)g∆ (Figure 3.24).
Overall, my data show that global transcriptomic changes in the Dcp2-deficient
strain are mitigated by suppressors. Therefore, Dcp2 plays important roles in regulating
not only mRNA but also non-coding RNAs such as snoRNAs and XUTs.
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3.3. DISCUSSION
Cytoplasmic mRNA turnover is one of the important processes that regulate the
gene expression. Despite the redundancy of multiple pathways in cytoplasmic mRNA
decay, disruption of certain genes involved in the mRNA turnover show more severe
growth defects than the deletion of others. For instance, although inconsistent between
studies, DCP2, has been suggested to be essential for viability in budding yeast. In
contrast, XRN1, which is functioning downstream of DCP2 in 5`-to-3` decay pathway, is
not essential. This difference suggests that DCP2 may have an additional function that is
critical for the cell growth.
In this study, I showed that DCP2 is indeed essential for the viability of S.
cerevisiae. Through experimental evolution, I identified multiple mutations,
including kap123, tl(gag)g, and whi2, that suppress the lethality of dcp2∆. I also found
that the dcp2∆ strains previously reported as viable possess pre-existing suppressor
mutations in KAP123 and tL(GAG)G.
I sought to determine how the identified mutations suppress dcp2∆ lethality. I
observed that suppressors do not complement mRNA decay defects in the
dcp2∆ mutant. The RNA exosome-mediated 3`-to-5` decay of mRNA is still active in the
absence of DCP2, but its contribution to overall mRNA turnover is not improved by the
suppressors. Similarly, mRNA decapping activity remains defective in the suppressor
mutants. These data show that alternative mRNA decay pathways do not compensate
for the loss of DCP2 and that the lethal phenotype of dcp2∆ is unlikely due to defective
decapping and mRNA decay. This conclusion led me to speculate that the
physiologically crucial role of DCP2 is unrelated to the turnover of bulk cytoplasmic
mRNA. In support of this, Dcp2 and Xrn1 have been shown to regulate a specific cellular
process, autophagy, in yeast and mammalian cells (Hu et al. 2016, Delorme-Axford
2018). In addition, several studies suggested other roles of Dcp2 than decapping of
85

cytoplasmic mRNAs. DCP2 and XRN1 have been proposed to play roles in transcription
(van Dijk et al., 2011; Geisler et al., 2012; Haimovich et al., 2013).
Our transcriptomic analysis of dcp2 mutants suggests the possibility that DCP2 is
involved in the regulation of snoRNAs in S. cerevisiae. Accumulation of snoRNAs in the
dcp2-7 mutant was reduced by kap123∆, and it was further reduced by kap123∆
tl(gag)g∆. Also, the genes related to RNA modification were enriched in the transcripts
that are differentially expressed in dcp2-7 with suppressors relative to dcp2-7.
Interestingly, NUDIX domain-containing enzymes other than Dcp2 have been implied in
the snoRNA regulation in mammals, Xenopus, and C. elegans (Cohen et al., 2005;
Gaviraghi et al., 2018; Ghosh et al., 2004). These studies showed that Dcp2 homologs
remove trimethylguanosine (TMG) cap on snoRNAs or synthetic RNA molecules.
Additionally, Cohen et al. showed that yeast Dcp2 has a decapping activity toward TMG
capped RNA in vitro even though it was less efficient than the C. elegans Dcp2. Further
study is necessary to determine whether the yeast Dcp2 has the TMG hydrolysis activity
in vivo. It is tempting to test whether the yeast Dcp2 is involved in the snoRNA
decapping.
While snoRNA genes are enriched in transcripts that are dysregulated in Dcp2deficient cells and partially rescued with suppressors, I have not found mutations in
snoRNA genes, snoRNA biogenesis genes, or RNA modification enzyme genes in WGS
analysis. This result suggests that changes in snoRNA expression are a consequence of
improved growth rather than the mechanism of suppression. Alternatively, changes in
snoRNA expression by suppressors drive improved growth. Although dysregulation of a
single snoRNA gene may not be significant as most snoRNAs are not essential for
viability, simultaneous alteration of multiple snoRNAs could be detrimental to the cell.
Although I have not experimentally shown impaired snoRNA functions in the
dcp2 mutant, it is possible that the biogenesis of ribosomal RNAs or tRNAs is defective
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Figure 3. 25. Summary.
Growth: DCP2 is required for normal growth, and suppressor screening of dcp2∆
identified mutations in KAP123 and tL(GAG)G that partially restore the growth defect.
mRNA decay: Several assays have shown that 5`-to-3` decay is still defective in
suppression mutants, while the RNA exosome-mediated 3`-to-5` decay mediates
mRNA decay in the absence of DCP2. Transcriptome: Suppressor mutations partially
restore transcriptomic defect of dcp2∆. This effect is the most significant for snoRNA,
and less prominent for XUT and mRNA.

87

in the dcp2 mutant.
Lastly, the additive effects observed for both the growth improvement and the
snoRNA levels by two suppressors, kap123∆ and tl(gag)g∆, implies that mechanisms of
suppression by these two mutations are independent. In addition, there is no hierarchy
among suppressors in alleviating the growth defect of the dcp2 mutant.
Taken together, data presented in this chapter show that DCP2 is an essential
gene in budding yeast, and the essential function of Dcp2 is not attributed to its mRNA
decapping activity. The suppressor screen I performed identified a small number of
genes whose deletion suppresses the lethality of dcp2∆. Instead, transcriptomic
analyses showed that dysregulation of snoRNAs, mRNA, and XUTs in dcp2-7 is
alleviated by suppressors (Figure 3.25).
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Chapter 4. Genetic interaction between DCP2 and tL(GAG)G required for
suppression of dcp2∆ lethality

Portions of this chapter have been taken from the following published article*:
Kim, M., & van Hoof, A. (2020). Suppressors of mRNA Decapping Defects Restore
Growth Without Major Effects on mRNA Decay Rates or Abundance. Genetics, 216(4),
1051–1069. https://doi.org/10.1534/genetics.120.303641
*Permission from the Genetics Society of America is not needed if an article on which I
am an author is reproduced for dissertation.
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4.1. INTRODUCTION
As previously shown in chapter 3, experimental evolution of a dcp2 null (dcp2∆)
strain selects for mutations that confer growth improvement. In addition to mutations in
KAP123, I identified two independently arising mutations in tL(GAG)G encoding a
leucine tRNA with a GAG anticodon. In this chapter, I will further discuss how mutations
in tL(GAG)G mediate suppression of lethality of dcp2∆.
During translation, tRNAs decode mRNA codons and bring the cognate amino
acids to the ribosome (Rich and Rajbhandary, 1976). The yeast genome encodes four
different leucine tRNAs to decode six different leucine codons, UUG, UUA, CUA, CUG,
CUC, and CUU. Although there are only four different leucine tRNAs, there are 21
leucine tRNA genes. There are ten tL(CAA) genes for leucine tRNAs with a CAA
anticodon that are thought to translate only UUG codons, seven tL(UAA) genes for
leucine tRNAs with a UAA anticodon to translate UUA codons, and three tL(UAG) genes
for leucine tRNAs with a UAG anticodon that can translate all four CUN codons
(Weissenbach et al., 1977). Lastly, a single tL(GAG) gene decodes CUC and CUU
codons (http://gtrnadb.ucsc.edu/) (Chan and Lowe, 2009, 2016; Percudani et al., 1997).
Although each of six different codons codes for leucine, the frequency by which these
codons are used varies up to approximately 5-fold. UUG and UUA are the most
frequently used as they comprise 28% and 27% of total leucine codons, respectively.
While 14%, 13% and 11% of leucine codons are CUA, CUU and CUG, only 6% is CUC.
Interestingly, although the tL(GAG)G tRNA is the only tRNA that can decode
CUC/CUU codons through standard base pairs, the tL(GAG)G gene is not essential for
viability (Crick, 1966; Huang et al., 2012). It has been shown that the absence of
tL(GAG)G can be partially compensated by tL(UAG) tRNAs that form superwobbling
base pairs to CUC/CUU codons (Alkatib et al., 2012; Bloom-Ackermann et al., 2014;
Huang et al., 2012; Rogalski et al., 2008). Specifically, strains with deletions of either
tL(GAG)G or two of the three tL(UAG) genes are viable, but a triple deletion of
90

tL(GAG)G and two tL(UAG) genes is inviable (Bloom-Ackermann et al., 2014). Although
the translational efficiency of CUC/CUU codons by tL(UAG) tRNA in tl(gag)g∆ has not
been directly tested, the superwobbling between GGC/GGU codons and tRNAGly(UCC)
in plants is known to decrease translational efficiency (Rogalski et al., 2008). Thus, it is
possible that inefficient translation of CUC/CUU codons by tL(UAG) tRNAs in tl(gag)g∆
causes ribosome pausing.
In addition to affecting translation, codon choice and the abundance of tRNAs
can also affect mRNA degradation. As discussed in the introduction, no-go mRNA decay
is triggered when a ribosome is stalled during translation. One efficient trigger of no-go
decay is having 2 or more CGA codons in a row. Translation of a CGA codon requires
an A-I base pair between the third nucleotide of the codon and the first nucleotide of the
ICG anticodon. Replacing the I in the anticodon with a U prevents no-go decay at CGA
codons (Letzring et al., 2010). More broadly, mRNA decay rates are affected by the
codons being used, with nonoptimal codons destabilizing mRNAs, while optimal codon
stabilizing mRNAs (Presnyak et al., 2015). For leucine, the UUG codon has the highest
optimality, followed by UUA, CUU, CUA, CUC and CUG (Presnyak et al., 2015). The
optimality scores for CUU, CUA, and CUC are very similar (Presnyak et al., 2015), and
thus are expected to have similar effects on mRNA stability, although the equivalence of
these Leu codons has not been experimentally addressed.
In addition to their function in mRNA translation, tRNAs are involved in signaling
pathways. A very well-characterized example is that uncharged tRNAs accumulated
under amino acid starvation activate General Control Nonderepressor 2 (Gcn2), a
protein kinase that mediates general amino acid control (GAAC) signaling in yeast and
mammals (Dever et al., 1992; Dong et al., 2000; Zhang et al., 2002b). Activated Gcn2
induces general translational repression through phosphorylation of translation initiation
factor eIF2a. Amino acid starvation also inhibits the target of rapamycin complex 1
(TORC1) in a signaling pathway that is a master regulator of cellular growth. Studies
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showed that uncharged tRNA itself or activated Gcn2 inhibits TORC1 in budding yeast in
response to amino acid starvation, including leucine (Kamada, 2017; Yuan et al., 2017),
which would slow down growth. Thus, it is interesting to study if uncharged tRNAmediated signaling is associated with the suppression of dcp2∆ lethality.
In addition to intact uncharged tRNAs functioning as signaling molecules, tRNA
fragments are also thought to serve signaling functions and have been implicated in
diverse human diseases (Anderson and Ivanov, 2014). In yeast, and other eukaryotes,
such tRNA halves are produced via splicing of the anticodon loop of tRNAs in response
to oxidative stress (Thompson et al., 2008) and this promotes cell death (Thompson and
Parker, 2009). How these tRNA fragments are sensed is unknown.
Finally, tRNA genes can have effects that are independent of the tRNA product.
tRNA genes and their flanking regions are localized to the nucleolus (Thompson et al.,
2003) and function as boundary elements that delineate regions of heterochromatin and
euchromatin (McFarlane and Whitehall, 2009). Both of these effects are thought to be
due to the high transcription rate of RNA polymerase III instead of the tRNA molecules
themselves. Both altered localization within the nucleus and altered chromatin state
could affect expression of genes linked to tL(GAG)G.
In this chapter, I demonstrate that the identified mutations in tL(GAG)G suppress
the lethality of dcp2∆ and a null mutation of tL(GAG)G is sufficient for the suppression.
Additionally, I sought to delineate the mechanism by which tl(gag)g mutations suppress
the lethality of Dcp2-deficient cells. First, I show that the tL(GAG)G effect on dcp2∆
viability is independent of its chromosomal location. Thus, it does not appear to act by
altering expression of neighboring genes. Second, I wondered whether tL(GAG)G was
required for the efficient translation of CUC/CUU codons. However, the loss of
tL(GAG)G does not impact the expression of mRNAs designed to contain CUC/CUU
codons. This result suggests that translation of these codons by tL(UAG) and tL(GAG)G
is equally efficient. Third, tL(GAG)G differs from other tRNAs at multiple positions. I
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show that only the presence of a GAG anticodon of this tRNA plays an important role in
the genetic relationship with dcp2∆. Overall, I propose that tL(GAG)G affects translation
of CUC/CUU codons in specific but unknown context, and this specialized translation
role affects dcp2∆ lethality.
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4.2. RESULTS
4.2.1. The growth defect of dcp2∆ is suppressed by absence of mature tL(GAG)G
As explained in chapter 3, I selected for suppressors of the growth defect of a
decapping mutant in pursuit of understanding the essential function of DCP2. Briefly,
experimental evolution of slow growing dcp2∆ strains resulted in cells with improved
growth. Whole genome sequence analysis revealed mutations that might confer growth
improvement of dcp2∆. One of the interesting genes that were mutated in dcp2∆ was
tL(GAG)G. Two different tl(gag)g alleles, tl(gag)g_nt25_G>T and tl(gag)g_nt47_T>C,
were independently identified from three evolved dcp2Δ out of eight evolved isolates.
The single base substitutions I identified are located in the D-arm
(tl(gag)g_nt25_G>T) and variable stem (tl(gag)g_nt47_T>C) of tL(GAG)G and are
predicted to disrupt tRNA folding (Figure 4.1 and 4.2). The tRNA structure is important
for processing of pre-tRNA to mature tRNA, stability of the tRNA, and function of the
tRNA (Reviewed in (Phizicky and Hopper, 2010; Rak et al., 2018). Thus, I examined the
processing and expression levels of transcripts from mutant tl(gag)g by northern blot.
Strains carrying the wild-type tL(GAG)G allele express both the precursor and mature
tRNA (Figure 4.3). In contrast, three evolved dcp2Δ isolates harboring mutations in
tL(GAG)G only produce the 5` extended precursor. The 5` extended precursor was more
abundant in the three evolved dcp2∆ isolates compared to wild-type tL(GAG)G strains.
The increased levels of pre-tRNA but reduced level of mature suggest that the mutations
do not prevent transcription, but may inhibit the processing of tL(GAG)G. Transcription
by RNA polymerase III is directed by sequence elements located in the beginning of the
D-stem loop and in the y-loop (Sharp et al., 1981), and these regions are not mutated.
On the other hand, pre-tRNA processing by RNase P and Z and mature tRNA stability
require the intact tRNA fold (Brillante et al., 2016; Hartmann et al., 2009; Lan et al.,
2018; Skowronek et al., 2014; Xiao et al., 2001). Thus, perhaps the mutations in
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Figure 4. 1. Disruption of the secondary structure of mutant tL(GAG)G tRNAs in
dcp2∆ suppressor mutants.
(A) A predicted secondary structure of the wild-type tL(GAG)G tRNA is shown. The
tRNA structural elements are indicated. (B) Predicted secondary structures of mutant
tL(GAG)G tRNAs. Mutations identified in evolved dcp2∆ isolates are indicated with an
arrow (See also Figure 4.2).
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Figure 4. 2. Disruption of tertiary structure of mutant tL(GAG)G tRNA in dcp2∆
suppressor mutants.
(A) A predicted tertiary structure of the wild-type tL(GAG)G tRNA is shown (top).
Sequences for a GAG anticodon is indicated. Different colors were assigned to
different tRNA structural elements. The color scheme used is shown at the bottom. (B)
Predicted tertiary structures of tl(gag)g_nt25_G>T (right) and tl(gag)g_nt47_T>C (left).
The same color scheme is used as in (A). All three structures were predicted by
RNAComposer, RNA structure 3D modeling server. All structures are presented in the
orientation relative to the GAG anticodon.
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Figure 4. 3. Defects in tRNA processing of evolved dcp2∆ isolates harboring
mutations in tL(GAG)G.
A northern blot shows the expression of tL(GAG)G tRNA from indicated strains (top
and middle). SCR1 is used for lading control (bottom). Evolved dcp2∆_2-1, 4-1, and 42 are identified to have the indicated mutation in tL(GAG)G. These three isolates do
not express mature tL(GAG)G tRNA. An oligonucleotide complementary to mature
tRNA (top) or to 5` extended precursor of tRNA (middle) is used for probing.
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tL(GAG)G cause structural perturbations that interfere with 5` end processing by RNase
P and may also reduce stability of the mature tRNA.
Interestingly, non-evolved dcp2Δ_4 strain accumulated the pre-tRNA and did not
produce the mature tRNA (Figure 4.3). The two evolved dcp2∆ strains derived from the
dcp2∆_4 (evolved dcp2∆_4-1 and 4-2) had the same allele, suggesting that G to T
mutation had already arisen in their common ancestor strain, non-evolved dcp2Δ_4.
Since mutations in tL(GAG)G result in the accumulation of unprocessed pretRNA transcripts, I wondered whether these mutant transcripts could be responsible for
the suppression of dcp2Δ lethality. Thus, I examined the growth of dcp2∆ tl(gag)g∆
complemented by the wild-type tL(GAG)G or mutant tl(gag)g. For this, the dcp2Δ
tl(gag)gΔ strain carrying a URA3 plasmid expressing DCP2 and a LEU2 plasmid
encoding tL(GAG)G variants was generated from a double heterozygous DCP2/dcp2∆
tL(GAG)G/tl(gag)g∆ strain. To avoid the accumulation of suppressors in the absence of
essential DCP2 gene, a plasmid encoding a functional DCP2 allele (DCP2-RFP) was
included during the strain generation. Growth on media containing 5-FOA, which
counter-selects against the DCP2 URA3 plasmid, showed the suppression of dcp2∆
lethality by tl(gag)g∆ as previously shown in chapter 3 (Figure 4.4, the 4th row). One
important result is that the wild type tL(GAG)G gene complemented the tl(gag)g∆
(restored dcp2∆ lethality Figure 4.4, compare the 4th and 5th rows). Thus tL(GAG)G
affects dcp2∆ viability even when it is expressed outside its normal locus. A second
important result is that growth of dcp2∆ tl(gag)g∆ containing the tl(gag)g_nt25_G>T or
tl(gag)g_nt47_T>C alleles was similar to vector only controls (Figure 4.4, the 4th and 6th7th rows). These results show that the mutant tRNA locus does not produce some
aberrant RNAs that affect dcp2Δ lethality.
To summarize, the data suggest that the G25T and T47C mutations in tL(GAG)G
cause a processing and/or stability defect of the tRNA. However, the suppression of the
growth defect of dcp2∆ is not due to effects on flanking chromatin structure or
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Figure 4. 4. Suppression of dcp2Δ lethality by two identified mutant tl(gag)g
alleles.
Growth assay shows that the lethality of dcp2∆ is suppressed by a null mutation of
tL(GAG)G or by mutations identified in evolved dcp2∆ isolates. Each strain was
transformed with a URA3 plasmid expression DCP2 and a LEU2 plasmid expressing
tL(GAG)G variants. Cells were serially diluted and spotted on 5-FOA and SC-URALEU (control) solid media.
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localization or the accumulation of the precursors of tL(GAG)G or aberrant RNAs.
Instead, the suppression results from the loss of mature tL(GAG)G, and loss of
functional tL(GAG)G tRNA is sufficient to suppress the lethality of dcp2Δ.

4.2.2. The loss of tL(GAG)G has no detectable impact on the translation of reporter
mRNAs harboring CUC and CUU codons
Because the major function of tRNAs is to decode mRNA codons during
translation, the loss of functional tRNA would be expected to impair translation.
However, tL(GAG)G is not essential for viability and thus not essential for translation
(Bloom-Ackermann et al., 2014; Huang et al., 2012). Furthermore, tl(gag)g∆ does not
cause slow growth (Huang et al., 2012), suggesting that global translation is not severely
defective. However, it is possible that in the absence of tL(GAG)G, suboptimal decoding
at CUC/CUU codons causes ribosome pausing. To examine the impact of tl(gag)g∆ on
translation, I utilized two different mRNA reporter systems designed to sensitize
translation to the loss of tL(GAG)G.
The first reporter system encodes His3, an enzyme required for histidine
biosynthesis, and translational efficiency of it can be indirectly determined by cell growth
on media lacking histidine (e.g. (van Hoof et al., 2002). I engineered the HIS3 coding
region by replacing all 20 leucine codons with CUC/CUU codons (HIS3-CUY) or with a
synonymous CUA codon as a control (HIS3-CUA) (Figure 4.5.A). When choosing the
synonymous codon for the control reporter, codon optimality of mRNA was maintained
because it is one of the major determinants of mRNA stability (Presnyak et al., 2015).
Additionally, I constructed optimized HIS3 reporters where all codons except leucine
codons are replaced by optimal codons (HIS3-opt-CUY and HIS3-opt-CUA) (Figure
4.5.C). I reasoned that the effect of nonoptimal Leu codons might be enhanced if all
other non-optimal codons are removed. Using these reporters, I compared the
translational efficiency at CUC/CUU codons between wild type and tl(gag)g∆. Growth on
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Figure 4. 5. The loss of tL(GAG)G does not have detectable impact on decoding
at CUC and CUU codons.
(A) HIS3 reporter constructs for examining CUY (Y=C or U) or CUA decoding
efficiency. Reporters were constructed by replacing 20 leucine codons with either CUY
or CUA. (B) The HIS3 growth assay shows that the growth of wild type and tl(gag)g∆
expressing either CUY or CUA reporter in histidine depleted (SC-URA-HIS) and
control (SC-URA) solid media. (C) Optimized HIS3 reporter constructs for testing CUY
or CUA decoding efficiency. Similar to reporters shown in (A), leucine codons are
replaced with CUY or CUA. Additionally, all the other codons in HIS3 are replaced with
optimal codons. (D)The HIS3 growth assay shows that the growth of wild type and
tl(gag)g∆ expressing optimized CUY or CUA reporter in histidine depleted (SC-URAHIS) and control (SC-URA) solid media. Decoding of CUC/CUU codons in HIS3
coding region is sufficient to support the growth of tl(gag)g∆ in histidine depleted
media.
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media lacking histidine was determined as a proxy for translation of His3 from the
reporter. The tl(gag)gΔ mutant expressing empty vector grew comparably to the wildtype strain expressing empty vector on control media (Figure 4.5.B). This result
corroborates the previous study showing that tL(GAG)G does not affect growth or
viability (Huang et al., 2012). Wild type expressing either the HIS3-CUY or HIS3-CUA
reporter grew similarly on histidine-deprived media, suggesting that the usage of
different synonymous codons does not detectably impact translation. Most importantly,
the growth of tl(gag)g∆ expressing the HIS3-CUY reporter was comparable to that of
wild type expressing HIS3-CUY reporter (Figure 4.5.B). These results indicate that the
translation of HIS3-CUY reporter is sufficient to support growth of tl(gag)gΔ in histidinedeprived media. Similar results were observed for the growth of cells expressing
optimized reporters (Figure 4.5.D). These data confirm that tL(GAG)G-mediated
decoding at CUC/CUU codons is not essential in normal condition as reported in the
previous study (Huang et al., 2012). While the decoding efficiency at CUC/CUU codons
by tL(UAG) tRNAs through superwobbling might be lower than decoding by cognate
tL(GAG)G tRNA, any defect is not severe enough to be detected by the HIS3 growth
assay.
In the second reporter mRNA system I inserted 12 consecutive Leu codons into
an mRNA. In the HIS3 reporter, the 20 leucine codons are spread throughout the 220
codon coding region. Other codon effects, such as the effect of CGA codons on no-go
decay, is much more pronounced if the codon is repeated (Letzring et al., 2010). Thus, I
constructed reporters where 12 consecutive leucine codons link Protein A and Green
Fluorescent Protein (GFP) (Figure 4.6.A). In one construct all 12 codons were CUC,
while a control construct contained CUA codons instead. This reporter design is similar
to that used to detect translation stalls and no-go mRNA decay triggered by CGA codon
repeats (Brandman et al., 2012; Dimitrova et al., 2009). The diagnostic readout of severe
stalls is a reduction of the level of full-length protein and a production of truncated
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Figure 4. 6. The loss of tL(GAG)G does not have detectable impact on decoding
at CUC codon.
(A) Reporter constructs for testing CUC or CUA decoding efficiency. Sequences
encoding 12 consecutive leucine codons is inserted between Protein A and GFP
sequences. Leucine codons are encoded by either CUC or CUA codon. (B) Western
blot analysis shows the expression of Protein A-Leu12-GFP from the (CUC)12 or
(CUA)12 reporter shown in (A) (top). Pgk1 is used for loading control (bottom). Note
that the Protein A signals remain on the Pgk1 blot (*). The level of Protein A-Leu12GFP from (CUC)12 reporter in tl(gag)∆ is comparable to wild type.
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proteins that end at the repeat. I thus measured production of both full-length Protein A(Leu)12-GFP protein and truncated Protein A-(Leu)n protein by western blotting assay
using anti-Protein A antibody. Protein A-Leu12-GFP from the reporter where CUC codon
is used was expressed similarly in tl(gag)g∆ and wild type (Figure 4.6.B). Additionally,
the expression of the Protein A-Leu12-GFP was similar between the CUC and CUA
reporters (Figure 4.6.B), and none of the reporters accumulated detectable truncated
proteins that contained the protein-A sequences but lacked the GFP portion. These
results suggest that even 12 consecutive CUC codons are efficiently translated in the
absence of tL(GAG)G.
The above experiments were performed in strains with an intact DCP2 gene.
Thus, I wondered whether tL(GAG)G is important for decoding CUC/CUU codons only in
Dcp2-deficient cells. In addition, as the suppression of dcp2Δ lethality is more noticeable
with tl(gag)gΔ kap123Δ double mutations than with tl(gag)gΔ single mutation (Figure
3.10), I decided to test the CUC/CUU decoding in the absence of both DCP2 and
KAP123. For this, I examined the translation of the aforementioned HIS3 reporters in
dcp2∆ tl(gag)g∆ kap123∆ by the HIS3 growth assay. The data showed that dcp2Δ
tl(gag)gΔ kap123Δ expressing the HIS3-CUY or HIS3-CUA reporters grew comparably,
indicating tl(gag)g∆ does not have a detectable impact on the decoding of CUC/CUU
codons in dcp2∆ (Figure 4.7). Thus, I concluded that the growth suppression of dcp2∆
by the tL(GAG)G deletion is not because of inefficient global translation and ribosome
stalling on suboptimal CUC/CUU codons.
Taken together, data suggest that overall translation of CUC/CUU codons is not
detectably affected by the loss of tL(GAG)G. The data also corroborate previous studies
suggesting that tL(UAG) tRNAs decode CUC/CUU codons in the absence of tL(GAG)G
via unconventional superwobble base pairing (Alkatib et al., 2012; Bloom-Ackermann et
al., 2014; Huang et al., 2012; Rogalski et al., 2008).
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Figure 4. 7.The loss of tL(GAG)G does not have detectable impact on decoding
at CUC and CUU codons in the dcp2 mutant.
(A) HIS3 reporter constructs for testing CUY (Y=C or U) or CUA decoding efficiency.
These are the same reporters shown in Figure 4.5. (A) and (C). (B) The HIS3 growth
assay shows that the growth of dcp2∆ kap123∆ tl(gag)g∆ expressing reporters shown
in (A) in histidine depleted (SC-URA-HIS) and control (SC-URA) solid media.
Decoding of CUC/CUU codons in HIS3 coding region is sufficient to support the
growth of dcp2∆ kap123∆ tl(gag)g∆ in histidine depleted media.
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4.2.3. Suppression of dcp2Δ lethality by tl(gag)g is attributed to a GAG anticodon
The tl(gag)g∆ that affects viability of dcp2∆ affects one specific tRNA gene out of
the 275 tRNA genes in the yeast genome. This suggests that this tRNA must have some
unique feature that governs the dcp2∆ genetic interaction. I therefore determined what
sequence elements of tL(GAG)G are important for genetic interaction with dcp2∆.
My experimental evolution experiment also identified mutations in WHI2, and
Whi2 is thought to signal leucine starvation to the TOR pathway (Chen et al., 2018; Teng
et al., 2018). Therefore, I first considered the possibility that uncharged tL(GAG)G might
serve a signaling function. Two variants of tL(GAG)G, tL(GAG)GA73C and tL(GAG)GU55G,
were constructed to test a possible relationship between the suppression
of dcp2Δ lethality and uncharged tRNA levels (Table 4.1). Both A73 and U55 are known
to be critical for aminoacylation (Du and Wang, 2003; Soma et al., 1996; Yao et al.,
2008). Unlike expression of wild-type tL(GAG)G tRNA, the growth of dcp2∆ kap123∆
tl(gag)g∆ strain transformed with A73C or U55G mutant is comparable to the empty
vector control (Figure 4.8.A). However, northern blot analysis shows that the expression
levels of these mutant tRNAs are strongly reduced (Figure 4.8.B). These results indicate
A73 and U55 are important for the stability of tL(GAG)G, and the resulted growth
improvement by the expression of these mutants is due to the absence of tRNA but not
due to the presence of uncharged tL(GAG)G tRNAs. Thus, it is hard to conclude whether
uncharged tRNA is directly involved in the tl(gag)g-mediated suppression mechanism.
Next, I focused on the nucleotides that are different between tL(GAG)G and other
leucine tRNAs. There are 12 nucleotides that are unique in tL(GAG)G. Eight of these
replace one base pair with another and seemed unlikely to affect tRNA function. The
other four includes three nucleotides in the anticodon loop and one in the y loop. Thus,
the anticodon loop of tL(GAG)G was replaced by that of tL(UAG) in one allele, and A57
was changed to a G in another allele. Both of these mutant tRNAs were expressed
similarly to WT (Figure 4.8.B) but caused different growth phenotypes (Figure 4.8.A).
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Table 4. 1. Six tl(gag)g mutants used in Figure 4.7
* Note. Numbering of tRNA base is based on the tRNA numbering system (Sprinzl et
al., 1998).
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Figure 4. 8. The anticodon mutation of tL(GAG)G is sufficient to suppress the
lethality of dcp2∆.
(A) The growth of dcp2∆ kap123∆ tl(gag)g∆ expressing tL(GAG)G tRNA variants is
shown. The expression of UAG or AC loop mutant of tL(GAG)G does not inhibit the
growth of dcp2∆ kap123∆ tl(gag)g∆. ((Note. Data shown in (A) was obtained by LeeAnn Notice, a GSBS student, during her tutorial rotation in the lab). (B) A northern blot
shows the expression of tL(GAG)G tRNA from the indicated strains (top). SCR1 is
used for a loading control (bottom). A73C and U55G mutant tRNAs are unstable.
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When the A57G mutant was introduced into a dcp2∆ kap123∆ tl(gag)g∆ strain
the growth phenotype was similar to that of wild type tL(GAG)G. Thus, the A57 that is
unique to tL(GAG)G is not relevant to the genetic interaction with dcp2∆. In contrast, the
anticodon loop mutant behaved similar to empty vector in this growth assay, and
different from the WT tL(GAG)G gene. Therefore, the specific sequence of the anticodon
stem loop is critical for the genetic interaction with dcp2∆.
Finally, to further narrow down what nucleotides within the anticodon loop are
critical, I focused on two striking differences. First, tL(GAG)G is the only tRNA with a C in
position 33, the position immediately preceding the anticodon. All tRNAs, except
tL(GAG)G, have U33 in budding yeast. Importantly, it has been shown that U33 is
important for efficient translation (Santos et al., 1996; Silva et al., 2007) presumably
because it is critical to from the “U-turn” 3D structure that makes the anticodon available
to base pair with the codon (Ashraf et al., 1999). I thus changed C33 in tL(GAG)G to
U33 to match all other tRNAs. This allele was expressed similar to wild type and affected
growth of the dcp2∆ kap123 tl(gag)g∆ strain like wild type (Figure 4.8). Thus, while C33
is unique to tL(GAG)G, it is not relevant to the dcp2∆ genetic interaction. The other
striking difference between the anticodon loop of tL(GAG)G and other Leu tRNAs is of
course the anticodon itself. I therefore changed the G to a U, to match the sequence of
tL(UAG). Northern blot analysis showed that the level of this mutant tRNA is comparable
to wild-type tL(GAG)G (Figure 4.8.B). Interestingly, when I compared growth, the mutant
tRNA with a UAG anticodon behaved similar to an empty vector control and different
from the wild-type tL(GAG)G tRNA. Thus, I concluded that the GAG anticodon is crucial
for the genetic interaction with DCP2.
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4.3. DISCUSSION
Through suppressor screening of the dcp2 mutant, I have found a genetic
interaction between DCP2 and tL(GAG)G. In this chapter, I investigated the mechanism
of suppression by the loss of functional tL(GAG)G. While the decoding of CUC/CUU
codons does not require the GAG anticodon of tL(GAG)G tRNA, the suppression of
dcp2∆ lethality is dependent on the GAG anticodon. Although the impact of the absence
of GAG anticodon of tL(GAG)G in general translation is not detected by assays I
performed (HIS3 growth and western blot assays), the genetic interaction of the GAG
anticodon with DCP2 suggests that the translation is involved in the suppression
mechanism (See a model in Figure 4.9). Previous analyses have all suggested that
tL(GAG)G function is redundant with the three tL(UAG) genes. My results reveal that
tL(GAG)G has a specific function and that this function requires the GAG anticodon. It
has been shown that deletion of tL(GAG) does not affect growth, but shows synthetic
phenotypes with the loss of tL(UAG) genes (Bloom-Ackermann et al., 2014; Huang et
al., 2012). Furthermore, a mutant tL(GAG)G with the GAG anticodon mutated to UAG
could complement the lethality of a triple deletion of tL(UAG) genes (Huang et al., 2012).
This GAG to UAG mutation that allows for translation of all four CUN codons is the same
as the one that I have shown to be sufficient to allow viability of dcp2∆. Overall, previous
research suggested that tL(GAG)G and tL(UAG) have overlapping functions, which does
not explain why tL(GAG)G is conserved. My results show that tL(GAG)G has a specific
function that is not interchangeable with tL(UAG), although I have not been able to
precisely define that function.
Although CUC and CUU codons can clearly be decoded in the absence of
tL(GAG)G, it has not been previously tested how efficient this is. I studied this by using
reporter genes where all leucine codons were replaced by CUC/CUU or that had twelve
sequential CUC codons. These reporters were designed to try to maximize any defect in
CUC/CUU translation. I showed that the protein output from decoding of CUC/CUU
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Figure 4. 9. A model for possible suppression mechanism of dcp2∆ lethality by
the loss of functional tL(GAG)G tRNA.
A growth defect of dcp2∆ is partially restored by the loss of tL(GAG)G (Top). The
translational defect in the absence of tL(GAG)G was not detectable by assays I
performed. However, a GAG anticodon is important for the genetic interaction with
DCP2. Thus, it is expected that the loss of tL(GAG)G causes a translational defect on
CUU or CUC codons. The loss of tL(GAG)G might affect translational defect in some
specific context (e.g. 1) transient ribosomal pausing on certain or all mRNAs harboring
CUC or CUC codons 2) +1 programmed frameshift sequences, CUUAGUU, triggered
by the initial binding of tL(UAG) tRNA).
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codons in the absence of tL(GAG)G is not severely affected, suggesting that the
tl(gag)g∆-mediated suppression is not due to defective or suboptimal global translation
(Figure 4.5-7). However, this kind of assay may not be able to capture subtle changes in
translational efficiency. For instance, if ribosome stalling at CUC or CUU codon is not
persistent, but eventually resolved by tL(UAG), it could be hard to determine the impact
of tl(gag)g∆ on translation by growth or western blot assays. Future studies that
precisely examine changes in translational efficiency on CUC/CUU codons would further
delineate the relationship between the translational role of tL(GAG)G and tl(gag)g∆mediated suppression of dcp2∆ lethality. More sensitive assays will be required to test
the role of tL(GAG)G in translation such as ribosome profiling (Ingolia et al., 2009).
tRNA genes have also been shown to serve a variety of functions outside of
translation. My results that the dcp2∆ tl(gag)g∆ phenotype could be suppressed by a
functional tL(GAG)G gene on a plasmid rules out local effects of the tRNA gene on
chromatin or nearby genes. It also facilitated mutational analysis of the tL(GAG)G gene,
which showed that the ability to produce a stable tRNA with a GAG anticodon was
critical. I considered the possibility that uncharged tL(GAG)G served as a signal for
leucine starvation. It has previously been shown that A73C or U55G mutants in tL(UAG)
cause the accumulation of stable tRNAs that are defective in aminoacylation (Huang et
al., 2012). Unfortunately, these same mutations in tL(GAG)G destabilize tRNAs (Figure
4.8.B). This makes it hard to definitively conclude whether the suppression mechanism
is related to uncharged tRNA-mediated signaling pathways. However, it seems less
likely that tL(GAG)G would be stable when uncharged, and thus uncharged tL(GAG)G
would be unlikely to accumulate in response to leucine starvation. Furthermore, if
tL(GAG)G acts as a signaling molecule, my results indicate that the signaling pathway
would have to be specific for the GAG anticodon, but not other unique features of
tL(GAG)G. The initial reason to suggest s signaling function was that Whi2 is thought to
somehow sense leucine starvation and whi2∆ and tl(gag)g∆ both suppress dcp2∆
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lethality. However, whi2∆ and tl(gag)g∆ have additive effects on dcp2∆ growth (Figure
3.10), indicating that they do not act in the same pathway. Thus, while I cannot rule out a
signaling function of tL(GAG)G, none of my results provide evidence for it.
It is interesting that no other components of the translation machinery were
identified as dcp2∆ suppressors. In addition to tL(GAG)G, there are five other singlegene tRNAs. Four of them are essential, while tR(CCU)J is not. However, tR(CCU)J was
not identified as dcp2∆ suppressor mutants. More broadly, none of the translation
elongation factors, ribosomal subunits, or amino acyltransferases were mutated in my
evolved strains. It is possible that the such mutations would be found in a larger screen,
but it seems unlikely that such a large number of genes would have been missed, while
finding two alleles of the small tL(GAG)G gene. This, together with my CUC/CUU
enriched reporter genes makes it unlikely that a general translation defect causes dcp2∆
viability.
Because the anticodon sequence is important, but global translation efficiency
does not seem to be affected, I propose that tL(GAG)G affects translation in some
specific context. One such codon specific context would be programmed frame shifting.
For instance, the EST3 and ABP140 genes have +1 translational frame-shift sequence
that is composed of CUUAGUU. This frame shifting requires tL(UAG) to initially bind the
CUU codon and then slip to the UUA codon (Farabaugh, 1996; Morris and Lundblad,
1997; Taliaferro and Farabaugh, 2007). This model predicts that tL(GAG)G reduces
frame shifting because it competes for binding to CUU, but cannot pair with the UUA
codon in the +1 frame. As previously mentioned, ribosome profiling would be useful to
identify mRNA undergoing aberrant frame-shift in the absence of tL(GAG)G and might
reveal other specific translation contexts where tL(GAG)G is important.
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Chapter 5. The role of Ski7 in the nonstop mRNA surveillance pathway.

A part of data presented in this chapter (Figure 5.7) has been published*:
Marshall, A.N., Han, J., Kim, M., and van Hoof, A. (2018). Conservation of mRNA quality
control factor Ski7 and its diversification through changes in alternative splicing and
gene duplication. Proc. Natl. Acad. Sci.
*The authors retain copyright to individual PNAS articles, and PNAS authors need not
obtain permission if they include their article as part of their dissertations.
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5.1. INTRODUCTION
Faulty mRNAs are generated by mistake, and translation of these transcripts
produces aberrant proteins that are toxic to the cell (Jamar et al., 2017, 2018). Thus,
cells exploit multiple mRNA surveillance pathways to eliminate aberrant transcripts. In
this chapter, I investigated the function of Ski7 in nonstop decay, the surveillance
pathway targeting mRNAs that lack an in frame stop codon.
Nonstop mRNAs can be generated by premature polyadenylation during mRNA
processing. Pre-mRNA cleavage and polyadenylation downstream of a stop codon
generates normal mRNAs. However, many studies have shown the endogenous usage
of alternative polyadenylation sites before the stop codon, which produces nonstop
mRNAs (Frischmeyer et al., 2002; Ozsolak et al., 2010; Pelechano et al., 2013; Sparks
and Dieckmann, 1998). Nonstop mRNAs can also be generated from mutant genes if
the mutation changes the sole stop codon to a sense codon (called nonstop mutation).
Most genes contain additional in-frame stop codons in the 3` UTR, which ensures
translation termination (Williams et al., 2004). However, several human diseases are
associated with a nonstop mutation, and these nonstop disease mutations lead to a
decrease in mRNA levels, protein levels, or both (Hamby et al., 2011; Klauer and van
Hoof, 2012).
Similar to other mRNA surveillance mechanisms, nonstop decay is a translationdependent pathway (Frischmeyer et al., 2002). Because nonstop mRNAs do not
possess a termination codon, the ribosome translating the transcript cannot complete
the normal termination process and keeps translating until it reaches the poly(A) tail and
stalls. Additional ribosomes that trail behind the leading ribosome can then cause
ribosome collision. It is not clear how ribosomes stalled on nonstop mRNA are
dissociated, and whether the leading ribosome is dissociated differently from trailing
collided ribosomes. Recent evidence suggests that the leading ribosome combinatorially
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recognizes the presence of at least 2 lysine residues (encoded by AAA or AAG) in the
nascent chain and the presence of at least two AAA codons in the decoding site. For
example, (AAG)10 or (AAA)2(AAG)8 cause little stalling in vivo, but (AAG)8(AAA)2 does
(Chandrasekaran et al., 2019). Poly-lysine residues in the ribosomal exit tunnel alters
the conformation of the peptidyl-transferase center making it unfavorable for peptide
bond formation. Additionally, a single-stranded helix formed by poly(A) mRNA alters the
decoding center making it unable to accommodate incoming tRNA (Chandrasekaran et
al., 2019) These two effects induce the ribosome stall on poly(A) mRNA. Although the
ribosome senses translation of a poly(A) tail as a hallmark of an aberrant mRNA,
mRNAs can be recognized as aberrant even if they lack a poly(A) tail. For these other
aberrant mRNAs (called no-go mRNAs), stalling is initiated by mRNA secondary
structure, mRNA damage, or mRNA cleavage (Harigaya and Parker, 2010). The
conformation and recognition of the leading ribosome may differ by the stalling feature,
but additional collided ribosome may adopt a similar conformation. It is thus perhaps not
surprising that multiple trans-acting factors have been proposed to recognize stalled
ribosomes, with overlapping specificities for the type of mRNA aberrancies (Doma and
Parker, 2006; Kashima et al., 2014; Matsuo et al., 2017, 2020; Sitron et al., 2017; Tsuboi
et al., 2012).
The degradation of nonstop mRNAs is mediated by the RNA exosome and its
cytoplasmic cofactors, the Ski complex and Ski7. While the RNA exosome and the Ski
complex are important for the degradation of both nonstop and normal mRNAs, the
requirement of Ski7 in the surveillance pathway and mRNA turnover is different. In
budding yeast, the N-terminal domain of Ski7 bridging the RNA exosome and Ski
complex is essential for any cytoplasmic RNA exosome-mediated functions (Araki et al.,
2001; Kowalinski et al., 2015; Wang et al., 2005). However, the C-terminal domain of
Ski7 is only required for nonstop decay and dispensable for normal mRNA turnover (van
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Hoof et al., 2002). The exact function of the C-terminus of Ski7 in nonstop decay is
currently not understood.
The C-terminus of Ski7 belongs to the translational GTPase family and
structurally resembles other translational GTPases including eRF3 and Hbs1 (Benard et
al., 1999; Kowalinski et al., 2015). eRF3 delivers another protein, eRF1, to the ribosome
when a stop codon is present in the decoding site of the ribosome as the first step in
termination (Hellen, 2018). Unlike normal translation termination, the canonical eRF1eRF3 complex cannot cause termination on nonstop or no-go mRNAs because eRF1
recognizes the stop codon (Bertram et al., 2000; Frolova et al., 1994). Similar to eRF3,
Hbs1 delivers its partner, Dom34, to stalled ribosomes as the first step in disassociating
the stalled ribosome on no-go mRNAs (Becker et al., 2011; Shoemaker et al., 2010;
Tsuboi et al., 2012). This similarity suggests that Ski7 might function similarly. However,
in contrast to eRF3 and Hbs1, Ski7 does not have GTPase activity, and a cofactor
analogous to Dom34 and eRF1 has not been discovered (Kowalinski et al., 2015).
Additionally, while the C-terminal pseudo-GTPase domain of Ski7 is essential for
nonstop mRNA decay in budding yeast, the mammalian homolog lacks the translational
GTPase domain (Kalisiak et al., 2017; Kowalinski et al., 2016; Marshall et al., 2018).
Instead, it has been suggested that Hbs1-Dom34 (Hbs1-Pelo) mediates nonstop decay
in mammalian cells (Saito et al., 2013). Thus, the function of yeast Ski7 in nonstop
decay is not well understood, and the function of the mammalian homolog is even less
clear.
In addition to the degradation of nonstop mRNA, the peptides translated from
nonstop mRNA (nonstop protein hereafter) are aberrant and targeted for rapid
degradation (Campioni et al., 2010; Jamar et al., 2017, 2018). If the nonstop mRNA is
generated by premature polyadenylation, the encoded protein lacks its normal Cterminus and instead contains a poly-lysine tail. Some of the factors that act on the
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peptide encoded by nonstop mRNAs are part of the Ribosome-associated Quality
Control (RQC) complex that is composed of Ltn1, Tae2 (also called Rqc2) and Rqc1
(Figure 5.1.) (Joazeiro, 2019). Among RQC complex components, Ltn1 was first
identified as a suppressor of nonstop mRNAs in a genetic screen (Wilson et al., 2007).
Later, it was shown that Ltn1 is a E3 ubiquitin ligase that binds the peptidyl-tRNA-60S
ribosomal subunit complex to ubiquitinate nascent peptides for degradation (Bengtson
and Joazeiro, 2010; Doamekpor et al., 2020; Lyumkis et al., 2014). Along with Ltn1,
Tae2 also binds dissociated 60S ribosomal subunit on the surface where the 40S
ribosomal subunit binds (Figure 5.1) (Lyumkis et al., 2014). Tae2 adds non-templated Cterminal Alanine-Threonine tails (CAT-tails) to the nascent peptide (Shen et al., 2015).
The addition of CAT-tails causes more of the nascent peptide to emerge from the
ribosome exit tunnel and Ltn1 ubiquitinates any lysine residues that emerge from the exit
tunnel (Kostova et al., 2017; Osuna et al., 2017). CAT-tails induce aggregation of the
nascent peptide when protein degradation is compromised and cause proteotoxicity
(Sitron et al., 2020). Eventually, Vms1 releases the nascent peptide from the last tRNA
while they are still bound to the 60S ribosomal subunit (Verma et al., 2018; Yip et al.,
2019). Finally, the nascent peptide is extracted from the exit tunnel by Cdc48, a AAA+
ATPase (ATPases Associated with diverse cellular Activities) and degraded by the
proteasome (Defenouillère et al., 2013; Verma et al., 2013).
While translation of nonstop mRNAs initiates both nonstop decay and RQC, it
has not been thoroughly studied whether these two surveillance mechanisms are
mechanistically linked or act independently to suppress the expression of nonstop
mRNA. In this chapter, I investigated how degradation of nonstop mRNAs and nonstop
proteins are conducted by testing genetic interaction of factors involved in these two
processes.
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Mutations in the human Ski complex cause trichohepatoenteric syndrome (Fabre et al.,
2011, 2012). In contrast, a very different disease has been described for a single patient
with a loss of function mutation in Hbs1 (O’Connell et al., 2019; Sankaran et al., 2013),
and Ltn1 (Listerin in mammals) and Tae2 (NEMF in mammals) mutations result in yet
another disease in mice (Chu et al., 2009; Martin et al., 2020). It is hard to determine if
any of these diseases are directly related to defective nonstop decay because each of
the mutated factors also have other functions. Thus, a better understanding of both
nonstop mRNA and protein decay is necessary to gain insight to the human diseases
associated with these pathways.
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Figure 5. 1. Nonstop decay pathway.
Ribosomes translating nonstop mRNA stalls during poly(A) translation. Whether the
ribosome reads through the entire poly(A) tail before stalling is not clear. By an
unknown mechanism, the leading ribosome is dissociated into 40S and 60S subunit
containing peptidyl-tRNA. RQC complex components, Ltn1 and Tae2, ubiquitinates
and adds CAT-tail, respectively by interacting with the 60S subunit. Peptidyl tRNA is
hydrolyzed by Vms1. Released nascent chains are targeted for proteasomal
degradation or form aggregates. Nonstop mRNA is degraded by the RNA exosome
and its cofactors, the Ski complex and Ski7.
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5.2. RESULTS
5.2.1. Ski7 and RQC complex function independently of each other on nonstop
mRNAs.
The expression of nonstop mRNAs is reduced by degradation of both the mRNA
and the peptide translated from it. While it has been shown that the RQC complex binds
to the dissociated 60S ribosomal subunit and triggers peptide degradation (Bengtson
and Joazeiro, 2010; Doamekpor et al., 2020; Lyumkis et al., 2014; Shen et al., 2015), it
is unclear how the stalled ribosome is dissociated from the nonstop mRNA and whether
ribosome dissociation mechanisms differ for different stalling states. Interestingly, the Cterminal domain of Ski7 has sequence and structural homology with translational
GTPases, which mediate ribosome dissociation during termination and no-go decay.
Thus, it has been suggested that Ski7 dissociates stalled ribosomes from nonstop
mRNA (van Hoof et al., 2002). If this model is correct, Ski7 is not only required for
nonstop mRNA degradation but also generates the substrate for the RQC complex. This
model predicts that the function of the RQC complex is dependent on Ski7. Therefore, I
investigated whether Ski7 and the RQC complex function independently of each other or
not.
For this, I tested the genetic relationship between surveillance machineries for
nonstop mRNA and nonstop protein in suppressing the expression of nonstop mRNA.
Briefly, I determined the effect of SKI7 and LTN1 or TAE2 on expression levels of
nonstop mRNA and nonstop protein (Figure 5.2 -5.7). First, I performed a growth assay
that utilizes a his3-nonstop mRNA reporter which is designed to monitor the activity of
nonstop decay (van Hoof et al., 2002) (Figure 5.2). The his3-nonstop reporter encodes
His3, a protein required for histidine biosynthesis, but has the in-frame stop codon
removed (van Hoof et al., 2002). Thus, the expression level of his3-nonstop positively
correlates with growth on histidine lacking media but negatively correlates with the
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functionality of nonstop decay. Both ltn1∆ and tae2∆, two RQC mutants, grow better
without supplemented histidine than the wild-type strain, suggesting that LTN1 or TAE2
limits the accumulation of nonstop His3 protein (Figure 5.2). A null mutant of SKI7 also
grows better on media lacking histidine (Figure 5.2), indicating that nonstop suppression
is disrupted in this mutant. Interestingly, when both SKI7 and either LTN1 or TAE2 are
deleted, cells grow better than each of single mutants (Figure 5.2). These results show
that simultaneous disruption of quality control pathways for nonstop mRNA and nonstop
proteins is more deleterious than disrupting either one. These additive effects of double
deletions suggest that the two quality control systems can function independently of
each other in reducing expression of this nonstop reporter gene expression.
I determined the effect of HBS1 on expression levels of His3-nonstop protein as
a control because Hbs1 in complex with Dom34 is mainly involved in no-go decay.
hbs1∆ does not grow on media lacking histidine (Figure 5.2), indicating that HBS1 does
not affect nonstop decay as expected. Furthermore, in the hbs1∆ background, ltn1∆ and
tae2∆ still increase growth on media lacking histidine. This indicates that neither Hbs1
nor Ski7 is required to generate the RQC substrate (Figure 5.2). Interestingly, however,
when HBS1 is deleted in ski7∆, the double mutant cells grow not as well as ski7∆
(Figure 5.2). This result suggests that HBS1 has an effect on nonstop decay only in the
absence of SKI7. I speculate that ribosomes are queued up upstream of the leading
ribosome stalled at poly(A) tail in the absence of SKI7, and these upstream ribosomes
which would be normally dissociated by the Dom34-Hbs1 complex are now protecting
nonstop mRNA and nonstop protein and preventing further translation initiation. As a
result, less translation of his3-nonstop in the absence of HBS1 resulted in the
intermediate growth phenotype even in the absence of SKI7 (see 5.3. Discussion).
To extend these results to additional reporters and disentangle the effects on the
nonstop mRNA and nonstop protein levels, I used another nonstop reporter, Protein
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Figure 5. 2. Ski7 and RQC components independently reduce his3-nonstop
expression.
Growth assay showing defective nonstop decay in ski7∆, ltn1∆, and tae2∆. The defect
in nonstop decay is more severe in ski7∆ ltn1∆ and ski7∆ tae2∆, indicating
independent mechanism of nonstop suppression by Ski7-mediated mRNA decay and
RQC complex.
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A-nonstop mRNA. Similar to the his3-nonstop reporter, the Protein A-nonstop reporter
was constructed to lack all in frame stop codons. It contains a GAL promoter, the coding
region of Staphylococcus aureus cell wall protein, Protein A, and a PGK1 3` UTR and
thus does not share any sequences with the his3-nonstop reporter (Figure 5.3) (Meaux
and van Hoof, 2006). Deletion of LTN1 or TAE2 results in increased accumulation of
Protein A-nonstop protein (Figure 5.3). Deletion of SKI7 also leads to the accumulation
of Protein A-nonstop protein. When SKI7 and either LTN1 or TAE2 are deleted, further
increased levels of Protein A-nonstop protein accumulated compared to the single
mutants (Figure 5.3). In contrast, hbs1∆ had no effect by itself or when combined with
ltn1∆ or tae2∆ (Figure 5.3). Thus, as with his3-nonstop, neither Ski7 nor Hbs1 is required
to generate RQC substrates.
One advantage of using the Protein A-nonstop reporter is that different forms of
the protein can be analyzed by western blotting. CAT-tailed proteins form very stable
amyloid-like aggregates that are SDS resistant and migrate very slowly in SDS-PAGE.
These aggregates were detectable in the ltn1∆ strain and in the ski7∆ ltn1∆ and hbs1∆
ltn1∆ strains, indicating that Ski7 and Hbs1 are not required for CAT-tailing (Figure 5.3).
In addition to Protein A-nonstop protein (~20kDa) and aggregates (>150kDa),
deletion of SKI7, LTN1, and/or TAE2 results in the accumulation of another species of
around 37kDa (Figure 5.3 and 5.4). Western blotting of RNase A treated lysate shows
that this protein species is sensitive to RNase (Figure 5.4), indicative of the nascent
peptide bound to peptidyl tRNA in nonstop decay defective condition.
To determine if the increased level of Protein A-nonstop protein is due to the
stabilized nonstop mRNA, I examined the level of Protein A-nonstop mRNA in the
mutants described above. As previously shown, deletion of SKI7 stabilizes nonstop
mRNA (van Hoof et al., 2002), and I saw a similar affect in the ski7∆ ltn1∆ and ski7∆
tae2∆ double mutants (Figure 5.5). In contrast, deletion of LTN1, TAE2, or HBS1 does
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Figure 5. 3. Ski7 and RQC components independently reduce Protein A-nonstop
expression.
(A) Western blotting shows the accumulation of Protein A-nonstop protein in ski7∆,
ltn1∆, and tae2∆, suggesting defective nonstop decay in theses strains. The defect in
nonstop decay is more severe in ski7∆ ltn1∆ and ski7∆ tae2∆, indicating independent
mechanism of nonstop suppression by Ski7-mediated mRNA decay and RQC
complex. Under RQC-defective condition due to the loss of LTN1, higher molecular
protein aggregates (>150kDa) accumulate. These are still present in ski7∆ ltn1∆ and
hbs1∆ ltn1∆ double mutants. Pgk1 is used as a loading control. (B) Quantification of
biological triplicate western blotting assays of Protein A-nonstop protein.
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1: wild type
2: wild type [Protein A-nonstop]
3: ski7∆ [Protein A-nonstop]
4: ski7∆ hbs1∆ [Protein A-nonstop]

1: wild type
2: wild type [Protein A-nonstop]
3: ltn1∆ [Protein A-nonstop]
4: ski7∆ ltn1∆ [Protein A-nonstop]
5: hbs1∆ ltn1∆ [Protein A-nonstop]

1: wild type
2: wild type [Protein A-nonstop]
3: tae2∆ [Protein A-nonstop]
4: ski7∆ tae2∆ [Protein A-nonstop]
5: hbs1∆ tae2∆ [Protein A-nonstop]

Figure 5. 4. Peptidyl-tRNA from the Protein A-nonstop mRNA accumulates in the
absence of functional nonstop decay.
Western blotting shows that peptidyl-tRNA-Protein A accumulates in the absence of
SKI7, LTN1, and/or TAE2. This complex disappears upon RNase A treatment.
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Figure 5. 5. Protein A-nonstop mRNA degradation requires Ski7 but not RQC
components.
Northern blotting shows the accumulation of Protein A-nonstop mRNA in mutants
where SKI7 is absent, while ltn1∆ and tae2∆ do not affect the levels of Protein Anonstop mRNA. The loss of Hbs1 does not have any effect on nonstop mRNA. SCR1
is used as a loading control.
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not affect the level of nonstop mRNA. These data suggest that the accumulation of
nonstop protein in ltn1∆ and tae2∆ mutants are due to defects in protein quality control,
whereas the accumulation of nonstop protein in ski7∆ is due to the defect in mRNA
quality control. Overall, RQC-mediated degradation of nonstop protein is not dependent
on the SKI7 or HBS1.
To ensure that what I observed is not specific for Protein A-nonstop mRNA, I
tested expression of another nonstop reporter, pgk1-nonstop reporter (Frischmeyer et
al., 2002; Meaux and van Hoof, 2006). Because the stop codon is mutated, and the ORF
extended, the Pgk1-nonstop protein is larger than the endogenous protein and they can
thus be distinguished from each other in a western blot. I confirmed that the RQC
complex is involved in the degradation of Pgk1-nonstop protein independently of Ski7
(Figure 5.6), and I did not detect any aggregates or tRNA-peptide conjugates for Pgk1nonstop protein. The decay of pgk1-nonstop mRNA is mediated by Ski7, not by RQC
complex (Figure 5.7). The pgk1-nonstop mRNA can be specifically detected using a
probe that hybridizes to a small insert in the 3` UTR that is absent from the endogenous
PGK1. Overall, I conclude that SKI7 and the RQC complex act independently of each
other on three different nonstop reporter mRNAs. Thus, Ski7 is not required to generate
the substrate for RQC.

5.2.2. The effect of Ski7 and RQC on a model no-go mRNA
A variety of ribosome stalling features has been shown to trigger no-go decay
(Harigaya and Parker, 2010). Specifically, both Ski7 and the RQC have also been
implicated in suppressing the expression of mRNAs that are truncated by a cleavage
event within the coding region (Matsuda et al., 2014; Meaux and van Hoof, 2006; Tsuboi
et al., 2012). These mRNAs lack a poly(A) tail and thus might cause ribosomes to stall in
a different conformation, and independently of poly-Lys in the nascent chain or poly(A) in
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Figure 5. 6. Ski7 and RQC components independently reduce pgk1-nonstop
expression.
Western blotting shows accumulation of Pgk1-nonstop protein in ski7∆, ltn1∆, and
tae2∆, suggesting defective nonstop decay in theses strains. The defect in nonstop
decay is more severe in ski7∆ ltn1∆ and ski7∆ tae2∆, indicating independent
mechanism of nonstop suppression by Ski7-mediated mRNA decay and RQC
complex. Endogenous Pgk1 is detected as well. In this experiment, GAPDH is used as
a loading control.
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Figure 5. 7. pgk1-nonstop mRNA degradation requires Ski7 but not RQC
components.
Northern blotting shows the accumulation of pgk1-nonstop mRNA in mutants where
SKI7 is absent, while ltn1∆ and tae2∆ do not affect the levels of pgk1-nonstop mRNA.
The loss of Hbs1 does not have any effect on nonstop mRNA. SCR1 is used as a
loading control.
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the decoding center. Thus, to compare my data on nonstop mRNAs to a different
aberrant mRNA, I also examined whether the RNA exosome-mediated and RQCmediated quality control systems are independent of each other in suppressing the
expression of truncated stop codon-less mRNA. I used a reporter in which a selfcleaving ribozyme (Rz) sequence is inserted at the end of the Protein A coding region
(Meaux and van Hoof, 2006). Any uncleaved mRNA encodes a much larger Protein AGFP fusion protein that ends at a stop codon.
I examined the steady-state level of the truncated mRNA (Protein A-Rz) and
aberrant protein translated from the mRNA (Protein A-Rz) of mutants in which the
functions of Ski7 and/or RQC complex are disrupted. When SKI7 is absent, Protein A-Rz
protein accumulates (Figure 5.8). Interestingly, deletion of the RQC factors, LTN1 or
TAE2, does not affect the level of Protein A. This result is inconsistent with the previous
studies showing the accumulation of aberrant protein from stop codon-less reporters in
ltn1∆ (Ikeuchi and Inada, 2016; Matsuda et al., 2014). Since ski7∆ ltn1∆ or ski7∆ tae2∆
did not show any additive effects, the increase of the Protein A protein levels correlates
with the increase of the Protein A-Rz mRNA in ski7∆, ski7∆ ltn1∆, and ski7∆ tae2∆.
Consistent with the western blot data, levels of the Protein A-Rz mRNA in ltn1∆ and
tae2∆ are comparable to that in wild type (Figure 5.9). These data suggest that the
suppression of this truncated reporter is mainly mediated by RNA decay machinery, and
the RQC-mediated protein degradation pathway is not required. However, other groups
showed that the RQC complex is required for suppression of the ribozyme-cleaved
mRNAs (Ikeuchi and Inada, 2016; Matsuda et al., 2014). It is possible that the effect of
ltn1∆ and tae2∆ depends on the reporter protein sequence (e.g. the presence or position
of Lysine residues for Ltn1 to act on; see 5.3. DISCUSSION)
Deletion of HBS1 had three intriguing effects on Protein A-Rz expression. First,
deletion of HBS1 resulted in the accumulation of a prominent higher molecular weight
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Figure 5. 8. Ski7, but not RQC components, reduces stop codon-less Protein A
expression.
Western blotting shows the accumulation of Protein A-Rz protein in mutants where
SKI7 is absent, while ltn1∆ and tae2∆ do not affect the levels of Protein A-Rz proteins.
The loss of Hbs1 results in the accumulation of higher molecular weight species (#).
Pgk1 is used as a loading control.
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Figure 5. 9. Protein A-Rz mRNA degradation requires Ski7 but not RQC
components.
Northern blotting shows the accumulation of Protein A-Rz mRNA in mutants where
SKI7 is absent, while ltn1∆ and tae2∆ do not affect the levels of Protein A-Rz mRNA.
When probing with p2 probe, cleavage fragments that accumulate in mutants where
HBS1 is absent are detectable.
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species (Figure 5.8 and 5.10). This higher molecular weight band disappeared when the
protein extract of hbs1∆ was treated with RNase A, indicating that this species consists
of the nascent peptide that is still covalently bound to the last tRNA (Figure 5.10). This
suggests that Hbs1, and possibly ribosome disassociation is required for peptidyl-tRNA
hydrolysis. Neither Ski7 nor Tae2 or Ltn1 affected the presence of this peptidyl-tRNA
species translated from truncated mRNA (Figure 5.10), and this is different from the
presence of peptidyl-tRNA species translated from nonstop mRNA in ski7∆, ltn1∆, and/or
tae2∆ mutants (Figure 5.4). Second, while both the ski7∆ and ski7∆ hbs1∆ accumulated
increased amounts of the Protein A-Rz reporter mRNA, only the ski7∆ strain
accumulated increased amounts of the encoded protein (Figure 5.8 and 5.9). Third,
hbs1∆ resulted in the accumulation of mRNA fragments of the Protein A-Rz mRNA
(Figure 5.9). This was also seen in double mutants of hbs1∆ with either ski7∆, ltn1∆ or
tae2∆. Similar fragments have been shown to result from endonucleolytic cleavage
upstream of collided ribosomes during no-go decay (D’Orazio et al., 2019; Doma and
Parker, 2006; Ikeuchi and Inada, 2016; Simms et al., 2017; Tsuboi et al., 2012). I
speculate that Hbs1 normally dissociates ribosomes that are stalled at the end of Protein
A-Rz, which allows for hydrolysis of the peptide-tRNA bond. One possibility is that in the
absence of Hbs1 the ribosomes are stalled for a prolonged period of time, which triggers
endonucleolytic cleavage. Alternatively, it is possible that endonucleolytic cleavage
occurs in both HBS1 and hbs1∆ strains, but that the cleavage product is stabilized in
hbs1∆ because ribosomes are trapped on it. The latter explains why the appearance of
the cleavage product is not accompanied by a change in the level of the uncleaved
mRNA. Prolonged stalling may also cause ribosomes to be queued up all along the
coding region, and prevent further translation initiation, proving a possible explanation
for the reduced protein levels in ski7∆ hbs1∆ (see 5.3. DISCUSSION).
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Figure 5. 10. Identification of peptidyl-tRNA from the Protein A-RZ mRNA that
accumulates in the absence of HBS1.
Higher molecular weight species (#) accumulated in hbs1 mutants disappear upon
RNase A treatment.
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5.2.3. Ski7 residues 1 to 226 are sufficient for normal mRNA decay.
As described earlier, the N-terminus of Ski7 is required for all cytoplasmic RNA
exosome-mediated processes including canonical mRNA turnover and mRNA
surveillance, while the C-terminus of Ski7 is only required for nonstop mRNA decay. This
distinction is based on a single truncation after 264 residues (ski7∆265) that was
generated before the sequence of many Ski7 homologs was known and before any
structural information was available. The structure of Ski7 bound to the RNA exosome
shows that residues 116 to 225 form four alpha-helices and are sufficient to bind to the
RNA exosome (Kowalinski et al., 2016). I thus generated additional deletions (ski7∆2263X HA and ski7∆213-3X HA) that ended either right after or right before the fourth RNA
exosome binding alpha helix and compared them to ski7∆265-3HA (Figure 5.11).
I tested the synthetic lethality of the ski7 truncations I made with dcp1-2. dcp1-2
is a temperature-sensitive mutation that disrupts 5`-to-3` mRNA decay at the restrictive
temperature (Anderson and Parker, 1998; Tharun and Parker, 1999). Thus, normal
mRNAs are only degraded by the Ski7/RNA exosome pathway which now is essential.
Wild-type control (SKI7-3X HA), ski7∆226-3HA, and ski7∆265-3HA are each viable when
Dcp1 is inactivated (Figure 5.12). In contrast, combining ski7∆213-3HA with dcp1-2
results in lethality at the restrictive temperature. These data confirm that the N-terminal
domain of Ski7 is essential for the general mRNA turnover while the C-terminal domain
is indispensable, and precisely define the general N-terminal domain and nonstop
mRNA specific C-terminal domain.
Next, I examined the function of the ski7 truncation mutants in nonstop decay.
The nonstop his3 growth assay shows that ski7∆ expressing empty vector or C-terminal
truncated mutant allele, ski7∆226-3X HA and ski7∆265-3X HA, grow in medium lacking
histidine, indicating that the deleted regions are required for nonstop decay (Figure
5.13). Interestingly, the C-terminally truncated mutants of ski7 partially rescued the
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Figure 5. 11. Architecture of Ski7 mutants.
A schematic showing domain structure of wild-type Ski7 fused to 3X HA tag (top). Ski7
interacts with the Ski complex through amino acid residues 1-105 and with the RNA
exosome through amino acid residues 116-225. The C-terminal domain of Ski7 is
translational GTPase. 3X HA tag is fused to the C-terminal end of Ski7, Ski7-∆265,
Ski7-∆226, and Ski7-∆213. Ski7-∆213 is expected to disrupt the RNA exosome
interaction.
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Figure 5. 12. Ski7 residues 1 to 226 are sufficient for normal mRNA decay.
(A) Growth assay shows that synthetic lethal phenotype of dcp1-2 ski7∆ at restrictive
temperatures (30˚C and 37˚C) is restored by wild-type Ski7-3X HA, Ski7-∆226-3X HA,
and Ski7-∆265-3X HA. Ski7-∆213-3X HA complements dcp1-2 ski7∆ at 30˚C, but not
at 37˚C. (B) Western blotting shows the expression of wild-type Ski7-3X HA (#).
Expression of Ski7 truncation mutants (#) is shown under adjusted contrast. Pgk1 is
used as a loading control. Total lysates extracted from cultures grown at room
temperature was used.
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Figure 5. 13. C-terminal region of Ski7 (resides 227-747) is required for nonstop
decay.
his3-nonstop growth assay shows that Ski7-3X HA complements ski7∆ in nonstop
decay, while Sk7-∆226-3X HA and Ski7-∆265-3X HA cannot.
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Figure 5. 14. Distinct role of Ski7 and the Ski complex in nonstop decay.
Western blotting shows accumulation of Protein A-nonstop protein in mutants where
the 3`-to-5` decay is disrupted. The loss of SKI2 results in the accumulation of proteins
of ~25kDa, while ski7 mutations (ski7∆ or ski7∆226) result in the accumulation of
protein of < 25kDa. Pgk1 is used as loading control. This result implies the function of
Ski7 is distinct from Ski2 in nonstop decay.
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defect of nonstop decay in ski7∆. This is consistent with the previous study showing the
stability of pgk1-nonstop mRNA is 6 to 7-fold higher in ski7∆ or ski7∆N but only 3-fold
higher in ski7∆C (van Hoof et al., 2002). This result suggests that the C-terminus of Ski7
is required for fully efficient nonstop decay. However, the function of the C-terminal
domain of Ski7 is not clear.
I also examined the effect of Ski7 truncation on Protein A-nonstop expression. I
observed that ski7∆, ski2∆ and ski7∆226 each resulted in an increase in the level of
Protein A-nonstop protein, consistent with the results from the his3-nonstop growth
assay (Figure 5.14). However, I also noticed that the Protein A-nonstop proteins
accumulated in ski2∆ and ski7 mutants differ in size (Figure 5.14). This size difference of
the major band on the western blot is approximately ~3kDa. The molecular nature of this
size difference remains to be determined, but it reveals that Ski2 and Ski7 have subtly
different functions in nonstop mRNA metabolism.
To ensure that the different effects of Ski7 truncations were not due to different
protein levels I performed a western blot. As shown in Figure 5.12.B, the ski7∆265-3HA,
ski7∆226-3HA, and ski7∆213-3HA, were expressed at equivalent levels, suggesting that
the functional differences between ski7∆226-3HA, and ski7∆213-3HA were not a
consequence of expression level. However, the expression level of all three truncations
was reduced when compared to full length Ski7. I had originally planned to use the BioID
proximity labeling method to identify proteins that interact with either full-length Ski7 or
truncated Ski7 (5.2.4. and Figure 5.15). Although this method proved not to efficiently
work in yeast (Branon et al., 2018), I discovered that the BirA* C-terminal fusions to
truncated Ski7 were expressed at normal levels (Figure 5.16.B and Figure 5.17.B). Ski7BirA*-3X HA, Ski7-∆226-BirA*-3X HA and Ski7-∆265-BirA*-3X HA and Ski7-3X HA are
each expressed to comparable levels. Similar to the result shown in Figure 5.12.A, BirA*
C-terminal fusions are capable of complementing synthetic lethality of dcp1-2 ski7∆
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Figure 5. 15. Architecture of Ski7-BirA*-3X HA fusion proteins.
Ski7 interacts with the Ski complex through amino acid residues 1-105 and with the
RNA exosome through amino acid residues 116-225. C-terminal domain of Ski7 is
translational GTPase. BirA* is fused to the C-terminal end of Ski7, Ski7-∆265, and
Ski7-∆226.
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Figure 5. 16. Functionality of C-terminal truncated Ski7-BirA* mutants.
(A) Growth assay shows that synthetic lethal phenotype of dcp1-2 ski7∆ at restrictive
temperatures (30˚c and 37˚C) is restored by wild-type Ski7-BirA*-3X HA, Ski7-∆226BirA*-3X HA, and Ski7-∆265-BirA*-3X HA. (B) Western blotting shows the expression
of Ski7-BirA*-3X HA, Ski7-∆226-BirA*-3X HA, and Ski7-∆265-BirA*-3X HA (#). Pgk1 is
used as a loading control. Total lysates extracted from cultures grown at room
temperature was used.
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Figure 5. 17 The C-terminal region of Ski7 (resides 227-747) is required for
nonstop decay.
(A) his3-nonstop growth assay shows that Ski7-BirA*-3X HA complements ski7∆ in
nonstop decay as Ski7-3X HA does. In contrast, Sk7-∆226-BirA*-3X HA and Ski7∆265-BirA*-3X HA are defective in nonstop decay. (B) Western blotting shows the
expression of wild-type Ski7-BirA*-3X HA, Ski7-∆226-BirA*-3X HA, and Ski7-∆265BirA*-3X HA (#). Pgk1 is used as a loading control.
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(Figure 5.16.A). Ski7-BirA*-3HA and Ski7-3HA reduce His3-nonstop expression to the
same extent as endogenous Ski7 (Figure 5.17.A compare row 1 to rows 3 and 4). In
contrast, Ski7-∆226-BirA*-3HA and Ski7-∆265-BirA-3HA show a clear defect in nonstop
mRNA decay (Figure 5.17 compare rows 1 and 4 to rows 5 and 6). Overall, these results
strengthen the data that the C-terminus of Ski7, starting at residue 227, is specifically
required for nonstop mRNA decay.

5.2.4. Towards proximity labeling to identify proteins that interact with the Cterminal domain of Ski7.
To study the function of the C-terminal domain of Ski7 in nonstop decay, I hoped
to identify proteins that interact with it by utilizing proximity-dependent labeling with
biotin. BirA* is a mutant biotin ligase (E. coli BirA_R118G) that has lost its specificity
(Figure 5.15). BirA* leads to promiscuous biotinylation of proteins that are in close
proximity, and labeled proteins are purified using streptavidin (Roux et al., 2012). Unlike
conventional immunoprecipitation techniques, this BioID technique is useful for detecting
not only stable interactions but also transient interactions.
To utilize BioID in identifying Ski7 interacting proteins, I confirmed if BirA* has
biotin ligase activity when fused to Ski7. In addition to labeling proteins that are
interacting with BirA*-tagged protein in close proximity, BirA* should biotinylate the
tagged protein itself. Thus, I immunoprecipitated Ski7-BirA* fusion proteins with anti-HA
antibody and tested biotinylation using streptavidin HRP conjugate (Figure 5.18). All
three BirA* fusion proteins and Ski7-3HA were pulled down with anti-HA antibody
(Figure 5.18, top), while only BirA* fusion proteins were biotinylated (Figure 5.18,
bottom). These data indicate that BirA* fused to Ski7 is fully functional, both as a Ski7
and a BirA* (see 5.3. Discussion).
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Figure 5. 18. BirA*-mediated biotinylation of Ski7.
Western blotting shows biotinylation of Ski7 proteins by BriA*. Ski7-3X HA, Ski7-BirA*3X HA, Ski7-∆226-BirA*-3X HA, and Ski7-∆265-BirA*-3X HA are immunoprecipitated
with Protein A Sepharose coated with anti-HA antibody (top, #). BirA* tagged Ski7
proteins are biotinylated, but Ski7-3X HA is not (bottom, #).
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Next I attempted to purify proteins that were biotinylated in the presence of Ski7BirA*. For this, I expressed either Ski7-3HA or Ski7-BirA*-3HA, isolated total proteins,
and purified biotinylated proteins by streptavidin pull-down. Both the total fraction and
the streptavidin bound fraction were then analyzed by western blot analysis (Figure
5.19). Probing the western blot with streptavidin-HRP for biotinylated proteins showed
strong enrichment of the known endogenous biotinylated proteins (Acc1, Hfa1, Pyc1,
Pyc2, and Arc1; Figure 5.19, top), but no obvious band that corresponds to Ski7-BirA*3HA or other BirA*-biotinylated proteins. Probing the blot with anti-HA detected Ski7BirA*-3HA in the streptavidin pull-down fraction, but also detected low levels of the Ski73HA control (Figure 5.19, middle).
Because the prominent bands of endogenous biotinylated proteins might be
interfering with detection of BirA* biotinylated proteins, I analyzed a strain with a
temperature-sensitive mutation in BPL1, which encodes the yeast Biotin Protein Ligase
that biotinylates Acc1, Hfa1, Pyc1, Pyc2, and Arc1 (Kim et al., 2004). As shown in Figure
5.20, the bpl1-ts strain had dramatically reduced levels of endogenous biotinylated
proteins, but even in this strain background I failed to detect any difference in
biotinylation pattern between Ski7-3HA and Ski7-BirA*-3HA. Thus bpl1-ts has potential
to reduce background signal in a BioID experiment, but would have to be combined with
other optimization to identify Ski7-interacting proteins (see 5.3 Discussion).
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Figure 5. 19. BirA*-mediated biotinylation is undetectable due to highly
abundant endogenous biotinylated proteins.
Western blotting shows the biotinylation of substrates of S. cerevisiae biotin ligase
Bpl1. Biotinylated proteins purified with Streptavidin magnetic beads are analyzed by
probing with Streptavidin-HRP conjugate (top) and anti-HA antibody (bottom). Pgk1 is
used as a loading control and a negative control for pull-down.
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Figure 5. 20. Endogenous biotinylation is strongly reduced by a bpl1-ts
mutation.
Western blotting shows the biotinylated Acc1/Hfa1, Pyc1/Pyc2, and Arc1 in wild type
(left). Biotinylation of these proteins decreases in bpl1-ts. Pgk1 is used as a loading
control.
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5.3. DISCUSSION
In this chapter, I have investigated the function of Ski7 in nonstop decay. Ski7
has been known as a cofactor of the cytoplasmic RNA exosome complex and to be
involved in both normal and nonstop mRNA decay (van Hoof et al., 2000; van Hoof et
al., 2002). While the C-terminal domain of Ski7 is found to be important for fully efficient
nonstop decay, its function in nonstop decay has remained unclear. The C-terminal
domain of Ski7 is structurally similar to translational GTPases such as Hbs1 which
dissociates stalled ribosomes during no-go decay (Kowalinski et al., 2015). Thus, I
hypothesized that Ski7 is required for dissociation of stalled ribosomes on nonstop
mRNA. This model predicts that the function of the RQC complex is dependent on the
Ski7 function. Thus, I first determined the genetic relationship of Ski7 with the RQC
complex. Data shown in this chapter suggest that the Ski7-mediated nonstop mRNA
decay pathway is independent of the nonstop protein degradation pathway that is
mediated by RQC complex. This result indicates that Ski7 is not required to generate the
dissociated ribosomes that are the RQC substrate. This leaves the dissociation factor for
nonstop decay unknown.
Based on structural homology and its involvement in other surveillance
pathways, I also tested whether Hbs1-Dom34 complex is involved in ribosome
dissociation during nonstop decay. The effect of the HBS1 deletion was minor in nonstop
decay (Figures 5.2, 3, and 5). The function of RQC complex is independent of HBS1
because ltn1∆ hbs1∆ produces aggregates and CAT-tailed protein species. Interestingly,
the effect of HBS1 on reducing nonstop protein expression becomes noticeable only in
the absence of SKI7, where ski7∆ hbs1∆ accumulates decreased level of nonstop
protein compared to the ski7∆ single mutant (Figure 5.2 and 5.3). The Hbs1-Dom34
complex has been implicated in dissociating stalled ribosomes (Guydosh and Green,
2014). However, nonstop mRNAs still generate RQC substrates in a ski7∆ or hbs1∆
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background. I conclude that neither of these factors is required and it is still not clear
how the leading ribosome on a polyadenylated nonstop mRNA is dissociated.
In addition to nonstop decay triggered by translation of the poly(A) tail, Ski7 and
RQC complex are involved in the degradation of truncated mRNA that is independent of
poly(A) sequence or poly-Lys. As expected, deletion of SKI7 results in the accumulation
of Protein A-Rz mRNA, which then leads to the accumulation of proteins. However,
deletion of RQC components does not affect the level of Protein A-RZ proteins. This
result may be explained by the availability of lysine residues in the nascent peptide for
Ltn1-mediated ubiquitination. The catalytic domain of Ltn1 sits near the ribosome exit
tunnel (Lyumkis et al., 2014; Shao et al., 2015), and it ubiquitinates lysine residues in
close proximity (~12 residues) to the ribosome exit tunnel (Kostova et al., 2017). The exit
tunnel accommodates ~40 amino acid residues. Therefore, Ltn1 can ubiquitinate lysine
residues that are 40 to 52 residues from the C-terminus of the stalled nascent peptide.
The Protein A-Rz mRNA encodes lysine residues 9, 17, 18, and 32 residues from the Cterminus, which should all be inside the ribosome exit tunnel and inaccessible to Ltn1.
The next most C-terminal residue is 60 residues from the end, which may be too far from
the exit tunnel to be an efficient Ltn1 substrate. The lysine residues at -9 to -32 can be
exposed by Tae2-mediated CAT-tailing. However, we did not detect any aggregates
indicative of CAT-tailing and Protein A-Rz reporter does not seem to be sensitive to
either Ltn1 or Tae2. Unlike other reporters that contain flexible linkers used in the study
proving the importance of the accessibility of Ltn1 to lysine (Kostova et al., 2017), the
very stably folded Z-domain of Protein A may further reduce the exposure of lysine
residues to Ltn1.
The absence of Hbs1 results in the accumulation of peptidyl-tRNA translated
from the Protein A-Rz reporter. This is in contrast to the Protein A-nonstop reporter
which accumulated as peptidyl-tRNA species both in the presence and absence of
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Hbs1. This reporter-specific result indicates that the Hbs1-Dom34 complex is an
important ribosome dissociation factor for cleaved mRNAs but not for polyadenylated
nonstop mRNAs. Interestingly, while the ltn1∆ strain did not accumulate aggregates
indicative of CAT-tailing for Protein A-Rz, I did observe aggregates in the absence of
both Hbs1 and Ltn1. This result implies that there is another factor involved in the
ribosome dissociation stalled on truncated mRNA as reported recently (Matsuo et al.,
2020).
To study the function of C-terminus of Ski7 that is specific for nonstop decay, I
attempted to use BioID, a tool for identifying proteins interacting to Ski7. While setting up
this experiment, I encountered challenges where the endogenous biotin ligase Bpl1 in S.
cerevisiae biotinylates its own substrates, Acc1/Hfa1, Pyc1/Pyc2, and Arc1 (Kim et al.,
2004). ACC1 and HFA1 encode acetyl-CoA carboxylase, while PYC1 and PYC2 encode
pyruvate carboxylase. In each case biotin is required in the carboxylase active site.
ACC1 is essential and the cell also requires either PYC1 or PYC2 for viability, thus
deleting these genes to reduce background is impossible. However, I have shown that
mutating the Bpl1 Biotin protein ligase can greatly reduce background signal.
Interestingly, others have shown that BirA* does not work well in yeast because it has
low activity at 30 degrees (Branon et al., 2018). Despite this reported low activity, I did
observe some auto-biotinylation of Ski7-BirA*-3HA (Figure 5.18). These same authors
report that a heavily mutated version, named TurboID, can be used in yeast (Branon et
al., 2018). Combining the optimization of TurboID with the use of bpl1-ts may further
increase its utility.
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Chapter 6. Final conclusions and perspectives
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SUMMARY
Post-transcriptional regulation is critical in controlling gene expression, and it
involves multiple processes such as RNA modification (e.g. 5`-m7G cap of mRNA),
processing (e.g. splicing), localization (e.g. export, formation of membrane-less
organelles), decay (e.g. turnover, surveillance pathway), and translation. In this study, I
investigated post-transcriptional regulation of protein-coding genes focusing on normal
and aberrant mRNA degradation. When mRNA is no longer required, it is degraded by
highly conserved eukaryotic mRNA decay pathways. While the function of mRNA decay
factors has been well studied, how they affect the physiology of the organism is not fully
understood. I investigated the physiological function of mRNA decapping enzyme, Dcp2,
through suppressor selection. In chapter 3, I showed that the decapping enzyme Dcp2 is
essential for continuous growth of Saccharomyces cerevisiae under standard lab
conditions and identified suppressors of dcp2∆ growth defect (or lethality). Until now,
whether DCP2 is essential was not clear, which complicated functional studies on DCP2.
I also revealed that dcp2∆ strains that have been shown to be viable in previous studies
(Dunckley and Parker, 1999; Geisler et al., 2012; Giaever et al., 2002; He and Jacobson,
2015) possess mutations in genes that I identified as suppressors in this study. In
chapters 3 and 4, I sought to determine the mechanism of suppression of dcp2∆ lethality
by mutations in KAP123 and tL(GAG)G, two genes that are frequently mutated in
multiple dcp2∆ strains. Data showed that the suppression mechanism of dcp2∆ lethality
by null mutation in KAP123 and tL(GAG)G does not involve restoration of mRNA decay
in the dcp2 mutant. Instead, suppressors partially restore the transcriptomic defect in the
dcp2 mutant. While the exact mechanism of suppression needs to be further
investigated, I have shown that the anticodon of tL(GAG)G tRNA is critical for the
genetic interaction with DCP2, which implies that suppression of dcp2∆ involves a
change in translation.
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In addition to normal mRNA turnover, aberrant mRNA is degraded by RNA decay
mechanisms to prevent production of aberrant proteins that are potentially toxic to cells. I
investigated the function of Ski7, which is a cofactor of the 3`-to-5` exoribonuclease
complex in a surveillance mechanism for transcripts without stop codons termed nonstop
decay. It has been known that the C-terminal domain of Ski7 that is a translational
pseudo-GTPase is required for nonstop decay specific function, but the exact function of
it remains elusive. Homology of the C-terminus of Ski7 to the translational GTPases that
dissociate ribosomes during translation termination led me to hypothesize that Ski7
functions in ribosome dissociation. In chapter 5, I showed that Ski7 functions in nonstop
decay independent of the protein quality control mechanism for nonstop proteins. This
further indicates that Ski7 is not required for the dissociation of stalled ribosome during
nonstop decay unlike other translational GTPases such as Hbs1 and eRF3 that are
involved in ribosome dissociation (Becker et al., 2011; Hellen, 2018; Shoemaker et al.,
2010; Tsuboi et al., 2012). The C-terminal domain of Ski7 is required for nonstop decay
as the loss of it leads to the stabilization of nonstop mRNA (van Hoof et al., 2002).
However, it is dispensable for normal mRNA decay. This result suggests a specific role
of the C-terminus of Ski7 in nonstop decay. I attempted to further investigate the role of
Ski7 in nonstop decay by focusing on the function of its C-terminus. In chapter 5, I also
showed that the effect of deletion of the Ski2 on nonstop decay is distinct from the
deletion of Ski7. To understand the nonstop decay specific function of Ski7, I sought to
identify Ski7 interactome. Based on the structural homology of C-terminus of Ski7 to that
of Hbs1 or eRF3, I hypothesized that it could interact with the stalled ribosome
(Kowalinski et al., 2015). However, I expected this interaction would be transient and/or
weak, and thus many previous biochemical studies that used a conventional pull-down
technique could not identify Ski7 interacting proteins other than the RNA exosome and
the Ski complex in S. cerevisiae (Araki et al., 2001; Wang et al., 2005). While the Ski
complex has been shown to interact with the 80S ribosome in a cryo-EM study (Schmidt
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et al., 2016), the interaction of Ski7 with the ribosome was not defined. It is also possible
that Ski7 interacts with unknown proteins that are involved in nonstop decay. To identify
the Ski7 interactome, I sought to utilize a proximity labeling assay called BioID, a
technique that enables labeling of interacting proteins by E. coli biotin ligase, which
could detect both stable and transient interactions (Roux et al., 2012). In chapter 5, I
presented a proof of concept for BioID that will be used in a future study.
In conclusion, I investigated the physiological function of the major mRNA
decapping proteins Dcp2 and the function Ski7 in nonstop decay, which are important
steps in post-transcriptional regulation. There are still many important questions that
needs to be addressed, which will be discussed in the following section. These future
directions would further improve our fundamental understanding of mRNA decay
mechanisms.

Suppression mechanism of dcp2∆ lethality
One limit to studying the defects caused by dcp2∆ and the mechanisms by which
the defects can be suppressed is that a dcp2∆ strain cannot be maintained without
suppressors and thus cannot be used. In chapter 3, I therefore used dcp2-7. One
drawback is that dcp2-7 has only a minor growth defect at the restrictive temperature
(Wilson et al., 2007) and the kap123 and tl(gag)g suppressors do not have a large effect
on growth of dcp2-7 (Figure 6.1). This may indicate that dcp2-7 maintains sufficient
function even at the restrictive temperature to support its essential function. Ideally,
future studies would use a different conditional allele, such as a different temperaturesensitive mutation or an auxin-induced degron approach, that more completely
represses the essential function. Such alleles are unknown at this time and one study
that used an auxin-induced degron reported residual growth in the presence of auxin
(Zhang et al., 2019). If a tightly controlled allele could be developed it would be useful for
future studies on Dcp2.
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Figure 6. 1. Growth of dcp2 mutants at the restrictive temperature.
Suppressor mutations, kap123∆ and tl(gag)g∆, do not have a significant impact on the
growth of dcp2-7. Cells were grown in YPD at restrictive temperature, 37˚C, and
OD600 was measured every 10 minutes for ~14 hours. Shown is the average OD from
three replicate cultures and their standard deviations, plotted on a log scale.
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Determine the status of the mRNA 5` cap in dcp2 and suppressor mutants
Dcp2 is the decapping enzyme that removes m7G from the 5` end of mRNA,
which leads to the subsequent degradation of the mRNA by a 5`-to-3` ribonuclease,
Xrn1. This process is an essential step of the 5`-to-3` mRNA decay pathway, and
perhaps the lethal phenotype of dcp2∆ is due to the disruption of this pathway. Thus, I
have hypothesized that other decapping enzymes may acquire activity directed to m7G
decapping in dcp2 suppressor mutants. However, an in vivo decapping assay shows
that the defect in the 5`-to-3` decay in dcp2 mutant is not rescued by suppressors
(Chapter 3). I thus excluded the possibility of the presence of decapping activity arising
from other decapping enzymes which could triggers bulk mRNA decay in 5`-to-3`
direction in the absence of Dcp2 as the mechanism of suppression. However, the in vivo
decapping assay I conducted has a limitation in that it could not distinguish different
types of cap structures. While Dcp2 removes m7GDP and leaves 5` monophosphate
mRNA which is degraded by Xrn1, other decapping enzymes like Dcs1 have decapping
activity that release m7GMP and generate mRNA with 5` diphosphate that cannot be
degraded by Xrn1. The status of 5` cap is important because i) 5` m7G cap is required for
efficient translation and ii) only 5` monophosphate mRNA is degraded by Xrn1. Thus, it
is possible that an alternative decapping enzyme removes the cap structure in such a
way that the mRNA is removed from the translatable pool, but not a substrate for further
decay by Xrn1. For example, while translation initiation factor eIF4E binds to m7G cap to
initiate translation, binding of eIF4E to cap analogs showed inhibitory effect on
translation (Niedzwiecka et al., 2002; Topisirovic et al., 2011). Additionally, a mutant
defective in methylation of 5` cap showed a defect in translation (Schwer et al., 2000)
Therefore, I propose additional experiments to further investigate the 5` cap status
and/or the exact 5` end of mRNA in the dcp2 mutant and suppressor strains.
First, a low-throughput assay such as primer extension can be exploited
(Muhlrad et al., 1995). Primer extension assay would precisely determine the 5` end of
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mRNA with nucleotide resolution, which tests not only the removal of m7G cap but also
nucleotide removal from the 5’ end of mRNA. Thus, primer extension can be used to
examine the 5` end of target mRNA in dcp2 and dcp2 suppressor mutants compared to
that of wild type.
Transcriptome-wide assays can also be used to examine the 5` end of mRNAs.
Parallel Analysis of RNA Ends (PARE) is well established to identify mRNAs that end
with a 5` monophosphate. I would expect these to be largely absent from dcp2 strains
with or without suppressors. Capped ends can be mapped by either by using the
reactivity of its diol (in CAGE-seq), or by using recombinant Dcp2 (neb.com) to convert
them to 5` monophosphate combined with PARE (C-PARE) (Nagarajan et al., 2019). To
detect possible alternative 5` ends in dcp2 strains, 5` OH mRNAs can be identified by
using E. coli RtcB (neb.com) to ligate adaptors specifically onto 5` OH ends, followed by
sequencing (Peach et al., 2015). mRNAs that have a diphosphate or triphosphate 5` end
are not as easily identifiable. One option may be to treat total RNA with recombinant
Dcp2 and Xrn1 (both neb.com) to remove capped and 5` monophosphate RNAs and
identify RNAs that are resistant. The RNAs that are resistant to this combination
treatment can be identified by RNA-seq.
Alternative genetic approaches could also be used to test whether an alternative
decapping enzyme is activated by the suppressor mutations. Such an alternative
decapping enzyme is predicted to be essential in the dcp2∆ kap123∆ tl(gag)g∆ strain,
but not in DCP2 strains. This could be tested in a directed manner for the small number
of alternative decapping enzymes or in an undirected synthetic lethal screen. My data
that ski2∆ is lethal when combined with dcp2∆ kap123∆ tl(gag)g∆ suggests that some
essential RNA decay is carried out by the cytoplasmic exosome in the suppressed
mutant, but does not completely rule out that alternative decapping enzymes also
become essential in the absence of dcp2∆.
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Further investigating the 5` cap status is important considering that I did not find
suppressor mutations in other decapping defective dcp2 mutants, including dcp2-7,
dcp2-N245-E153Q, and dcp2-N245-E198Q. RNA-seq data of these other dcp2 mutants
revealed that they do not possess a kap123 mutation like those I found in dcp1∆ and
dcp2∆ mutants (He et al., 2018; Wery et al., 2016). Previous research on these other
dcp2 alleles shows a severe decapping defect, using the same MFA2pG assay I used or
assaying steady state levels of several mRNAs (Dunckley and Parker, 1999; He and
Jacobson, 2015; He et al., 2018). However, dcp2-7 is a conditional mutant where some
residual decapping activity might occur even under restrictive conditions. More
importantly, Dcp2-E153Q and Dcp2-E198Q, two catalytic site mutants of Dcp2, are not
completely inactive even though they have been used as catalytically inactive mutants.
In vitro, both Dcp2-E153Q and Dcp2-E198Q produce m7GTP and m7GMP decapping
products in addition to m7GDP (Aglietti et al., 2013), indicating that they may produce 5`
hydroxylated or 5` diphosphate Xrn1-resistant mRNAs in vivo. It is likely that the
presence of 5` cap other than m7G makes such mRNAs translation incompetent, which is
sufficient to suppress the lethality caused by Dcp2-mediated m7G decapping defect in
these dcp2 mutants.

Determine if suppressors regulate transcription in the dcp2 mutant
Dcp2 and Xrn1 are generally considered as cytoplasmic proteins (Huh et al.,
2003) involved in cytoplasmic mRNA decay (Parker, 2012). In addition, several studies
recently have shown that cytoplasmic mRNA decay factors including Dcp2 affect
transcription by degrading non-coding RNAs and/or by shuttling back to the nucleus to
affect RNA polymerase II-mediated transcription (van Dijk et al., 2011; Geisler et al.,
2012; Haimovich et al., 2013). Interestingly, three of the evolved strains contain
mutations that may affect transcription (Chapter 3). RPO21 encodes the largest subunit
of RNA polymerase II, CSE2 encodes a subunit of the mediator complex, and SET1
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encodes a histone methyl transferase. Whether these mutations improve growth of the
dcp2∆ strain or are random irrelevant mutations remains to be determined. These
observations led me to consider a potential effect of dcp2∆ on transcription and
suppression mechanisms that involves transcriptional regulation. Although I have
performed RNA-seq analysis on dcp2 and dcp2 suppressor mutants to compare their
transcriptome, this method only reflects steady-state levels of RNA. Moreover, as shown
in chapter 3, the loss of functional Dcp2 results in global disturbance in transcriptome
where hundreds of genes are up- and down-regulated, suggesting indirect effects of the
decapping defect. Two major pathways for mRNA turnover seems to be unchanged in
the suppressor mutants compared to dcp2. Thus, I propose an experiment that can
examine transcriptional activity in the dcp2 mutants to determine if suppressors of dcp2∆
can regulate transcription. Chromatin immunoprecipitation of the RNA polymerase II
subunit combined with next generation sequencing (RNAP II ChIP-seq) can be utilized to
test transcriptional activity (Park, 2009; Sandoval et al., 2004). Unlike conventional total
RNA sequencing, RNAP II ChIP-seq reflects active transcription, and can be used to
determine transcriptional regulation by the dcp2 suppressors.

Determine the translational effect by the tRNA mutation in dcp2
Screening of dcp2∆ suppressors revealed that null mutants of tL(GAG)G
suppress the lethality of dcp2∆, and the GAG anticodon of tL(GAG)G plays a critical role
in this genetic interaction (Chapter 3 and 4). However, it is unclear how mutating this
particular tRNA and its anticodon contribute to restoring growth of dcp2∆. I proposed that
the loss of tL(GAG)G results in suboptimal translation of CUC/CUU codons in the dcp2
mutant, but low-throughput assays examining production of CUC/CUU reporter proteins
suggested that this is not the case (Chapter 4).
Another possibility is that the loss of tL(GAG)G promotes +1 programmed
frameshift to suppress the lethality of dcp2∆. It has been shown that +1 frame shift at
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CUU-AGG-C sequences in EST3 and ABP140 mRNAs occurs at a rate ~50% due to the
ribosomal slippage when the CUU codon is decoded by non-cognate tL(UAG) tRNA
(Farabaugh et al., 2006; Taliaferro and Farabaugh, 2007). In the absence of tL(GAG)G,
tL(UAG) tRNA has more chance to read CUU codon, which increases the rate of
ribosome frameshifting at these sequences. This effect is expected to occur at
programmed frameshift sites in EST3 or ABP140 but may also occur at unintended
sequences in similar context that have not been reported to induce ribosome
frameshifting.
The rationale for both hypotheses is that the suppression is mediated by the
absence of decoding of CUC/CUU codons by the cognate tL(GAG)G tRNA in the dcp2
mutants. Thus, I propose additional experiments to investigate the importance of the
GAG anticodon in decoding of CUC/CUU codons. Prolonged ribosome pausing (or
translational arrest) triggers quality control to resolve stalling and to degrade nascent
peptides, and this can be easily detected by the reduced steady-state levels of protein in
the cell. However, if the ribosome pausing in the absence of tL(GAG)G is transient, it
would be less likely to be detected through examining changes in steady-state level of
proteins. Based on the results from chapter 4, the tl(gag)g-mediated suppression of
dcp2∆ lethality seems to involve the latter. To investigate ribosome pausing (or delayed
elongation) in the absence of tL(GAG)G, ribosome profiling assays can be exploited
(Ingolia et al., 2009). If the loss of tL(GAG)G indeed causes transient ribosome pausing,
it is important to determine how such transient ribosome pausing suppresses the
lethality of dcp2∆. Unlike the permanent stalling of ribosomes which triggers degradation
of nascent peptides, transient ribosome pausing that slows down elongation should not
affect protein synthesis levels, but could alter proteostasis in a different manner. For
example, ribosome pausing could affect nascent peptides folding (Collart and Weiss,
2020; Komar et al., 1999). It is also possible that the loss of tL(GAG)G induces +1
programmed frameshift more frequently, which can be studied using the ribosome
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profiling assay as well. As mentioned above, two genes in S. cerevisiae, EST3 and
ABP140, are known to undergo programmed frameshift by tL(UAG)-mediated ribosome
slippage at CUU-AGG-C sequences (Farabaugh et al., 2006; Taliaferro and Farabaugh,
2007). Ribosome profiling could reveal aberrant frameshifting on other mRNAs under the
specific condition as well (e.g. Dcp2-deficient cells). Briefly, cells from wild type, dcp2,
tl(gag)g, and dcp2 tl(gag)g should be analyzed by ribosome profiling to provide
information about translation efficiency and rate or pausing at nucleotide resolution so
that it can be determined whether dcp2 has a defect in translation and how tl(gag)g
changes translation in dcp2.

Determine the mechanism of suppression by kap123 mutations
Null mutation of KAP123 is identified as a suppressor of dcp2∆ lethality in our
screen (Chapter 3). Kap123 is a b-karyopherin family protein that mediates the import of
proteins to the nucleus. Several proteins including histone proteins, ribosomal proteins,
and ribosome-associated proteins are known to be transported into the nucleus in
Kap123-dependent manner (Grosshans et al., 2001; Mosammaparast et al., 2002; Rout
et al., 1997). KAP123 is not essential and the loss of Kap123 can be compensated by
another karyopherin Kap121, the paralog of Kap123 (Chook and Süel, 2011). However,
the deletion of KAP123 restores growth and RNA homeostasis in dcp2 mutant even in
the presence of other importin proteins (Chapter 3). These results show the genetic
interaction between KAP123 and DCP2 and suggest that the interaction with DCP2 is
specific to KAP123, but not to other importins.
A possible mechanism of suppression of dcp2∆ lethality by mutations in KAP123
is changes in subcellular localization of proteins of which nuclear localization is
(primarily) mediated by Kap123. To test this hypothesis, I propose an experiment that
examines changes in distribution of proteins in different cellular compartments. Mass
spectrometry analysis on proteins in fractionated cellular compartments (nucleus vs.
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cytoplasm) can be done in wild-type, dcp2, and dcp2 kap123 strains. While changes in
localization of known cargos of Kap123 can be directly tested, I would expect that there
might be proteins that are not identified as a Kap123 cargo yet and changes in
localization of these proteins are involved in the suppression of dcp2∆ lethality. Thus,
instead of low throughput approach, high throughput approach would be desirable.
Although I did not find any mutations in other importin genes including KAP121 via
suppressor screen, kap121 mutant can be also included in this proteomic analysis. In
the absence of Kap123, the availability of Kap121 for the transport of proteins might
decrease. It is possible that transport of cargo is not completely abrogated but is partially
affected in the absence of Kap123. Identification of proteins of which nuclear localization
is affected by dcp2 and restored with kap123 would provide information for the
mechanism of kap123-mediated suppression of dcp2∆ lethality.

Nonstop decay in S. cerevisiae
Determine the distinct role of Ski7 and the Ski complex in nonstop decay
Both Ski7 and the Ski complex are cofactors of the cytoplasmic RNA exosome,
where Ski7 bridges the RNA exosome and Ski complex through its N-terminal domain.
In S. cerevisiae, the C-terminal domain of Ski7 is specifically required for nonstop decay.
The human homolog of Ski7, HBS1LV3, has been shown to interact with the RNA
exosome and the Ski complex (Kalisiak et al., 2017; Kowalinski et al., 2016; Marshall et
al., 2018), while whether HBS1LV3 is involved in the nonstop decay is not clear. Unlike
S. cerevisiae Ski7, the C-terminal GTPase domain is missing in HBS1LV3. While the
RNA exosome and the Ski complex are conserved, a lack of conservation on GTPase
domain implies the possibility that the nonstop decay specific function of (the C-terminal
domain of) Ski7 is limited to budding yeast. The Ski complex that is composed of Ski2,
Ski3, and two Ski8 proteins has been shown to interact with the 80S ribosome (Schmidt
et al., 2016). In the same study, Ski7 has not been shown to interact with the ribosome.
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The results presented in chapter 5 imply distinct roles of Ski7 and the Ski
complex in nonstop decay. The size of Protein A-nonstop protein that accumulates upon
the loss of SKI2 is larger than that of SKI7 in SDS-PAGE. This difference is possibly due
to the difference in translation of the poly(A) tail in the absence of Ski7 or Ski2. However,
it has been a challenge to investigate the translation and stalling of ribosome at poly(A)
tail through conventional methods such as sequencing of ribosome protected fragment
because of the repetitive A sequences hindering the proper analysis of results. Whether
the ribosome translates the entire poly(A) tail and then stalls at the 3` extremity and how
the leading ribosome is dissociated are not clear. I estimated the size difference to be
about 3kDa, which is too small for mono-ubiquitination (8.6 kDa). The addition of 20
lysine residues would add approximately 3 KDa. This would require translation of most
of the poly(A) tail, but the added charge of poly-Lys could also cause anomalous
migration. One possibility is that the larger protein is generated by the leading ribosome,
and the smaller protein by collided ribosomes. Other possible explanations for the 3kDa
size shift include a difference in CAT-tailing, or the presence of a remnant of the last
tRNA. I propose a biochemical assay to distinguish between these possibilities and how
it is differentially regulated by Ski2 and Ski7. As shown in Figure 6.2, a nonstop mRNA
encoding the N-terminal 6X His tag and TEV protease site at the C-terminal region can
be generated. Purification of His tagged nonstop protein followed by elution by TEV
protease cleavage will purify the C-terminal fragment of the nonstop protein. This protein
can be sequenced by Edman degradation or analyzed by mass-spec. This would
provide information if poly(A) tail is translated or whether the protein is otherwise
modified. It would determine how far the ribosome translates the poly(A) tail while
overcoming electrostatic interaction between poly-Lys of nascent peptides and the
ribosome exit tunnel, and if Ski2 or Ski7 has a role in this process.

165

Figure 6. 2. A schematic for determining translation of poly(A) tail in nonstop
mRNA.
A plasmid encoding 6X-His-GFP-nonstop followed by TEV cleavage site is shown at
the top. Translation of this construct would produce His tagged nonstop GFP protein
with TEV site and the unknown number of poly lysine residues at the C-terminus. This
nonstop protein is purified by using Ni2+-NTA. Treatment of bound proteins with TEV
protease would cleave off the C-terminal fragment of nonstop protein, which can then
be sequenced by Edman degradation.
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Figure 6. 3.TID tagged Ski7 is functional in nonstop decay.
(A) his3-nonstop growth assay shows that Ski7-TID-3X HA complements ski7∆ in
nonstop decay as Ski7-3X HA does. In contrast, Ski7∆226-TID-3X HA and Ski7∆265TID-3X HA cannot complement despite the expression of proteins. (B) Western blot
shows the expression of TID tagged Ski7 proteins (#). Pgk1 is used as a loading
control.

167

Investigate nonstop decay specific role of the C-terminal domain Ski7
As shown in chapter 5, I have attempted to investigate the Ski7 interactome to
reveal the nonstop decay specific role of the C-terminal domain of Ski7 using BioID.
However, the activity of S. cerevisiae biotin ligase Bpl1 resulted in strong background
signal that masks biotinylation of Ski7 interacting proteins by BirA*. To increase the
specific biotinylation of Ski7 interacting proteins, I decided to use TurboID (TID) (Branon
et al., 2018). I made a full-length Ski7-TID-3X HA fusion construct and confirmed that
this fusion protein is fully functional in nonstop decay (Figure 6.3). In contrast, ski7∆226TID-3X HA and ski7∆265-TID-3X HA are defective in nonstop decay as expected.
ski7∆213-TID-3X HA was not stably expressed. In the future, bpl1-ts, a temperaturesensitive mutant of BPL1, can be used to reduce the background biotinylation signals
and TID construct to increase specific biotinylation for identifying Ski7 interacting
proteins. This should identify proteins that interact with the C-terminal domain of Ski7 or
whose interaction is dependent on the C-terminal domain. Briefly, the blp1-ts strain that
expresses TID alone, SKI7-TID-3X HA, ski7∆226-TID-3X HA, or ski7∆265-TID-3X HA
should be exposed to restrictive temperature to inactivate Blp1 followed by addition of
biotin to media. After biotin labeling, cells should be lysed, and biotin pull-down should
be conducted using streptavidin beads. Specific biotinylation could be tested by western
blot probing TID-fused proteins as it has been shown that TID biotinylates the protein
that is fused to it. Upon confirmation of successful biotinylation, samples should be
analyzed by mass spectrometry to identify biotinylated proteins, which are potential
interacting proteins. Proteins identified as strong interactors in mass spectrometry could
be individually tested to validate the results and further analyses should investigate their
functions in nonstop decay. Results from this study would lay a foundation for future
studies that will lead to determining the nonstop decay-exclusive function of Ski7.
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